Bei grossen Gesetzen wie OR und ZGB kann dies bis zu 30 Sekunden dauern

Title 4 Existing Exposure Situations

Chapter 1 Principles

Art. 148  

1For ex­ist­ing ex­pos­ure situ­ations, a ref­er­ence level of 1 mSv per cal­en­dar year ap­plies. This is without pre­ju­dice to the radon ref­er­ence level spe­cified in Art­icle 155 and the threshold level spe­cified in Art­icle 156.

2 The FOPH may re­com­mend to the Fed­er­al Coun­cil, in in­di­vidu­al cases, ref­er­ence levels of up to 20 mSv per cal­en­dar year, in par­tic­u­lar if meas­ures are re­quired in ac­cord­ance with Art­icle 171.

Chapter 2 Radiological Legacies

Section 1 Definition

Art. 149  

Ra­di­olo­gic­al legacies means:

a.
art­icles from past activ­it­ies con­tain­ing ra­di­o­nuc­lides which would be clas­si­fied as ra­dio­act­ive ma­ter­i­al un­der this Or­din­ance;
b.
art­icles whose type li­cence for gen­er­al or re­stric­ted use in ac­cord­ance with Art­icle 29 let­ter c of the RPA has ex­pired and is not re­newed;
c.
prop­er­ties con­tam­in­ated from past activ­it­ies where the re­quire­ments spe­cified in this Or­din­ance are not met.

Section 2 Articles

Art. 150  

1The FOPH is re­spons­ible for the dis­pos­al of ra­di­olo­gic­al legacies in the form of art­icles. This dis­pos­al is gov­erned in oth­er re­spects by Art­icles 108–121.

2 Fur­ther use of these art­icles is per­miss­ible if a li­cence has been gran­ted to this ef­fect.

Section 3 Properties

Art. 151 Inventory of properties with possible contamination  

1The FOPH shall main­tain an in­vent­ory of pos­sibly con­tam­in­ated prop­er­ties and shall pro­cess the fol­low­ing data to this end:

a.
de­tails of the prop­erty (geo­graph­ic­al co­ordin­ates, plot num­ber, build­ing and sub­strate);
b.
de­tails of earli­er activ­it­ies on the prop­erty, in­clud­ing the peri­od;
c.
in­vest­ig­a­tion data;
d.
data on the own­er and the user of the prop­erty (name, ad­dress, post­code, place);
e.
re­medi­ation de­cision;
f.
re­medi­ation data and res­ults of clear­ance meas­ure­ments after re­medi­ation, in­clud­ing any re­stric­tions.

2 To ful­fil the re­spons­ib­il­it­ies as­signed to them, the staff of the FOPH Ra­di­olo­gic­al Pro­tec­tion Di­vi­sion shall have elec­tron­ic ac­cess to the in­vent­ory data.

3 The FOPH shall reg­u­larly in­form Suva and the can­tons con­cerned as to the status of the in­vent­ory.

Art. 152 Investigation of properties  

1 The FOPH shall or­der an in­vest­ig­a­tion of prop­er­ties as spe­cified in Art­icle 151 if a risk to people and the en­vir­on­ment from ion­ising ra­di­ation can­not be ruled out. It shall in­form in ad­vance the can­ton and the com­mune con­cerned.

2 The own­ers and users are re­quired to grant the FOPH ac­cess to the prop­er­ties con­cerned for the in­vest­ig­a­tion.

3 The FOPH shall spe­cify the in­vest­ig­a­tion pro­ced­ure.

4 It shall carry out the in­vest­ig­a­tions. It may re­quest third parties to carry out the in­vest­ig­a­tions.

Art. 153 Remediation of properties  

1 On the basis of the in­vest­ig­a­tion, the FOPH shall es­tim­ate the ef­fect­ive dose to per­sons who may be present in the build­ing.

2 The FOPH shall in­form the per­sons con­cerned, the own­er and user of the prop­erty, and the can­ton and com­mune con­cerned as to the res­ults of the in­vest­ig­a­tion.

3 If the dose is above the ref­er­ence level as spe­cified in Art­icle 148 para­graph 1, the FOPH shall de­clare the prop­erty to be in need of re­medi­ation and shall in­form the own­er ac­cord­ingly.

Art. 154 Exchange of information  

1 The FOPH shall in­form the can­tons con­cerned as to pos­sible ra­di­olo­gic­al legacies.

2 The can­tons shall in­form the FOPH of planned stud­ies, mon­it­or­ing meas­ures and re­medi­ations of con­tam­in­ated sites if there is an in­creased like­li­hood that ra­di­olo­gic­al legacies are present. This is the case in par­tic­u­lar if ra­di­um-con­tain­ing lu­min­ous paint was used by in­dustry.

Chapter 3 Radon

Section 1 General Provisions

Art. 155 Radon reference level  

1 The radon ref­er­ence level is the radon gas con­cen­tra­tion which, if ex­ceeded, re­quires meas­ures to be taken in ac­cord­ance with Art­icle 166.

2 For the an­nu­al av­er­age radon gas con­cen­tra­tion in rooms where per­sons are reg­u­larly present for sev­er­al hours per day, a radon ref­er­ence level of 300 Bq/m3 ap­plies. This is without pre­ju­dice to the pro­vi­sions of Art­icle 156.

Art. 156 Threshold level at radon-exposed workplaces  

1 The threshold level at radon-ex­posed work­places is the radon gas con­cen­tra­tion which, if ex­ceeded, re­quires meas­ures to be taken in ac­cord­ance with Art­icle 167.

2 For the an­nu­al av­er­age radon gas con­cen­tra­tion at radon-ex­posed work­places, a threshold level of 1000 Bq/m3 ap­plies.

3Work­places at which the threshold level is cer­tainly or pre­sum­ably ex­ceeded are con­sidered to be radon-ex­posed. These are, in par­tic­u­lar, work­places in un­der­ground struc­tures, mines, cav­erns and wa­ter sup­ply in­stall­a­tions, as well as those clas­si­fied as radon-ex­posed by the su­per­vis­ory au­thor­ity.

Art. 157 Radon Technical and Information Centre  

1 The FOPH shall op­er­ate a Radon Tech­nic­al and In­form­a­tion Centre.

2 The Centre shall carry out, in par­tic­u­lar, the fol­low­ing tasks:

reg­u­larly is­su­ing re­com­mend­a­tions on mit­ig­a­tion meas­ures and sup­port­ing the can­tons in im­ple­ment­a­tion;
pub­lish­ing the radon map in con­sulta­tion with the can­tons;
c.
provid­ing in­form­a­tion and ad­vice for the can­tons, build­ing own­ers, ten­ants, con­struc­tion pro­fes­sion­als and oth­er in­ter­ested groups;
d.
ad­vising per­sons con­cerned and in­ter­ested bod­ies on ap­pro­pri­ate mit­ig­a­tion meas­ures;
e.
reg­u­larly provid­ing the can­tons with an over­view of build­ings where meas­ure­ments have been con­duc­ted;
f.
ap­prov­ing and su­per­vising radon meas­ure­ment pro­viders in ac­cord­ance with Art­icle 159;
g.
es­tab­lish­ing the sci­entif­ic found­a­tions re­quired for the ap­plic­a­tion of radon mit­ig­a­tion meas­ures;
h.
reg­u­larly eval­u­at­ing the ef­fects of mit­ig­a­tion meas­ures and mak­ing the ne­ces­sary ad­just­ments.

3 The FOPH may re­quest third parties to provide ad­vice in ac­cord­ance with para­graph 2 let­ter d.

Art. 158 Responsibility  

The fol­low­ing are re­spons­ible for the en­force­ment of radon mit­ig­a­tion meas­ures:

a.
in rooms where per­sons are reg­u­larly present for sev­er­al hours per day (Art. 155 para. 2):
1.
the can­tons,
2.
in the case of mil­it­ary build­ings: the DDPS;
b.
at radon-ex­posed work­places as spe­cified in Art­icle 156: the su­per­vis­ory au­thor­it­ies.
Art. 159 Approval of radon measurement providers  

1 Radon meas­ure­ments must be con­duc­ted by an ap­proved radon meas­ure­ment pro­vider in ac­cord­ance with pre­scribed meas­ure­ment pro­to­cols.

2 The FOPH shall ap­prove a radon meas­ure­ment pro­vider if it:

a.
has the spe­cial­ist staff and meas­ure­ment sys­tem re­quired for due ful­fil­ment of its re­spons­ib­il­it­ies; and
b.
can as­sure prop­er ful­fil­ment of its re­spons­ib­il­it­ies, and in par­tic­u­lar if no con­flicts of in­terest ex­ist.

3 The FOPH shall grant ap­prov­al for a max­im­um peri­od of five years.

4 The FD­JP shall spe­cify the tech­nic­al re­quire­ments for meas­ure­ment sys­tems and the meth­ods for main­ten­ance of meas­ure­ment sta­bil­ity.

Art. 160 Duties of radon measurement providers  

Ap­proved radon meas­ure­ment pro­viders are re­quired:

a.
to com­ply with the pre­scribed meas­ure­ment pro­to­cols;
b.
to enter their data in the radon data­base with­in two months after the com­ple­tion of meas­ure­ments.
Art. 161 Radon consultants  

1 Radon con­sult­ants shall sup­port and ad­vise cli­ents, con­struc­tion pro­fes­sion­als, build­ing own­ers and oth­er in­ter­ested parties on the im­ple­ment­a­tion of pre­vent­ive and re­medi­al meas­ures for radon mit­ig­a­tion ac­cord­ing to the state of the art.

2The FOPH shall main­tain a list in which radon con­sult­ants work­ing in Switzer­land who have un­der­gone train­ing and con­tinu­ing edu­ca­tion in ac­cord­ance with Art­icle 183 let­ter c are in­cluded on re­quest. It shall pub­lish the list54 and reg­u­larly up­date it.

54 The list may be con­sul­ted free of charge on the FOPH web­site at www.bag.ad­min.ch > Top­ics > People & health > Ra­di­ation, ra­dio­activ­ity & sound > Radon > Ad­vice by radon con­sult­ants.

Art. 162 Radon database  

1 The FOPH shall main­tain a cent­ral radon data­base. In this data­base, it shall store the data which is re­quired to al­low con­tinu­ous as­sess­ment of the im­ple­ment­a­tion of meas­ure­ments and re­medi­ation pro­jects and to draw stat­ist­ic­al and sci­entif­ic con­clu­sions.

2 The fol­low­ing data on in­di­vidu­al build­ings shall be stored in the cent­ral radon data­base:

a.
loc­a­tion (co­ordin­ates, plot num­ber);
b.
Swiss fed­er­al build­ing iden­ti­fi­er (EGID) and dwell­ing iden­ti­fi­er (EWID) in ac­cord­ance with the Or­din­ance of 31 May 200055 on the Fed­er­al Re­gister of Build­ings and Dwell­ings;
c.
in­form­a­tion on the premises;
d.
meas­ure­ment data;
e.
re­medi­ation data;
f.
own­er and user (name, ad­dress, post­code, place);
g.
year of con­struc­tion.

3 The staff of the FOPH Radon Tech­nic­al and In­form­a­tion Centre are en­titled to pro­cess the data in the data­base.

4 To ful­fil the re­spons­ib­il­it­ies as­signed to them, the fol­low­ing shall have elec­tron­ic ac­cess to data in the data­base as spe­cified be­low:

a.
the ap­proved radon meas­ure­ment pro­viders: to the data which they have col­lec­ted them­selves;
b.
the can­tons: to all data col­lec­ted on their ter­rit­ory;
c.
Suva: to all data col­lec­ted at work­places.

5 The FOPH may, on the basis of a data pro­tec­tion agree­ment, make avail­able to third parties data from the radon data­base for re­search pur­poses sub­ject to the fol­low­ing re­quire­ments and con­di­tions:

a.
The data shall be an­onymised as soon as the pur­pose of pro­cessing per­mits.
b.
The data shall not be trans­ferred.
c.
If the res­ults are pub­lished, this must be done in a com­pletely an­onymised form.

55 [AS 2000 1555, 2004 3367, 2005 3381, 2007 33996719An­nex No 7, 20124707. AS 2017 3459An­nex No 2 I]. See Now the O of 9 June 2017 (RS 431.841).

Section 2 Preventive Mitigation Measures and Radon Measurements

Art. 163 Radon mitigation in new buildings and building alterations  

1 In the course of the per­mis­sion pro­ced­ure for new build­ings and build­ing al­ter­a­tions, the build­ing per­mis­sion au­thor­ity shall, where ap­pro­pri­ate, draw the at­ten­tion of the build­ing own­er or, in the case of new build­ings, the cli­ent to the re­quire­ments of this Or­din­ance con­cern­ing radon mit­ig­a­tion.

2The build­ing own­er or, in the case of new build­ings, the cli­ent shall en­sure that pre­vent­ive struc­tur­al meas­ures are taken in ac­cord­ance with the state of the art to achieve a radon gas con­cen­tra­tion be­low the ref­er­ence level spe­cified in Art­icle 155 para­graph 2. If the cur­rent state of sci­ence and tech­no­logy so re­quires, a radon meas­ure­ment must be con­duc­ted in ac­cord­ance with Art­icle 159 para­graph 1.

Art. 164 Cantonal radon measurements  

1 The can­ton may re­quire the build­ing own­er to have radon meas­ure­ments con­duc­ted in rooms where per­sons are reg­u­larly present for sev­er­al hours per day.

2 The can­ton shall en­sure that radon meas­ure­ments are con­duc­ted in schools and nurs­ery schools in ac­cord­ance with Art­icle 159 para­graph 1.

3 The can­ton may con­duct fur­ther radon meas­ure­ments.

4In the case of mil­it­ary build­ings, the DDPS is re­spons­ible for or­der­ing radon meas­ure­ments.

Art. 165 Radon measurements at radon-exposed workplaces  

1En­ter­prises with radon-ex­posed work­places shall en­sure that meas­ure­ments are con­duc­ted by an ap­proved radon meas­ure­ment pro­vider in ac­cord­ance with Art­icle 159 para­graph 1.

2 The su­per­vis­ory au­thor­ity may con­duct spot-check meas­ure­ments at radon-ex­posed work­places.

Section 3 Measures to Reduce Radon Exposure

Art. 166 Radon remediation  

1 If the ref­er­ence level spe­cified in Art­icle 155 para­graph 2 is ex­ceeded, the build­ing own­er shall take the ne­ces­sary re­medi­al meas­ures. Re­com­mend­a­tions con­cern­ing the ur­gency of re­medi­al meas­ures shall be provided by the FOPH and the can­tons.

2 If the build­ing own­er fails to take ac­tion, the can­ton may or­der radon re­medi­ation.

3If it is de­term­ined that the ref­er­ence level is ex­ceeded at a school or nurs­ery school, the can­ton shall or­der radon re­medi­ation with­in three years after the time of de­term­in­a­tion.

4The costs of re­medi­ation shall be borne by the build­ing own­er.

Art. 167 Workplace measures  

1 If the threshold level spe­cified in Art­icle 156 is ex­ceeded, the en­ter­prise must de­term­ine the an­nu­al radon-re­lated ef­fect­ive dose to ex­posed per­sons and re­view this at least every five years.

2 If the ef­fect­ive dose to a per­son at the work­place is above 10 mSv per cal­en­dar year, the en­ter­prise shall take or­gan­isa­tion­al or tech­nic­al meas­ures to re­duce the dose as rap­idly as pos­sible.

3 If, in spite of meas­ures be­ing taken, the ef­fect­ive dose to a per­son at the work­place is above 10 mSv per cal­en­dar year, this per­son is con­sidered to be oc­cu­pa­tion­ally ex­posed.

4 The FDHA, after a hear­ing with Suva, shall spe­cify how the an­nu­al radon-re­lated ef­fect­ive dose is to be de­term­ined.

Chapter 4 Naturally Occurring Radioactive Material (NORM)

Art. 168 Industrial sectors concerned  

1 In­dus­tri­al sec­tors in­volving NORM are, in par­tic­u­lar:

a.
ground­wa­ter fil­tra­tion fa­cil­it­ies;
b.
gas pro­duc­tion;
c.
geo­therm­al en­ergy pro­duc­tion (deep geo­therm­al en­ergy);
d.
zir­con and zir­coni­um in­dustry;
e.
ce­ment pro­duc­tion and main­ten­ance of clinker ovens;
f.
main­ten­ance and re­mov­al of heat-res­ist­ant zir­coni­um al­loy clad­ding;
g.
tun­nel­ling in rock form­a­tions with el­ev­ated urani­um or thori­um con­cen­tra­tions.

2 In in­dus­tri­al sec­tors in­volving NORM, en­ter­prises shall de­term­ine by means of rep­res­ent­at­ive meas­ure­ments wheth­er:

a.
the NORM clear­ance lim­it is ex­ceeded in dis­charged ma­ter­i­als;
b.
staff are oc­cu­pa­tion­ally ex­posed per­sons as defined in Art­icle 51 para­graphs 1 and 2;
c.
the hand­ling of NORM may lead to a dose for mem­bers of the pub­lic which is not neg­li­gible from a ra­di­olo­gic­al pro­tec­tion point of view.

3 The en­ter­prises shall sub­mit evid­ence of the tests con­duc­ted in ac­cord­ance with para­graph 2 and the res­ults there­of to the FOPH.

4 The FOPH shall sup­port the en­ter­prises in the de­term­in­a­tion of the situ­ations spe­cified in para­graph 2 let­ters b and c.

5In in­dus­tri­al sec­tors in­volving NORM, the FOPH and Suva may con­duct spot-check meas­ure­ments.

Art. 169 Discharge of NORM to the environment  

1 NORM with a spe­cif­ic activ­ity above the rel­ev­ant NORM clear­ance lim­it may, with the ap­prov­al of the li­cens­ing au­thor­ity, be dis­charged to the en­vir­on­ment if:

a.
dis­pos­al via the usu­al chan­nels would be im­possible or would in­volve dis­pro­por­tion­ate ef­fort; and
b.
as a res­ult of ap­pro­pri­ate meas­ures, the ef­fect­ive dose to mem­bers of the pub­lic arising from the dis­charge re­mains be­low 0.3 mSv per cal­en­dar year.

2 The FOPH shall mon­it­or com­pli­ance with the per­miss­ible ef­fect­ive dose via the sampling and meas­ure­ment pro­gramme spe­cified in Art­icle 193.

3 NORM may only be ex­por­ted for dis­charge to the en­vir­on­ment if con­sent has been gran­ted by the com­pet­ent au­thor­ity of the re­cip­i­ent coun­try and the re­quire­ments spe­cified in para­graph 1 are com­plied with.

Art.170 Building materials  

1For build­ing ma­ter­i­als iden­ti­fied as be­ing of con­cern from a ra­di­olo­gic­al pro­tec­tion point of view, the FOPH shall, to de­term­ine pub­lic ex­pos­ure, es­tab­lish by means of spot checks wheth­er the activ­ity con­cen­tra­tion in­dex is great­er than 1.

2 If the activ­ity con­cen­tra­tion in­dex is great­er than 1, the FOPH shall carry out a dose es­tim­a­tion to en­sure that the ref­er­ence level spe­cified in Art­icle 148 is com­plied with.

3 The FOPH shall in­form the pub­lic of the res­ults.

Chapter 5 Long-Term Contamination following an Emergency

Art. 171  

The FOPH shall pre­pare the long-term fed­er­al and can­ton­al meas­ures for the man­age­ment of ef­fects after the trans­ition from an emer­gency ex­pos­ure situ­ation to an ex­ist­ing ex­pos­ure situ­ation in ac­cord­ance with Art­icle 141.

Title 5 Training and Continuing Education

Chapter 1 General Provisions

Art. 172 Persons who must undergo training and continuing education  

1The fol­low­ing per­sons must un­der­go ra­di­olo­gic­al pro­tec­tion train­ing and con­tinu­ing edu­ca­tion in line with their activ­it­ies and re­spons­ib­il­ity:

a.
per­sons who are in­volved in the hand­ling of ion­ising ra­di­ation, who may be ex­posed to it in the course of their spe­cif­ic activ­it­ies, or who plan or or­der the hand­ling there­of and, in the pro­cess, define ra­di­olo­gic­al pro­tec­tion meas­ures for self‑pro­tec­tion;
b.
per­sons who have ra­di­olo­gic­al pro­tec­tion re­spons­ib­il­it­ies vis-à-vis third parties;
c.
ra­di­olo­gic­al pro­tec­tion ex­perts;
d.
radon con­sult­ants as spe­cified in Art­icle 161 para­graph 1;
e.
per­sons who, in the case of a fail­ure or emer­gency, are in­volved in the hand­ling of ion­ising ra­di­ation, may be ex­posed to it, or plan or or­der the hand­ling there­of, or op­er­ate crit­ic­al in­fra­struc­ture or provide pub­lic ser­vices.

2The FDHA may, in con­sulta­tion with EN­SI and the DDPS, reg­u­late ex­emp­tions from man­dat­ory con­tinu­ing edu­ca­tion for the hand­ling of ion­ising ra­di­ation with a low haz­ard po­ten­tial.

Art. 173 Responsibility for training and continuing education  

1 The fol­low­ing are re­spons­ible for train­ing and con­tinu­ing edu­ca­tion:

a.
for per­sons spe­cified in Art­icle 172 para­graph 1 let­ters a–c: the li­cence hold­ers;
b.
for radon con­sult­ants as spe­cified in Art­icle 172 para­graph 1 let­ter d: these per­sons them­selves;
c.
for per­sons spe­cified in Art­icle 172 para­graph 1 let­ter e: the rel­ev­ant au­thor­it­ies, ad­min­is­trat­ive bod­ies, or­gan­isa­tions and un­der­tak­ings; they shall en­sure that, in ac­cord­ance with their size and struc­ture, an ad­equate num­ber of per­sons who have un­der­gone train­ing and con­tinu­ing edu­ca­tion is avail­able.

2 The parties re­spons­ible are re­quired to co­ordin­ate and doc­u­ment em­ploy­ees’ train­ing and con­tinu­ing edu­ca­tion activ­it­ies. The doc­u­ment­a­tion must be re­tained un­til the end of their em­ploy­ment at the en­ter­prise.

Art. 174 Training  

1 Per­sons spe­cified in Art­icle 172 para­graph 1 let­ters b–d who work in the med­ic­al, in­dus­tri­al and nuc­le­ar en­ergy sec­tors re­quire re­cog­nised ra­di­olo­gic­al pro­tec­tion train­ing in­clud­ing an ex­am­in­a­tion.

2The FDHA, in con­sulta­tion with EN­SI and the DDPS, shall de­term­ine which per­sons re­quire what train­ing.

3 The FDHA, in con­sulta­tion with EN­SI and the DDPS, shall spe­cify wheth­er the train­ing for per­sons spe­cified in Art­icle 172 para­graph 1 let­ters a and e re­quires re­cog­ni­tion.

Art. 175 Continuing education  

1 Con­tinu­ing edu­ca­tion is con­cerned with the know­ledge and skills already ac­quired in the course of train­ing. Con­tinu­ing edu­ca­tion must en­sure that skills, know­ledge and aware­ness of the state of the art and its ap­plic­a­tion in prac­tice are main­tained and brought up to date.

2 Per­sons sub­ject to man­dat­ory con­tinu­ing edu­ca­tion must un­der­go a course of con­tinu­ing edu­ca­tion at least every five years.

3 The FDHA, in con­sulta­tion with EN­SI and the DDPS, may, tak­ing in­to ac­count the haz­ard po­ten­tial:

a.
spe­cify short­er or longer in­ter­vals for con­tinu­ing edu­ca­tion courses;
b.
spe­cify that the con­tinu­ing edu­ca­tion must be re­cog­nised.
Art. 176 Training and continuing education courses  

1 The su­per­vis­ory au­thor­it­ies and the PSI shall con­duct train­ing and con­tinu­ing edu­ca­tion courses as re­quired.

2 The su­per­vis­ory au­thor­it­ies may re­quest oth­er agen­cies or in­sti­tu­tions to con­duct train­ing and con­tinu­ing edu­ca­tion courses.

3 The DDPS shall co­ordin­ate the train­ing and con­tinu­ing edu­ca­tion courses for per­sons who, in the case of an fail­ure or emer­gency, are in­volved in the hand­ling of ion­ising ra­di­ation, may be ex­posed to it, or plan or or­der the hand­ling there­of, or op­er­ate crit­ic­al in­fra­struc­ture or provide pub­lic ser­vices.

4 The su­per­vis­ory au­thor­it­ies and the DDPS may, with­in their area of re­spons­ib­il­ity, re­quire that the per­sons re­spons­ible for train­ing and con­tinu­ing edu­ca­tion in ac­cord­ance with Art­icle 173 re­port the date and the form, con­tent and ex­tent of train­ing and con­tinu­ing edu­ca­tion provided for per­sons sub­ject to man­dat­ory train­ing and con­tinu­ing edu­ca­tion.

Art. 177 Financial assistance  

1 With­in the lim­its of its ap­proved budget, the FOPH may provide fin­an­cial as­sist­ance for train­ing or con­tinu­ing edu­ca­tion courses in ra­di­olo­gic­al pro­tec­tion con­duc­ted by third parties, in par­tic­u­lar by schools, pro­fes­sion­al or­gan­isa­tions and in­dustry.

2 Fin­an­cial as­sist­ance shall only be provided if the train­ing or con­tinu­ing edu­ca­tion has been re­cog­nised by the su­per­vis­ory au­thor­ity.

3 Fin­an­cial as­sist­ance shall be cal­cu­lated so that, taken to­geth­er with oth­er rev­en­ues, it does not ex­ceed the course or­gan­iser’s doc­u­mented costs.

Art. 178 Recognition of individual training and continuing education  

The su­per­vis­ory au­thor­ity shall re­cog­nise as equi­val­ent in­di­vidu­al train­ing or con­tinu­ing edu­ca­tion which a per­son has re­ceived abroad or for a dif­fer­ent activ­ity if the ac­quired know­ledge and skills meet the re­quire­ments spe­cified in Chapter 2 of this Title.

Art. 179 Training and continuing education database  

1 The FOPH shall main­tain a train­ing and con­tinu­ing edu­ca­tion data­base, in which the fol­low­ing per­sons sub­ject to man­dat­ory train­ing and con­tinu­ing edu­ca­tion are re­gistered:

a.
per­sons who meet the re­quire­ments for be­ing able to serve as ra­di­olo­gic­al pro­tec­tion ex­perts;
b.
ra­di­olo­gic­al pro­tec­tion spe­cial­ists and ra­di­olo­gic­al pro­tec­tion tech­ni­cians as spe­cified in Art­icle 183 let­ter b;
c.
per­sons who re­quire re­cog­nised con­tinu­ing edu­ca­tion as spe­cified in Art­icle 182 or 183;
d.
radon con­sult­ants as spe­cified in Art­icle 161 para­graph 1.

2 The pur­pose of the data­base is:

a.
to make avail­able the in­form­a­tion re­quired for grant­ing li­cences on the oc­cu­pa­tion­al train­ing, re­cog­nised ra­di­olo­gic­al pro­tec­tion train­ing and con­tinu­ing edu­ca­tion of the per­son con­cerned;
b.
to sim­pli­fy the ad­min­is­trat­ive pro­ced­ures re­quired for grant­ing li­cences;
c.
to sim­pli­fy su­per­vi­sion by the au­thor­it­ies in the area of in­di­vidu­al train­ing and con­tinu­ing edu­ca­tion.

3 The fol­low­ing data con­cern­ing per­sons re­gistered in ac­cord­ance with para­graph 1 shall be stored in the data­base:

a.
name, former name, first name;
b.
date of birth;
c.
place of ori­gin (for for­eign na­tion­als: place of birth and na­tion­al­ity);
d.
oc­cu­pa­tion­al train­ing;
e.
type, ven­ue and date of ra­di­olo­gic­al pro­tec­tion train­ing courses;
f.
type, ven­ue and date of ra­di­olo­gic­al pro­tec­tion con­tinu­ing edu­ca­tion courses;
g.
for in­di­vidu­al train­ing and con­tinu­ing edu­ca­tion as spe­cified in Art­icle 178: date of re­cog­ni­tion of equi­val­ence.

4 The re­spons­ible staff of the su­per­vis­ory au­thor­it­ies are en­titled to pro­cess on­line the data of per­sons with­in their area of su­per­vi­sion.

5 Train­ing in­sti­tu­tions which of­fer re­cog­nised ra­di­olo­gic­al pro­tec­tion courses may re­cord and re­trieve on­line the data con­cern­ing per­sons who have com­pleted their train­ing or con­tinu­ing edu­ca­tion at the in­sti­tu­tion con­cerned. They may modi­fy data con­cern­ing such per­sons re­lat­ing to courses which they have con­duc­ted them­selves.

6 The FOPH shall en­able the per­sons con­cerned to ac­cess elec­tron­ic­ally their own data in the train­ing and con­tinu­ing edu­ca­tion data­base.

Art. 180 Recognition authorities  

1 The su­per­vis­ory au­thor­it­ies spe­cified in Art­icle 184 are re­spons­ible for the re­cog­ni­tion of train­ing and con­tinu­ing edu­ca­tion courses.

2 The Gen­er­al Sec­ret­ari­at of the DDPS (GS DDPS) is re­spons­ible for the re­cog­ni­tion of train­ing and con­tinu­ing edu­ca­tion courses for per­sons who ex­clus­ively in the case of an fail­ure or emer­gency are in­volved in the hand­ling of ion­ising ra­di­ation, may be ex­posed to it, or plan or or­der the hand­ling there­of, or op­er­ate crit­ic­al in­fra­struc­ture or provide pub­lic ser­vices.

3 In the event of un­cer­tainty con­cern­ing re­spons­ib­il­ity for re­cog­ni­tion, the FOPH, EN­SI, Suva and the GS DDPS shall con­sult each oth­er.

4 Train­ing and con­tinu­ing edu­ca­tion courses which are offered by a re­cog­ni­tion au­thor­ity must be re­cog­nised by a dif­fer­ent re­cog­ni­tion au­thor­ity.

5 The re­cog­ni­tion au­thor­it­ies spe­cified in para­graphs 1 and 2 are en­titled, in the course of their re­cog­ni­tion activ­it­ies, to mon­it­or the train­ing and con­tinu­ing edu­ca­tion re­quire­ments of per­sons con­cerned and to as­sess the qual­ity of train­ing and con­tinu­ing edu­ca­tion courses.

Chapter 2 Content of Regulation and Categories of Persons Subject to Mandatory Training and Continuing Education

Art. 181 Content of regulation in general  

1 The FDHA shall reg­u­late train­ing and con­tinu­ing edu­ca­tion. In par­tic­u­lar, it shall define:

a.
the ob­ject­ives, the re­quire­ments and the ex­tent of train­ing and con­tinu­ing edu­ca­tion in ra­di­olo­gic­al pro­tec­tion;
b.
the skills and know­ledge to be ac­quired by per­sons who must un­der­go train­ing and con­tinu­ing edu­ca­tion in ac­cord­ance with Art­icle 172;
c.
the train­ing and con­tinu­ing edu­ca­tion spe­cified in Art­icles 174–176, 178, 182 and 183 which re­quires re­cog­ni­tion;
d.
the re­quire­ments for re­cog­ni­tion of train­ing and con­tinu­ing edu­ca­tion as spe­cified in let­ter c;
e.
the con­tent of ex­am­in­a­tions and the ex­am­in­a­tion pro­ced­ure;
f.
the activ­it­ies per­miss­ible for per­sons with ra­di­olo­gic­al pro­tec­tion train­ing and con­tinu­ing edu­ca­tion which re­quires re­cog­ni­tion.

2 It shall reg­u­late train­ing and con­tinu­ing edu­ca­tion for per­sons in non-med­ic­al sec­tors, in con­sulta­tion with EN­SI and the DDPS.

Art. 182 Categories of persons subject to mandatory training and continuing education in the medical sector  

1 The re­quire­ments spe­cified by the FDHA for train­ing and con­tinu­ing edu­ca­tion in ra­di­olo­gic­al pro­tec­tion in the med­ic­al sec­tor shall be dif­fer­en­ti­ated ac­cord­ing to the fol­low­ing cat­egor­ies of per­sons re­spons­ible for ra­di­olo­gic­al pro­tec­tion for pa­tients or an­im­als:

a.
per­sons who pre­scribe dia­gnost­ic ap­plic­a­tions of ion­ising ra­di­ation in medi­cine and chiro­pract­ic;
b.
phys­i­cians who per­form thera­peut­ic or dia­gnost­ic med­ic­al pro­ced­ures in­volving ra­di­ation sources;
c.
dent­ists;
d.
chiro­pract­ors;
e.
veter­in­ari­ans;
f.
med­ic­al phys­i­cists;
g
ra­dio­phar­macists;
h.
med­ic­al ra­di­ation tech­no­lo­gists56 with a dip­loma from a pro­fes­sion­al edu­ca­tion in­sti­tu­tion (PEI) or a uni­versity of ap­plied sci­ences (UAS);
i.
med­ic­al prac­tice as­sist­ants with a fed­er­al cer­ti­fic­ate of pro­fi­ciency (CFC);
j.
oth­er med­ic­al per­son­nel;
k.
dent­al hy­gien­ists (PEI dip­loma);
l.
dent­al as­sist­ants (CFC);
m.
sur­gic­al tech­ni­cians (HF dip­loma) and qual­i­fied op­er­at­ing theatre nurses with a cer­ti­fic­ate of pro­fi­ciency from the Swiss Pro­fes­sion­al As­so­ci­ation for Nurses (ASI);
n.
veter­in­ary prac­tice as­sist­ants (CFC);
o.
per­sons who deal in, in­stall or main­tain med­ic­al X-ray sys­tems.

2 The fol­low­ing per­sons, if they have com­pleted ap­pro­pri­ate ra­di­olo­gic­al pro­tec­tion train­ing reg­u­lated by the FDHA and ful­fil their con­tinu­ing edu­ca­tion ob­lig­a­tions, meet the re­quire­ments for be­ing able to serve as ra­di­olo­gic­al pro­tec­tion ex­perts in their field of activ­ity:

phys­i­cians and chiro­pract­ors with an ap­pro­pri­ate Swiss spe­cial­ist title;
dent­ists and veter­in­ary sur­geons with an ap­pro­pri­ate Swiss de­gree;
med­ic­al phys­i­cists;
ra­dio­phar­macists;
e.
med­ic­al ra­di­ation tech­no­lo­gists57 (PEI, UAS).

56 Foot­note rel­ev­ant to Swiss lan­guage texts.

57 Foot­note rel­ev­ant to Swiss lan­guage texts.

Art. 183 Categories of persons subject to mandatory training and continuing education in non-medical sectors  

The re­quire­ments spe­cified by the FDHA, in con­sulta­tion with EN­SI and the DDPS, for train­ing and con­tinu­ing edu­ca­tion in ra­di­olo­gic­al pro­tec­tion in non-med­ic­al sec­tors shall be dif­fer­en­ti­ated ac­cord­ing to the fol­low­ing cat­egor­ies of per­sons:

a.
ra­di­olo­gic­al pro­tec­tion ex­perts and per­sons in the nuc­le­ar, in­dus­tri­al, com­mer­cial, teach­ing, trans­port and re­search sec­tors who are in­volved in the hand­ling of ion­ising ra­di­ation;
b.
ra­di­olo­gic­al pro­tec­tion spe­cial­ists, ra­di­olo­gic­al pro­tec­tion tech­ni­cians and ra­di­olo­gic­al pro­tec­tion of­ficers in nuc­le­ar in­stall­a­tions and at the PSI;
c.
radon con­sult­ants;
d.
per­sons who, in the case of an fail­ure or emer­gency, are in­volved in the hand­ling of ion­ising ra­di­ation, may be ex­posed to it, or plan or or­der the hand­ling there­of, or op­er­ate crit­ic­al in­fra­struc­ture or provide pub­lic ser­vices.

Title 6 Supervision, Enforcement and Advice

Chapter 1 Supervision

Art. 184 Supervisory authorities  

1 The FOPH, Suva and EN­SI are re­spons­ible for su­per­vi­sion in ac­cord­ance with this Or­din­ance.

2The FOPH shall su­per­vise those en­ter­prises which are not su­per­vised by Suva or EN­SI, in par­tic­u­lar:

a.
med­ic­al en­ter­prises;
b.
re­search and teach­ing es­tab­lish­ments.

3 EN­SI shall su­per­vise:

a.
nuc­le­ar in­stall­a­tions;
b.
geo­lo­gic­al in­vest­ig­a­tions as spe­cified in Art­icle 35 of the NEA58;
c.
the re­ceipt and ship­ment of ra­dio­act­ive sub­stances at or from nuc­le­ar in­stall­a­tions;
d.59
the de­cay stor­age of ra­dio­act­ive waste from nuc­le­ar in­stall­a­tions and all re­lated activ­it­ies.

4 Suva shall su­per­vise in­dus­tri­al and com­mer­cial en­ter­prises.

5 The su­per­vis­ory au­thor­it­ies shall co­ordin­ate en­force­ment and re­solve any un­cer­tain­ties re­gard­ing re­spons­ib­il­ity by mu­tu­al agree­ment. They shall meet reg­u­larly for this pur­pose.

58 SR 732.1

59 In­ser­ted by No II of the O of 7 Dec. 2018, in force since 1 Feb. 2019 (AS 2019 183).

Art. 185 Supervisory authorities’ archiving duties and duty to provide information  

1 The archiv­ing of doc­u­ments con­cern­ing the grant­ing and modi­fic­a­tion of li­cences and con­cern­ing su­per­vi­sion is gov­erned by the Archiv­ing Act of 26 June 199860.

2 The su­per­vis­ory au­thor­it­ies shall make the re­quired doc­u­ments avail­able to the li­cens­ing au­thor­it­ies at any time upon re­quest.

Art. 186 Research  

1 The su­per­vis­ory au­thor­it­ies may, by mu­tu­al agree­ment, com­mis­sion re­search pro­jects con­cern­ing the ef­fects of ra­di­ation and ra­di­olo­gic­al pro­tec­tion, or par­ti­cip­ate in such pro­jects.

2 The PSI, the Spiez Labor­at­ory and oth­er fed­er­al es­tab­lish­ments shall, as far as pos­sible, place them­selves at the dis­pos­al of the su­per­vis­ory au­thor­it­ies to carry out re­search pro­jects con­cern­ing the ef­fects of ra­di­ation and ra­di­olo­gic­al pro­tec­tion.

Chapter 2 Enforcement

Section 1 Monitoring

Art. 187 Principle  

The FOPH, Suva and EN­SI shall mon­it­or by means of spot checks, gradu­ated ac­cord­ing to the haz­ard po­ten­tial, wheth­er reg­u­la­tions are com­plied with and the pro­tec­tion of people and the en­vir­on­ment against dangers arising from ion­ising ra­di­ation is as­sured.

Art. 188 Cooperation duties  

1 All in­form­a­tion must be provided and all devices, art­icles and doc­u­ments re­quired for in­spec­tions must be made avail­able, at no cost, to the FOPH, Suva and EN­SI.

2 They must be gran­ted ac­cess to in­stall­a­tions, equip­ment and areas, in­so­far as this is ne­ces­sary for con­duct­ing in­spec­tions.

Art. 189 Engagement of third parties  

The FOPH may re­quest third parties to carry out in­spec­tions, in par­tic­u­lar:

a.
firms which con­duct qual­ity as­sur­ance of dia­gnost­ic equip­ment;
b.
ex­perts who co­ordin­ate, pre­pare and con­duct clin­ic­al audits.
Art. 190 Monitoring of import, export and transit  

1 In the course of im­port, ex­port and trans­it con­trols, the cus­toms of­fices shall check wheth­er a li­cence has been ob­tained for the trans­port of ra­dio­act­ive ma­ter­i­al.

2 If so re­ques­ted by the li­cens­ing au­thor­ity, they shall check wheth­er goods un­der­go­ing im­port, ex­port and trans­it com­ply with the pro­vi­sions of this Or­din­ance.

3 The FOPH shall or­gan­ise the con­duct of peri­od­ic tar­geted screen­ing of goods un­der­go­ing im­port, ex­port and trans­it and of per­sons en­ter­ing the coun­try; for this pur­pose, it shall con­sult in par­tic­u­lar the Dir­ect­or­ate Gen­er­al of Cus­toms.

4 It shall co­ordin­ate, in par­tic­u­lar with the Spiez Labor­at­ory, re­quire­ments for, and the pro­cure­ment and main­ten­ance of, the ne­ces­sary meas­ur­ing equip­ment and shall pre­pare de­ploy­ment in spe­cial situ­ations.

5 It is re­spons­ible for ap­prov­al of agree­ments con­cern­ing the pos­sible take-back of ex­por­ted ra­dio­act­ive waste as spe­cified in Art­icle 25 para­graph 3 let­ter d of the RPA.

6 The Dir­ect­or­ate Gen­er­al of Cus­toms, in con­sulta­tion with the li­cens­ing au­thor­it­ies, shall is­sue in­tern­al dir­ect­ives for mon­it­or­ing of the im­port, ex­port and trans­it of ra­dio­act­ive ma­ter­i­al.

7 The Swiss Fed­er­al Cus­toms Ad­min­is­tra­tion may, on re­quest, trans­fer data from cus­toms de­clar­a­tions to the li­cens­ing and su­per­vis­ory au­thor­it­ies.

Section 2 Monitoring of Ionising Radiation and Radioactivity in the Environment

Art. 191 Responsibilities  

1 The FOPH shall mon­it­or ion­ising ra­di­ation and ra­dio­activ­ity in the en­vir­on­ment.

2 EN­SI shall ad­di­tion­ally mon­it­or ion­ising ra­di­ation and ra­dio­activ­ity in the vi­cin­ity of nuc­le­ar in­stall­a­tions.

3 To as­sess pub­lic ex­pos­ure to ra­dio­activ­ity in the en­vir­on­ment, the FOPH shall carry out meas­ure­ments in ap­pro­pri­ate sampling me­dia such as air­borne par­tic­u­lates, wa­ter in­ten­ded for hu­man con­sump­tion, or food­stuffs. To this end, it may col­lab­or­ate with the can­tons.

4 To pro­tect the health of con­sumers, the can­tons shall mon­it­or ra­dio­activ­ity in food­stuffs and in art­icles of daily use.

5The FDHA, in con­sulta­tion with EN­SI and after a hear­ing with METAS, shall is­sue tech­nic­al pro­vi­sions for en­vir­on­ment­al do­si­metry.

Art. 192 Automatic network for monitoring radioactivity in Switzerland  

1 The FOPH shall op­er­ate an auto­mat­ic net­work for the gen­er­al mon­it­or­ing of ra­dio­activ­ity in the en­vir­on­ment. This net­work shall also meas­ure im­mis­sion levels in the vi­cin­ity of en­ter­prises which dis­charge ra­dio­act­ive sub­stances to the en­vir­on­ment or could dis­charge lar­ger quant­it­ies there­of.

2 The FOPH, in co­oper­a­tion with the com­pet­ent su­per­vis­ory au­thor­ity, shall spe­cify re­quire­ments for the mon­it­or­ing net­work with re­gard to mon­it­or­ing in the vi­cin­ity of en­ter­prises as spe­cified in para­graph 1.

3 En­ter­prises where a sub­stan­tial re­lease of ra­dio­activ­ity can­not be ruled out shall bear the costs of pur­chas­ing and op­er­at­ing those mon­it­or­ing sta­tions with­in the auto­mat­ic net­work which are used to mon­it­or ra­dio­activ­ity in their vi­cin­ity.

4The costs of pur­chas­ing equip­ment, ex­clud­ing plan­ning costs, are deemed to be ac­quis­i­tion costs. The costs of site rent­al, as­sur­ance of in­form­a­tion se­cur­ity, main­ten­ance and re­pair, and elec­tri­city are deemed to be op­er­at­ing costs.

5The FOPH shall charge the pre­vi­ous year’s costs for run­ning the rel­ev­ant mon­it­or­ing sta­tions an­nu­ally to the in­di­vidu­al en­ter­prises.

Art. 193 Sampling and measurement programme  

1 The FOPH, in co­oper­a­tion with EN­SI, Suva, the NEOC and the can­tons, shall pre­pare a sampling and meas­ure­ment pro­gramme for planned and for ex­ist­ing ex­pos­ure situ­ations.

2 For the im­ple­ment­a­tion of the sampling and meas­ure­ment pro­gramme, the fed­er­al labor­at­or­ies, in par­tic­u­lar the PSI, the Swiss Fed­er­al In­sti­tute of Aquat­ic Sci­ence and Tech­no­logy (Eawag) and the Spiez Labor­at­ory, are re­quired to co­oper­ate and to make avail­able at all times the ne­ces­sary hu­man and ma­ter­i­al re­sources.

3 Third parties may be en­gaged if needed to im­ple­ment the sampling and meas­ure­ment pro­gramme

Art. 194 Collection of data, radiological assessment and reporting  

1 EN­SI, Suva, the NEOC, the can­tons and the par­ti­cip­at­ing labor­at­or­ies shall make avail­able to the FOPH the mon­it­or­ing data gen­er­ated and in­ter­preted.

2 On the basis of the res­ults of the sampling and meas­ure­ment pro­gramme spe­cified in Art­icle 193, the FOPH shall as­sess the ra­di­olo­gic­al situ­ation. It shall cal­cu­late and as­sess the doses ac­cu­mu­lated by the pub­lic. This is without pre­ju­dice, in emer­gency ex­pos­ure situ­ations, to the pro­vi­sions of the CCMBO61.

3 The FOPH shall de­term­ine pub­lic ra­di­ation ex­pos­ure in ac­cord­ance with An­nexes 3–6.

4 It shall pre­pare and pub­lish an an­nu­al re­port on the mon­it­or­ing data and the res­ult­ant ra­di­ation doses to the pub­lic.

Art. 195 Investigation thresholds in environmental monitoring  

1 If con­cen­tra­tions of ar­ti­fi­cial ra­di­o­nuc­lides in the en­vir­on­ment are de­tec­ted which could lead to an ef­fect­ive dose of more than 10 µSv per year for a giv­en ex­pos­ure path­way and for mem­bers of the pub­lic, the FOPH shall seek to identi­fy the cause.

2 If the ra­di­o­nuc­lides were dis­charged by an en­ter­prise which has a li­cence, the FOPH shall in­form the su­per­vis­ory au­thor­ity con­cerned. Where pos­sible and ap­pro­pri­ate, this au­thor­ity shall re­quest the im­ple­ment­a­tion of op­tim­isa­tion meas­ures to re­duce the dis­charge.

3 If the ra­di­o­nuc­lides were dis­charged by an en­ter­prise which does not have a li­cence, if the ra­di­o­nuc­lides ori­gin­ated abroad, or if the cause is un­clear, the FOPH shall ap­pro­pri­ately sup­ple­ment its meas­ure­ment pro­gramme, if ne­ces­sary, and in­form the pub­lic.

Section 3 Further Enforcement Provisions

Art. 196 Provision of information on events of public interest  

The FOPH shall en­sure that the per­sons and can­tons con­cerned and the pub­lic are in­formed in a timely man­ner about events of pub­lic in­terest.

Art. 197 Monitoring of occupationally exposed aircrew  

The FO­CA shall su­per­vise air­craft op­er­at­ors with re­gard to the mon­it­or­ing of oc­cu­pa­tion­ally ex­posed air­crew.

Chapter 3 Federal Commission for Radiological Protection

Art. 198  

1 The KSR is a stand­ing ad­vis­ory com­mis­sion with­in the mean­ing of Art­icle 8a para­graph 2 of the GAOO62.

2 It shall ad­vise the Fed­er­al Coun­cil, the FDHA, the DE­TEC, the DDPS, EN­SI, in­ter­ested pub­lic of­fices and Suva on ra­di­olo­gic­al pro­tec­tion mat­ters. It has the fol­low­ing du­ties:

a.
reg­u­larly in­form­ing the pub­lic about the ra­di­olo­gic­al pro­tec­tion situ­ation in Switzer­land;
b.
provid­ing ad­vice on the fol­low­ing mat­ters in par­tic­u­lar:
1.
the in­ter­pret­a­tion and ap­prais­al of in­ter­na­tion­al re­com­mend­a­tions in the field of ra­di­olo­gic­al pro­tec­tion with re­gard to their ap­plic­a­tion in Switzer­land,
2.
the elab­or­a­tion and de­vel­op­ment of har­mon­ised prin­ciples for the ap­plic­a­tion of ra­di­olo­gic­al pro­tec­tion reg­u­la­tions,
3.
en­vir­on­ment­al ra­dio­activ­ity, the res­ults of mon­it­or­ing, their in­ter­pret­a­tion and the res­ult­ant ra­di­ation doses for the pub­lic;
c.
in col­lab­or­a­tion with the pro­fes­sion­al and sec­tor­al as­so­ci­ations con­cerned, pre­par­ing and pub­lish­ing re­com­mend­a­tions on the jus­ti­fic­a­tion of dia­gnost­ic or thera­peut­ic pro­ced­ures in ac­cord­ance with Art­icle 28 para­graphs 1 and 2;63
d
pre­par­ing re­ports and opin­ions on be­half of the Fed­er­al Coun­cil or the su­per­vis­ory au­thor­it­ies.

3 It is com­posed of ex­perts from aca­demia and in­dustry.

4 It shall col­lab­or­ate with the Fed­er­al Com­mis­sion for NBC Pro­tec­tion (Com­N­BC) and the Fed­er­al Nuc­le­ar Safety Com­mis­sion (NCS), deal­ing in par­tic­u­lar with joint re­spons­ib­il­it­ies in the field of ra­di­olo­gic­al pro­tec­tion.

5 The KSR and its com­mit­tees may en­gage ex­tern­al ex­perts for the ex­am­in­a­tion of spe­cial is­sues.

62 SR 172.010.1

63 www.ksr-cpr.ch

Title 7 Criminal Provisions

Art. 199  

1 In ac­cord­ance with Art­icle 44 para­graph 1 let­ter f of the RPA, an of­fence is com­mit­ted by any per­son who:

a.
without a li­cence, mixes ra­dio­act­ive with oth­er ma­ter­i­als so that the hand­ling there­of is not sub­ject to man­dat­ory li­cens­ing and su­per­vi­sion (Art. 107);
b.
per­forms an activ­ity which may in­volve an ion­ising ra­di­ation haz­ard without hav­ing the train­ing re­quired in ac­cord­ance with Art­icles 172–175;
c.
op­er­ates a per­son­al do­si­metry ser­vice without ap­prov­al (Art. 66);
d.
op­er­ates a per­son­al do­si­metry ser­vice and con­tra­venes the du­ties spe­cified in Art­icles 69–71;
e.
fails to in­clude in a cus­toms de­clar­a­tion the de­tails spe­cified in Art­icle 103, or fails to de­clare or know­ingly makes a false de­clar­a­tion in re­spect of ra­dio­act­ive goods.

2 Any per­son who wil­fully fails to as­sume re­spons­ib­il­it­ies im­posed in ac­cord­ance with Art­icle 20 para­graph 2 let­ter b of the RPA is li­able to a fine not ex­ceed­ing 20 000 Swiss francs.

Title 8 Final Provisions

Art. 200 Repeal of other legislation  

The Ra­di­olo­gic­al Pro­tec­tion Or­din­ance of 22 June 199464 is re­pealed.

64 [AS 1994 1947, 1995 4959No II 2, 1996 2129, 2000 1079342894, 2001 3294No II 7, 2005 601An­nex 7 No 3 2885 An­nex No 7, 2007 1469An­nex 4 No 44 5651, 2008 3153Art. 10 No 2 5747 An­nex No 22, 2010 5191Art. 20 No 4 5395 An­nex 2 No II 3, 2011 5227No I 2.7, 2012 7065No I 5 7157, 2013 3041No I 5 3407 An­nex 6 No 3]

Art. 201 Amendments to other legislation  

Amend­ments to oth­er le­gis­la­tion are dealt with in An­nex 11.

Art. 202 Transitional provisions  

1Li­cences gran­ted pri­or to the com­mence­ment of this Or­din­ance shall re­main val­id un­til their re­new­al or ex­piry. The du­ties arising from a li­cence are based on the pro­vi­sions of this Or­din­ance.

2Pro­ceed­ings which are pending when this Or­din­ance comes in­to force are sub­ject to the pro­vi­sions of this Or­din­ance.

3The lim­it for the equi­val­ent dose for the lens of the eye spe­cified in Art­icle 56 para­graph 3 let­ter a ap­plies from 1 Janu­ary 2019; be­fore that date, the lim­it spe­cified in cur­rent le­gis­la­tion ap­plies.

4 Art­icle 43 (Li­cence hold­ers’ self-eval­u­ation and qual­ity manu­al) must be im­ple­men­ted no later than two years after the com­mence­ment of this Or­din­ance.

5Any per­son who, when this Or­din­ance comes in­to force, holds a li­cence for a high‑activ­ity sealed source must:

a.
sub­mit to the li­cens­ing au­thor­ity, no later than two years after the com­mence­ment of this Or­din­ance, the in­form­a­tion spe­cified in Art­icle 97 for the pre­par­a­tion of the in­vent­ory;
b.
in­form the su­per­vis­ory au­thor­ity, no later than two years after the com­mence­ment of this Or­din­ance, what safety and se­cur­ity meas­ures have been defined in ac­cord­ance with Art­icle 99.

6Any per­son who, when this Or­din­ance comes in­to force, owns an en­ter­prise where there is an in­creased like­li­hood of orphan ra­dio­act­ive ma­ter­i­als be­ing en­countered must im­ple­ment the meas­ures spe­cified in Art­icle 104 no later than three years after the com­mence­ment of this Or­din­ance and ap­ply for a li­cence for the activ­ity.

7Ra­dio­act­ive waste which, when this Or­din­ance comes in­to force, is already in stor­age for de­cay as spe­cified in Art­icle 117 para­graph 2 may, after a new as­sess­ment on the basis of the new clear­ance lim­its, be stored for a max­im­um of an­oth­er 30 years. The as­sess­ment must be presen­ted to the su­per­vis­ory au­thor­ity no later than two years after the com­mence­ment of this Or­din­ance.

8The can­tons shall modi­fy the build­ing per­mis­sion pro­ced­ure with­in two years after the com­mence­ment of this Or­din­ance in such a way that it meets the re­quire­ments spe­cified in Art­icle 163 para­graph 1.

9Art­icle 171 (Long-term con­tam­in­a­tion fol­low­ing an emer­gency) does not ap­ply un­til three years after the com­mence­ment of this Or­din­ance.

Art. 203 Commencement  

This Or­din­ance comes in­to force on 1 Janu­ary 2018.

Annex 1

(Art. 2 para. 2 let. b)

Definitions of technical terms

Note

The terms are listed in alphabetical order.

Active personal dosimeter

Electronic personal dosimeter which provides a direct display of the accumulated dose as well as other dosimetric information, depending on the intended use.

Activity concentration index for building materials

The activity concentration index I is given by the following formula:

I = CRa226/300 Bq/kg + CTh232/200 Bq/kg+ CK40/3000 Bq/kg

where CRa226, CTh232 and CK40 are the activity concentrations in Bq/kg of the corresponding radionuclides in the building material.

Compact X-ray systems

X-ray systems with a tube voltage of up to 70 kV, a tube current of up to 15 milliamperes (mA) and a radiation field size of ≤ 6 cm diameter.

Diagnostic reference level

Dose level used for purposes of optimisation in diagnostic or interventional medical exposures, or activity level in the case of radiopharmaceuticals. Diagnostic reference levels are defined for typical examinations for groups of standard-sized patients or standard phantoms for broadly defined types of equipment.

Full protection system

Shielding of an installation or an irradiator, which ensures that useful, scattered and stray radiation is completely contained and shielded to such an extent that the ambient dose rate at a distance of 10 cm from the surface is reduced to less than 1 µSv per hour and that, at all accessible locations, the dose limits applicable for members of the public cannot be exceeded.

Interventional radiology

Diagnostic or therapeutic interventions performed under image guidance with ionising radiation. These also include interventions outside the field of radiology, e.g. in angiology, surgery, gastroenterology, cardiology, orthopaedics, pain therapy or urology.

Partial protection system

Shielding of an installation which ensures that, during operation, useful, scattered and stray radiation is completely contained, except for sample openings, and shielded to such an extent that the ambient dose rate at a distance of 10 cm from the surface is reduced to less than 1 µSv per hour and that, at all accessible locations, the dose limits applicable for members of the public cannot be exceeded.

Preparation of a radiopharmaceutical

Process in which the final radiopharmaceutical product is produced by following the radiolabelling instructions specified by the licence of a radiolabelling kit for diagnostic purposes.

Radiopharmaceuticals

Medicinal products containing radionuclides whose radiation is utilised for diagnosis or therapy. For the purposes of this Ordinance, the following are considered to be radiopharmaceuticals:

a.
pharmaceuticals which, when ready for use, contain one or more radionuclides to be used for a medicinal purpose;
b.
non-radioactive components (kits) used to prepare radiopharmaceuticals by reconstitution or combination with radionuclides immediately prior to use in humans;
c.
radionuclide generators incorporating a fixed parent radionuclide from which is produced a daughter radionuclide which is to be obtained by elution or by any other method and used to prepare a radiopharmaceutical;
d.
radionuclides used directly or as precursors for the radiolabelling of other substances (carrier compounds, cells, plasma proteins) prior to their administration.

Radon

The isotope radon-222.

Triage measurement

Procedure for detecting possible intakes without determining the effective dose. If a predefined threshold is exceeded, personal dosimetry must be performed to assess the committed effective dose.

Stray radiation sources

Equipment or devices in which only electrons are accelerated and which generate X‑rays without being operated for this purpose. Electron microscopes are also considered to be stray radiation sources.

Annex 2

(Art. 2 para. 1 let. k, 10 let. f, 168 para. 2 let. a and 169 para. 1)

NORM clearance limits

NORM Clearance limits for naturally occurring radionuclides in solid materials which are in full or partial secular equilibrium with their progeny:

Natural radionuclides from the U-238 series1 000 Bq/kg
Natural radionuclides from the Th-232 series1 000 Bq/kg
K-4010 000 Bq/kg

Annex 3 65

65 The correction of 24 April 2018 relates to the French text only (AS 2018 1653).

(Art. 2 para. 1 let. j, l and m and Art. 194 para. 3)

Data for operational radiological protection, clearance limits, licensing limits and guidance values

Explanatory notes on the individual columns and a list of footnotes are given at the end of the table.

Assessment quantities

Clearance limit

Licensing limit

Guidance values

Radionuclide

Half-life

Type of decay/
radiation

einh
Sv/Bq

eing
Sv/Bq

h10
(mSv/h)/ GBq at 1 m distance

h0,07
(mSv/h)/ GBq at 10 cm distance

hc,0,07
(mSv/h)/ (kBq/cm2)

LL
Bq/g

LA
Bq

CA
Bq/m3

CS
Bq/ cm2

Unstable daughter nuclide

1

2

3

4

5

6

7

8

9

10

11

12

13

H-3, OBT

12.32 a

β

4.10 E-11

4.20 E-11

<0.001

<1

<0.1

1.E+02

1.00 E+08

2.00 E+05

1000

H-3, HTO

β

1.80 E-11

1.80 E-11

<0.001

<1

<0.1

1.E+02

3.00 E+08

5.00 E+05

1000

H-3, gaz [7]

β

1.80 E-15

<0.001

<1

<0.1

3.00 E+12

5.00 E+09

Be-7

53.22 d

ec/ph

4.60 E-11

2.80 E-11

0.008

<1

0.1

1.E+01

1.00 E+08

2.00 E+05

100

Be-10

1.51 E6 a

β

1.90 E-08

1.10 E-09

<0.001

2000

1.6

1.E+02

3.00 E+05

4.00 E+02

3

C-11

20.39 min

ec, β+/ph

3.20 E-12

2.40 E-11

0.160

1000

1.7

1.E+01

[1]

7.00E+07

7.00 E+04

[3]

3

C-11 monoxide

1.2 E-12

7.00E+07

7.00 E+04

[3]

C-11 dioxide

2.2 E-12

7.00E+07

7.00 E+04

[3]

C-14

5.70 E3 a

β

5.80 E-10

5.80 E-10

<0.001

200

0.3

1.E+00

9.00E+06

1.00 E+04

30

C-14 monoxide

8.00 E-13

6.00E+09

1.00 E+07

C-14 dioxide

6.50 E-12

8.00E+08

1.00 E+06

N-13

9.965 min

ec, β+/ph

0.160

1000

1.7

1.E+02

[1]

7.00E+07

7.00 E+04

[3]

3

O-15

122.24 s

ec, β+/ph

0.161

1000

1.7

1.E+02

[1]

7.00E+07

7.00 E+04

[3]

3

F-18

109.77 min

ec, β+/ph

9.30 E-11

4.90 E-11

0.160

2000

1.7

1.E+01

[1]

7.00E+07

7.00 E+04

[3]

3

Na-22

2.6019 a

ec, β+/ph

2.00 E-09

3.20 E-09

0.330

2000

1.6

1.E-01

3.00E+06

4.00 E+03

3

Na-24

14.9590 h

β / ph

5.30 E-10

4.30 E-10

0.506

1000

1.9

1.E+00

9.00E+06

2.00 E+04

3

Mg-28 / Al-28

20.915 h

β / ph

1.70 E-09

2.20 E-09

0.529

2000

3.1

1.E+01

[2]

3.00E+06

5.00 E+03

3

Al-26

7.17 E5 a

ec, β+/ph

1.40 E-08

3.50 E-09

0.382

1000

1.5

1.E-01

4.00E+05

6.00 E+02

3

Si-31

157.3 min

β / ph

1.10 E-10

1.60 E-10

<0.001

1000

1.6

1.E+03

5.00E+07

8.00 E+04

3

Si-32

132 a

β

5.50 E-08

5.60 E-10

<0.001

500

0.6

1.E+02

[2]

9.00E+04

2.00 E+02

10

→ P-32

P-30

2.498 min

ec, β+/ph

0.371

900

1.7

3

P-32

14.263 d

β

2.90E-09

2.40E-09

<0.001

1000

1.6

1.E+03

2.00E+06

3.00E+03

3

P-33

25.34 d

β

1.30E-09

2.40E-10

<0.001

700

0.8

1.E+03

4.00E+06

6.00E+03

10

S-35 (inorg.)

87.51 d

β

1.10E-09

1.90E-10

<0.001

200

0.3

1.E+02

5.00E+06

8.00E+03

30

S-35 (org.)

87.51 d

β

1.20E-10

7.70E-10

<0.001

200

0.3

1.E+02

4.00E+07

7.00E+04

30

Cl-36

3.01 E5 a

β, ec, β+/ph

5.10E-09

9.30E-10

<0.001

1000

1.5

1.E+00

1.00E+06

2.00E+03

3

Cl-38

37.24 min

β/ph

7.30E-11

1.20E-10

1.551

1000

1.8

1.E+01

[1]

4.00E+07

4.00E+04

[3]

3

Cl-39

55.6 min

β/ph

7.60E-11

8.50E-11

0.241

1000

1.7

1.E+01

[1]

7.00E+07

1.00E+05

3

→ Ar-39

Ar-37

35.04 d

ec / ph

<0.001

<1

<0.1

6.00E+13

6.00E+10

Ar-39

269 a

β

<0.001

2000

1.5

6.00E+09

6.00E+06

[4]

Ar-41

109.61 min

β/ph

0.188

1000

1.7

5.00E+07

5.00E+04

K-38

7.636 min

ec, β+/ph

0.480

1000

1.8

3

K-40 [10]

1.251 E9 a

β, ec, β+/ph

3.00E-09

6.20E-09

0.022

1000

1.5

1.E+00

2.00E+06

3.00E+03

3

K-42

12.360 h

β/ph

2.00E-10

4.30E-10

0.464

1000

1.7

1.E+02

3.00E+07

4.00E+04

3

K-43

22.3 h

β/ph

2.60E-10

2.50E-10

0.152

1000

1.6

1.E+01

2.00E+07

3.00E+04

3

K-44

22.13 min

β/ph

3.70E-11

8.40E-11

1.553

1000

1.8

1.E+01

[1]

1.00E+08

2.00E+05

3

K-45

17.3 min

β/ph

2.80E-11

5.40E-11

0.302

1000

1.7

1.E+01

[1]

2.00E+08

3.00E+05

3

Ca-41

1.02 E5 a

ec / ph

1.90E-10

2.90E-10

<0.001

<1

<0.1

1.E+02

3.00E+07

4.00E+04

1000

Ca-45

162.67 d

β

2.30E-09

7.60E-10

<0.001

700

0.8

1.E+02

[2]

2.00E+06

4.00E+03

10

Ca-47

4.536 d

β/ph

2.10E-09

1.60E-09

0.156

1000

1.6

1.E+01

2.00E+06

4.00E+03

3

→ Sc-47

Sc-43

3.891 h

ec, β+/ph

1.80E-10

1.90E-10

0.174

1000

1.4

1.E+01

[1]

3.00E+07

5.00E+04

3

Sc-44

3.97 h

ec, β+/ph

3.00E-10

3.50E-10

0.324

1000

1.7

1.E+01

[1]

2.00E+07

3.00E+04

3

Sc-44m

58.61 h

it, ec / ph

2.00E-09

2.40E-09

0.045

200

0.2

1.E+01

[2]

3.00E+06

4.00E+03

30

→ Sc-44 [6]

Sc-46

83.79 d

β/ph

4.80E-09

1.50E-09

0.299

1000

1.2

1.E-01

1.00E+06

2.00E+03

3

Sc-47

3.3492 d

β/ph

7.30E-10

5.40E-10

0.017

1000

1.3

1.E+02

7.00E+06

1.00E+04

3

Sc-48

43.67 h

β/ph

1.60E-09

1.70E-09

0.495

2000

1.7

1.E+00

3.00E+06

5.00E+03

3

Sc-49

57.2 min

β/ph

6.10E-11

8.20E-11

0.001

1000

1.6

1.E+03

[1]

8.00E+07

1.00E+05

3

Ti-44

60.0 a

ec / ph

7.20E-08

5.80E-09

0.026

2

<0.1

1.E-01

[2]

7.00E+04

1.00E+02

30

→ Sc-44 [6]

Ti-45

184.8 min

ec, β+/ph

1.50E-10

1.50E-10

0.136

1000

1.5

1.E+01

[1]

3.00E+07

6.00E+04

3

V-47

32.6 min

ec, β+/ph

5.00E-11

6.30E-11

0.156

1000

1.7

1.E+01

[1]

1.00E+08

2.00E+05

3

V-48

15.9735 d

ec, β+/ph

2.70E-09

2.00E-09

0.432

900

1

1.E+00

2.00E+06

3.00E+03

10

V-49

330 d

ec / ph

2.60E-11

1.80E-11

<0.001

<1

<0.1

1.E+04

2.00E+08

3.00E+05

1000

Cr-48

21.56 h

ec, β+/ph

2.50E-10

2.00E-10

0.071

50

0.1

1.E+01

2.00E+07

3.00E+04

100

→ V-48 [6]

Cr-49

42.3 min

ec, β+/ph

5.90E-11

6.10E-11

0.166

1000

1.7

1.E+01

[1]

8.00E+07

1.00E+05

3

→ V-49

Cr-51

27.7025 d

ec / ph

3.60E-11

3.80E-11

0.005

3

<0.1

1.E+02

1.00E+08

2.00E+05

1000

Mn-51

46.2 min

ec, β+/ph

6.80E-11

9.30E-11

0.159

1000

1.7

1.E+01

[1]

7.00E+07

1.00E+05

3

→ Cr-51

Mn-52

5.591 d

ec, β+/ph

1.80E-09

1.80E-09

0.510

600

0.7

1.E+00

3.00E+06

5.00E+03

10

Mn-52m

21.1 min

ec, β+, it / ph

5.00E-11

6.90E-11

0.389

1000

1.7

1.E+01

[1]

1.00E+08

2.00E+05

3

→ Mn-52

Mn-53

3.7 E6 a

ec / ph

3.60E-11

3.00E-11

<0.001

20

<0.1

1.E+02

1.00E+08

2.00E+05

1000

Mn-54

312.12 d

ec, β+, β / ph

1.20E-09

7.10E-10

0.126

10

0.1

1.E-01

4.00E+06

7.00E+03

100

Mn-56

2.5789 h

β / ph

2.00E-10

2.50E-10

0.275

1000

1.7

1.E+01

[1]

3.00E+07

4.00E+04

3

Fe-52

8.275 h

ec, β+/ph

9.50E-10

1.40E-09

0.116

900

1

1.E+01

[2]

5.00E+06

9.00E+03

10

→ Mn-52m [6]

Fe-55

2.737 a

ec / ph

9.20E-10

3.30E-10

<0.001

20

<0.1

1.E+03

5.00E+06

9.00E+03

1000

Fe-59

44.495 d

β/ph

3.20E-09

1.80E-09

0.175

1000

1.1

1.E+00

2.00E+06

3.00E+03

3

Fe-60

1.5 E6 a

β

3.30E-07

1.10E-07

<0.001

90

0.3

1.E+01

2.00E+04

3.00E+01

3

→ Co-60m [10]

Co-55

17.53 h

ec, β+/ph

8.30E-10

1.10E-09

0.302

1000

1.4

1.E+01

6.00E+06

1.00E+04

3

→ Fe-55

Co-56

77.23 d

ec, β+/ph

4.90E-09

2.50E-09

0.485

300

0.6

1.E-01

1.00E+06

2.00E+03

10

Co-57

271.74 d

ec / ph

6.00E-10

2.10E-10

0.021

100

0.1

1.E+00

8.00E+06

1.00E+04

100

Co-58

70.86 d

ec, β+/ph

1.70E-09

7.40E-10

0.147

300

0.3

1.E+00

3.00E+06

5.00E+03

30

Co-58m

9.04 h

it / ph

1.70E-11

2.40E-11

<0.001

10

<0.1

1.E+04

3.00E+08

5.00E+05

1000

→ Co-58 [6]

Co-60

5.2713 a

β/ph

1.70E-08

3.40E-09

0.366

1000

1.1

1.E-01

3.00E+05

5.00E+02

3

Co-60m

10.467 min

it, β/ph

1.20E-12

1.70E-12

0.001

20

<0.1

1.E+03

4.00E+09

7.00E+06

1000

→ Co-60 [6]

Co-61

1.650 h

β/ph

7.50E-11

7.40E-11

0.017

1000

1.6

1.E+02

[1]

7.00E+07

1.00E+05

3

Co-62m

13.91 min

β / ph

3.70E-11

4.70E-11

0.436

1000

1.8

1.E+01

[1]

1.00E+08

2.00E+05

3

Ni-56

6.075 d

ec, β+ / ph

9.60E-10

8.60E-10

0.260

60

0.1

1.E+01

5.00E+06

9.00E+03

100

→ Co-56 [6]

Ni-57

35.60 h

ec, β+ / ph

7.60E-10

8.70E-10

0.278

700

0.8

1.E+01

7.00E+06

1.00E+04

10

→ Co-57

Ni-59

1.01 E5 a

ec, β+ / ph

2.20E-10

6.30E-11

<0.001

10

<0.1

1.E+02

2.00E+07

4.00E+04

1000

Ni-63

100.1 a

β

5.20E-10

1.50E-10

<0.001

<1

<0.1

1.E+02

1.00E+07

2.00E+04

1000

Ni-65

2.51719 h

β / ph

1.30E-10

1.80E-10

0.081

1000

1.6

1.E+01

[1]

4.00E+07

6.00E+04

3

Ni-66 / Cu-66

54.6 h

β / ph

1.90E-09

3.00E-09

0.039

2000

2.2

1.E+03

[2]

3.00E+06

4.00E+03

3

Cu-60

23.7 min

ec, β+ / ph

6.20E-11

7.00E-11

0.596

1000

1.8

1.E+01

[1]

8.00E+07

1.00E+05

3

Cu-61

3.333 h

ec, β+ / ph

1.20E-10

1.20E-10

0.128

900

1.1

1.E+01

[1]

4.00E+07

7.00E+04

3

Cu-64

12.700 h

ec, β+, β / ph

1.50E-10

1.20E-10

0.030

900

0.8

1.E+02

3.00E+07

6.00E+04

10

Cu-67

61.83 h

β / ph

5.80E-10

3.40E-10

0.018

1000

1.4

1.E+02

9.00E+06

1.00E+04

3

Zn-62 / Cu-62

9.186 h

ec, β+ / ph

6.60E-10

9.40E-10

0.319

1000

1.9

1.E+02

[2]

8.00E+06

1.00E+04

3

Zn-63

38.47 min

ec, β+ / ph

6.10E-11

7.90E-11

0.175

1000

1.6

1.E+01

[1]

8.00E+07

1.00E+05

3

Zn-65

244.06 d

ec, β+ / ph

2.80E-09

3.90E-09

0.086

40

0.1

1.E-01

2.00E+06

3.00E+03

100

Zn-69

56.4 min

β

4.30E-11

3.10E-11

<0.001

1000

1.6

1.E+03

1.00E+08

2.00E+05

3

Zn-69m

13.76 h

it, β/ ph

3.30E-10

3.30E-10

0.067

70

0.1

1.E+01

[2]

2.00E+07

3.00E+04

100

→ Zn-69

Zn-71m

3.96 h

β/ ph

2.40E-10

2.40E-10

0.240

1000

1.7

1.E+01

[1]

2.00E+07

3.00E+04

3

Zn-72

46.5 h

β/ ph

1.50E-09

1.40E-09

0.026

900

0.9

1.E+00

[2]

3.00E+06

6.00E+03

10

→ Ga-72 [6]

Ga-65

15.2 min

ec, β+ / ph

2.90E-11

3.70E-11

0.183

1000

1.6

1.E+01

[1]

2.00E+08

3.00E+05

3

→ Zn-65

Ga-66

9.49 h

ec, β+ / ph

7.10E-10

1.20E-09

0.877

600

1.1

1.E+01

7.00E+06

1.00E+04

3

Ga-67

3.2612 d

ec / ph

2.80E-10

1.90E-10

0.025

30

0.3

1.E+02

2.00E+07

3.00E+04

30

Ga-68

67.71 min

ec, β+ / ph

8.10E-11

1.00E-10

0.149

1000

1.5

1.E+01

[1]

6.00E+07

1.00E+05

3

Ga-70

21.14 min

β, ec / ph

2.60E-11

3.10E-11

0.001

1000

1.6

1.E+02

[1]

2.00E+08

3.00E+05

3

Ga-72

14.10 h

β / ph

8.40E-10

1.10E-09

0.386

1000

1.7

1.E+01

6.00E+06

1.00E+04

3

Ga-73

4.86 h

β / ph

2.00E-10

2.60E-10

0.052

1000

1.6

1.E+02

[1]

3.00E+07

4.00E+04

3

Ge-66

2.26 h

ec, β+ / ph

1.30E-10

1.00E-10

0.108

400

0.5

1.E+01

[1]

4.00E+07

6.00E+04

10

→ Ga-66 [6]

Ge-67

18.9 min

ec, β+ / ph

4.20E-11

6.50E-11

0.407

1000

1.7

1.E+01

[1]

1.00E+08

2.00E+05

3

→ Ga-67

Ge-68

270.95 d

ec / ph

7.90E-09

1.30E-09

<0.001

10

<0.1

1.E+01

[2]

6.00E+05

1.00E+03

300

→ Ga-68 [6]

Ge-69

39.05 h

ec, β+ / ph

3.70E-10

2.40E-10

0.132

500

0.6

1.E+01

1.00E+07

2.00E+04

10

Ge-71

11.43 d

ec / ph

1.10E-11

1.20E-11

<0.001

10

<0.1

1.E+04

[1]

5.00E+08

8.00E+05

1000

Ge-75

82.78 min

β / ph

5.40E-11

4.60E-11

0.006

1000

1.6

1.E+03

9.00E+07

2.00E+05

3

Ge-77

11.30 h

β / ph

4.50E-10

3.30E-10

0.163

1000

1.6

1.E+01

1.00E+07

2.00E+04

3

Ge-78

88 min

β / ph

1.40E-10

1.20E-10

0.045

1000

1.5

1.E+02

[1]

4.00E+07

6.00E+04

3

→ As-78 [6]

As-69

15.23 min

ec, β+ / ph

3.50E-11

5.70E-11

0.250

900

1.7

1.E+01

[1]

1.00E+08

2.00E+05

3

→ Ge-69

As-70

52.6 min

ec, β+ / ph

1.20E-10

1.30E-10

0.603

1000

1.7

1.E+01

[1]

4.00E+07

7.00E+04

3

As-71

65.28 h

ec, β+ / ph

5.00E-10

4.60E-10

0.088

700

0.7

1.E+01

1.00E+07

2.00E+04

10

→ Ge-71

As-72

26.0 h

ec, β+ / ph

1.30E-09

1.80E-09

0.339

900

1.6

1.E+01

4.00E+06

6.00E+03

3

As-73

80.30 d

ec / ph

6.50E-10

2.60E-10

0.003

20

<0.1

1.E+03

[2]

8.00E+06

1.00E+04

1000

As-74

17.77 d

ec, β+, β / ph

1.80E-09

1.30E-09

0.117

900

1.1

1.E+01

3.00E+06

5.00E+03

3

As-76

1.0778 d

β / ph

9.20E-10

1.60E-09

0.132

1000

1.6

1.E+01

5.00E+06

9.00E+03

3

As-77

38.83 h

β / ph

4.20E-10

4.00E-10

0.001

1000

1.5

1.E+03

1.00E+07

2.00E+04

3

As-78

90.7 min

β / ph

1.40E-10

2.10E-10

0.804

1000

1.7

1.E+01

[1]

4.00E+07

6.00E+04

3

Se-70

41.1 min

ec, β+ / ph

1.20E-10

1.40E-10

0.158

900

1.3

1.E+01

[1]

4.00E+07

7.00E+04

3

→ As-70 [6]

Se-73

7.15 h

ec, β+ / ph

2.40E-10

3.90E-10

0.174

900

1.2

1.E+01

[1]

2.00E+07

3.00E+04

3

→ As-73

Se-73m

39.8 min

it, ec, β+ / ph

2.70E-11

4.10E-11

0.038

300

0.4

1.E+02

[1]

2.00E+08

3.00E+05

10

→ Se-73

Se-75

119.779 d

ec / ph

1.70E-09

2.60E-09

0.064

80

0.1

1.E+00

3.00E+06

5.00E+03

100

Se-79

2.95 E5 a

β

3.10E-09

2.90E-09

<0.001

200

0.4

1.E-01

2.00E+06

3.00E+03

10

Se-81

18.45 min

β / ph

2.40E-11

2.70E-11

0.002

1000

1.6

1.E+03

[1]

2.00E+08

3.00E+05

3

Se-81m

57.28 min

it, β

6.80E-11

5.90E-11

0.004

100

1.1

1.E+03

[1]

7.00E+07

1.00E+05

3

→ Se-81

Se-83

22.3 min

β / ph

5.30E-11

5.10E-11

0.362

1000

1.7

1.E+01

[1]

9.00E+07

2.00E+05

3

→ Br-83

Br-74

25.4 min

ec, β+ / ph

6.80E-11

8.40E-11

1.022

1000

1.8

1.E+01

[1]

7.00E+07

1.00E+05

3

Br-74m

46 min

ec, β+ / ph

1.10E-10

1.40E-10

1.347

900

1.8

1.E+01

[1]

5.00E+07

8.00E+04

3

Br-75

96.7 min

ec, β+ / ph

8.50E-11

7.90E-11

0.189

900

1.3

1.E+01

[1]

6.00E+07

1.00E+05

3

→ Se-75

Br-76

16.2 h

ec, β+ / ph

5.80E-10

4.60E-10

0.503

700

1.1

1.E+01

9.00E+06

1.00E+04

3

Br-77

57.036 h

ec, β+ / ph

1.30E-10

9.60E-11

0.051

60

0.1

1.E+01

4.00E+07

6.00E+04

100

Br-80

17.68 min

β, ec, β+ / ph

1.70E-11

3.10E-11

0.013

1000

1.5

1.E+02

[1]

3.00E+08

5.00E+05

3

Br-80m

4.4205 h

it / ph

1.00E-10

1.10E-10

0.012

10

<0.1

1.E+03

[2]

5.00E+07

8.00E+04

1000

→ Br-80

Br-82

35.30 h

β / ph

8.80E-10

5.40E-10

0.395

1000

1.4

1.E+00

6.00E+06

9.00E+03

3

Br-83

2.40 h

β / ph

6.70E-11

4.30E-11

0.001

1000

1.5

1.E+03

[2]

7.00E+07

1.00E+05

3

Br-84

31.80 min

β / ph

6.20E-11

8.80E-11

0.923

1000

1.7

1.E+01

[1]

8.00E+07

1.00E+05

3

Kr-79

35.04 h

ec, β+ / ph

0.042

100

0.2

2.00E+08

2.00E+05

Kr-81

2.29 E5 a

ec / ph

0.004

8

<0.1

1.00E+10

1.00E+07

Kr-83m

1.83 h

it / ph

0.002

3

<0.1

1.00E+12

1.00E+09

Kr-85

10.756 a

β / ph

0.001

1000

1.5

5.00E+07 [8]

5.00E+06

[4]

Kr-85m

4.480 h

β, it / ph

0.026

1000

1.4

4.00E+08

4.00E+05

→ Kr-85

Kr-87

76.3 min

β / ph

0.501

1000

1.7

7.00E+07

7.00E+04

→ Rb-87

Kr-88

2.84 h

β / ph

0.264

1000

1.5

2.00E+07

2.00E+04

[5]

→ Rb-88 [6]

Kr-89

3.15 min

β / ph

2.047

900

1.8

3.00E+07

3.00E+04

→ Rb-89 [6]

Rb-79

22.9 min

ec, β+ / ph

3.00E-11

5.00E-11

0.217

2000

2.1

1.E+01

[1]

2.00E+08

3.00E+05

3

→ Kr-79

Rb-81

4.576 h

ec, β+ / ph

6.80E-11

5.40E-11

0.101

1000

1.2

1.E+01

[1]

7.00E+07

1.00E+05

3

→ Kr-81

Rb-81m

30.5 min

it, ec, β+ / ph

1.30E-11

9.70E-12

0.006

5

0.3

1.E+03

[1]

4.00E+08

6.00E+05

30

→ Rb-81 [6]

Rb-82m

6.472 h

ec, β+ / ph

2.20E-10

1.30E-10

0.436

400

0.6

1.E+01

2.00E+07

4.00E+04

10

Rb-83

86.2 d

ec / ph

1.00E-09

1.90E-09

0.082

20

<0.1

1.E+00

[2]

5.00E+06

8.00E+03

100

Rb-84

32.77 d

ec, β+, β / ph

1.50E-09

2.80E-09

0.141

400

0.6

1.E+00

3.00E+06

6.00E+03

10

Rb-86

18.642 d

β, ec / ph

1.30E-09

2.80E-09

0.014

1000

1.6

1.E+02

4.00E+06

6.00E+03

3

Rb-87

4.923 E10 a

β

7.60E-10

1.50E-09

<0.001

1000

1.2

1.E+01

7.00E+06

1.00E+04

3

Rb-88

17.78 min

β / ph

2.80E-11

9.00E-11

2.314

900

1.7

1.E+02

[1]

2.00E+08

3.00E+05

3

Rb-89

15.15 min

β / ph

2.50E-11

4.70E-11

0.659

1000

1.8

1.E+02

[1]

2.00E+08

3.00E+05

3

→ Sr-89

Sr-80 / Rb-80

106.3 min

ec, β+ / ph

2.10E-10

3.50E-10

1.750

900

1.7

1.E+03

[2]

2.00E+07

4.00E+04

3

Sr-81

22.3 min

ec, β+ / ph

6.10E-11

7.80E-11

0.247

1000

1.6

1.E+01

[1]

8.00E+07

1.00E+05

3

→ Rb-81 [6]

Sr-82 / Rb-82

25.36 d

ec / ph

7.70E-09

6.10E-09

0.434

900

1.6

1.E+01

[1]

6.00E+05

1.00E+03

3

Sr-83

32.41 h

ec, β+ / ph

4.90E-10

5.80E-10

0.127

400

0.5

1.E+01

1.00E+07

2.00E+04

10

→ Rb-83

Sr-85

64.84 d

ec / ph

6.40E-10

5.60E-10

0.086

20

0.1

1.E+00

8.00E+06

1.00E+04

100

Sr-85m

67.63 min

it, ec, β+ / ph

7.40E-12

6.10E-12

0.035

70

0.1

1.E+02

[1]

7.00E+08

1.00E+06

100

→ Sr-85

Sr-87m

2.815 h

it, ec / ph

3.50E-11

3.30E-11

0.053

300

0.3

1.E+02

[1]

1.00E+08

2.00E+05

30

→ Rb-87

Sr-89

50.53 d

β

5.60E-09

2.60E-09

<0.001

1000

1.6

1.E+03

[2]

9.00E+05

1.00E+03

3

Sr-90

28.79 a

β

7.70E-08

2.80E-08

<0.001

1000

1.4

1.E+00

[2]

6.00E+04

1.00E+02

3

→ Y-90 [6]

Sr-91

9.63 h

β / ph

5.70E-10

7.60E-10

0.117

1000

1.6

1.E+01

[2]

9.00E+06

1.00E+04

3

→ Y-91m, Y-91

Sr-92

2.66 h

β / ph

3.40E-10

4.90E-10

0.194

1000

1.4

1.E+01

[1]

1.00E+07

2.00E+04

3

→ Y-92 [6]

Y-86

14.74 h

ec, β+ / ph

8.10E-10

9.60E-10

0.515

500

0.8

1.E+00

6.00E+06

1.00E+04

10

Y-86m

48 min

it, ec, β+ / ph

4.90E-11

5.60E-11

0.034

200

0.1

1.E+02

[1]

1.00E+08

2.00E+05

100

→ Y-86 [6]

Y-87

79.8 h

ec, β+ / ph

5.30E-10

5.50E-10

0.080

20

<0.1

1.E+01

[2]

9.00E+06

2.00E+04

300

Y-88

106.65 d

ec, β+ / ph

3.30E-09

1.30E-09

0.380

40

0.2

1.E-01

2.00E+06

3.00E+03

30

Y-90

64.10 h

β

1.70E-09

2.70E-09

0.007

1000

1.6

1.E+03

3.00E+06

5.00E+03

3

Y-90m

3.19 h

it, β / ph

1.30E-10

1.70E-10

0.098

200

0.2

1.E+01

[1]

4.00E+07

6.00E+04

30

→ Y-90

Y-91

58.51 d

β / ph

6.10E-09

2.40E-09

0.001

1000

1.6

1.E+02

8.00E+05

1.00E+03

3

Y-91m

49.71 min

it / ph

1.50E-11

1.10E-11

0.082

70

0.1

1.E+02

[1]

3.00E+08

6.00E+05

100

→ Y-91

Y-92

3.54 h

β / ph

2.80E-10

4.90E-10

0.546

1000

1.7

1.E+02

2.00E+07

3.00E+04

3

Y-93

10.18 h

β / ph

6.00E-10

1.20E-09

0.098

1000

1.6

1.E+02

8.00E+06

1.00E+04

3

→ Zr-93

Y-94

18.7 min

β / ph

4.60E-11

8.10E-11

1.111

900

1.7

1.E+01

[1]

1.00E+08

2.00E+05

3

Y-95

10.3 min

β / ph

2.60E-11

4.60E-11

1.219

1000

1.7

1.E+01

[1]

2.00E+08

3.00E+05

3

→ Zr-95 [6]

Zr-86

16.5 h

ec, β+ / ph

7.00E-10

8.60E-10

0.069

100

0.1

1.E+01

[2]

7.00E+06

1.00E+04

100

→ Y-86 [6]

Zr-88

83.4 d

ec / ph

4.10E-09

3.30E-10

0.076

50

0.1

1.E+00

1.00E+06

2.00E+03

100

→ Y-88 [6]

Zr-89

78.41 h

ec, β+ / ph

7.50E-10

7.90E-10

0.182

400

0.5

1.E+01

[1]

7.00E+06

1.00E+04

10

Zr-93

1.53 E6 a

β

2.90E-08

2.80E-10

<0.001

<1

<0.1

1.E+01

2.00E+05

3.00E+02

1000

→ Nb-93m

Zr-95

64.032 d

β / ph

4.20E-09

8.80E-10

0.112

1000

1.1

1.E+00

[2]

1.00E+06

2.00E+03

3

→ Nb-95 [6]

Zr-97

16.744 h

β / ph

1.40E-09

2.10E-09

0.027

1000

1.6

1.E+01

[2]

4.00E+06

6.00E+03

3

→ Nb-97

Nb-88

14.5 min

ec, β+ / ph

5.00E-11

6.30E-11

0.719

1000

1.8

1.E+01

[1]

1.00E+08

2.00E+05

3

→ Zr-88

Nb-89

2.03 h

ec, β+ / ph

1.90E-10

3.00E-10

0.392

700

1.3

1.E+01

[1]

3.00E+07

4.00E+04

3

→ Zr-89

Nb-89m

66 min

ec, β+ / ph

1.20E-10

1.40E-10

0.306

900

1.5

1.E+01

[1]

4.00E+07

7.00E+04

3

→ Zr-89

Nb-90

14.60 h

ec, β+ / ph

1.10E-09

1.20E-09

0.574

2000

1.9

1.E+01

[1]

5.00E+06

8.00E+03

3

Nb-91

680 a

ec, β+ / ph

1.E+02

1.00E+06

2.00E+03

1000

Nb-91m

60.86 d

it, ec, β+ / ph

1.E+01

2.00E+06

4.00E+03

300

Nb-92m

10.15 d

ec, β+ / ph

1.E+01

8.00E+06

1.00E+04

300

Nb-93m

16.13 a

it / ph

8.60E-10

1.20E-10

0.003

<1

<0.1

1.E+01

6.00E+06

1.00E+04

1000

Nb-94

2.03 E4 a

β / ph

2.50E-08

1.70E-09

0.237

1000

1.5

1.E-01

2.00E+05

3.00E+02

3

Nb-95

34.991 d

β / ph

1.30E-09

5.80E-10

0.116

100

0.3

1.E+00

4.00E+06

6.00E+03

30

Nb-95m

3.61 d

it, β / ph

8.50E-10

5.60E-10

0.021

2000

1.4

1.E+02

6.00E+06

1.00E+04

3

→ Nb-95 [6]

Nb-96

23.35 h

β / ph

9.70E-10

1.10E-09

0.372

1000

1.6

1.E+00

5.00E+06

9.00E+03

3

Nb-97

72.1 min

β / ph

7.20E-11

6.80E-11

0.099

1000

1.6

1.E+01

[1]

7.00E+07

1.00E+05

3

Nb-98m

51.3 min

β / ph

9.90E-11

1.10E-10

0.393

1000

1.8

1.E+01

[1]

5.00E+07

8.00E+04

3

Mo-90

5.56 h

ec, β+ / ph

5.60E-10

6.20E-10

0.147

1000

1.4

1.E+01

[1]

9.00E+06

1.00E+04

3

→ Nb-90 [6]

Mo-93

4.0 E3 a

ec / ph

1.40E-09

2.60E-09

0.016

4

<0.1

1.E+01

4.00E+06

6.00E+03

100

Mo-93m

6.85 h

it, ec / ph

3.00E-10

2.80E-10

0.330

800

0.8

1.E+01

2.00E+07

3.00E+04

10

→ Mo-93

Mo-99

65.94 h

β / ph

1.10E-09

1.20E-09

0.024

1000

1.6

1.E+01

[2]

5.00E+06

8.00E+03

3

→ Tc-99m, Tc-99

Mo-101

14.61 min

β / ph

4.50E-11

4.20E-11

0.196

1000

1.7

1.E+01

[1]

1.00E+08

2.00E+05

3

→ Tc-101

Tc-93

2.75 h

ec, β+ / ph

6.50E-11

4.90E-11

0.222

20

0.1

1.E+01

[1]

8.00E+07

1.00E+05

100

→ Mo-93

Tc-93m

43.5 min

it, ec, β+ / ph

3.10E-11

2.40E-11

0.098

300

0.4

1.E+01

[1]

2.00E+08

3.00E+05

10

→ Tc-93, Mo-93

Tc-94

293 min

ec, β+ / ph

2.20E-10

1.80E-10

0.414

200

0.4

1.E+01

[1]

2.00E+07

4.00E+04

10

Tc-94m

52.0 min

ec, β+ / ph

8.00E-11

1.10E-10

0.285

700

1.3

1.E+01

[1]

6.00E+07

1.00E+05

3

Tc-95

20.0 h

ec / ph

1.80E-10

1.60E-10

0.135

20

0.1

1.E+01

3.00E+07

5.00E+04

100

Tc-95m

61 d

ec, β+, it / ph

8.60E-10

6.20E-10

0.117

100

0.1

1.E+00

[2]

6.00E+06

1.00E+04

100

→ Tc-95

Tc-96

4.28 d

ec / ph

1.00E-09

1.10E-09

0.388

40

0.2

1.E+00

5.00E+06

8.00E+03

30

Tc-96m

51.5 min

it, ec, β+ / ph

1.10E-11

1.30E-11

0.016

3

<0.1

1.E+03

[1]

5.00E+08

8.00E+05

1000

→ Tc-96

Tc-97

2.6 E6 a

ec / ph

1.60E-10

8.30E-11

0.017

4

<0.1

1.E+01

3.00E+07

5.00E+04

1000

Tc-97m

90.1 d

it / ph

2.70E-09

6.60E-10

0.014

30

0.7

1.E+02

2.00E+06

3.00E+03

10

→ Tc-97

Tc-98

4.2 E6 a

β / ph

6.10E-09

2.30E-09

0.215

2000

1.5

1.E-01

8.00E+05

1.00E+03

3

Tc-99

2.111 E5 a

β

3.20E-09

7.80E-10

<0.001

1000

1.1

1.E+00

2.00E+06

3.00E+03

3

Tc-99m

6.015 h

it, β/ ph

2.90E-11

2.20E-11

0.022

300

0.2

1.E+02

[1]

2.00E+08

3.00E+05

30

→ Tc-99

Tc-101

14.2 min

β / ph

2.10E-11

1.90E-11

0.055

1000

1.6

1.E+02

[1]

2.00E+08

4.00E+05

3

Tc-104

18.3 min

β / ph

4.80E-11

8.10E-11

1.219

1000

1.8

1.E+01

[1]

1.00E+08

2.00E+05

3

Ru-94

51.8 min

ec, β+ / ph

7.40E-11

9.40E-11

0.100

20

0.1

1.E+02

[1]

7.00E+07

1.00E+05

100

→ Tc-94

Ru-97

2.9 d

ec / ph

1.60E-10

1.50E-10

0.055

100

0.1

1.E+01

3.00E+07

5.00E+04

100

→ Tc-97

Ru-103

39.26 d

β / ph

2.20E-09

7.30E-10

0.073

500

0.6

1.E+00

[2]

2.00E+06

4.00E+03

10

Ru-105

4.44 h

β / ph

2.50E-10

2.60E-10

0.119

1000

1.6

1.E+01

[1]

2.00E+07

3.00E+04

3

→ Rh-105

Ru-106 / Rh-106

373.59 d

β / ph

3.50E-08

7.00E-09

0.357

1000

1.6

1.E-01

[2]

1.00E+05

2.00E+02

3

Rh-99

16.1 d

ec, β+ / ph

8.90E-10

5.10E-10

0.115

100

0.2

1.E+01

[1]

6.00E+06

9.00E+03

30

Rh-99m

4.7 h

ec, β+ / ph

7.30E-11

6.60E-11

0.122

100

0.2

1.E+01

[1]

7.00E+07

1.00E+05

30

Rh-100

20.8 h

ec, β+ / ph

6.30E-10

7.10E-10

0.392

100

0.3

1.E+00

8.00E+06

1.00E+04

30

Rh-101

3.3 a

ec / ph

3.10E-09

5.50E-10

0.062

300

0.4

1.E+00

2.00E+06

3.00E+03

10

Rh-101m

4.34 d

ec,it / ph

2.70E-10

2.20E-10

0.066

200

0.2

1.E+01

2.00E+07

3.00E+04

30

→ Rh-101

Rh-102

207 d

ec, β+, β / ph

4.20E-09

1.20E-09

0.085

400

0.6

1.E-01

1.00E+06

2.00E+03

10

Rh-102m

3.742 a

ec, β+, it / ph

9.00E-09

2.60E-09

0.339

50

0.2

1.E+00

6.00E+05

9.00E+02

30

→ Rh-102

Rh-103m

56.114 min

it / ph

2.50E-12

3.80E-12

0.002

<1

<0.1

1.E+04

[1]

2.00E+09

3.00E+06

1000

Rh-105

35.36 h

β / ph

4.40E-10

3.70E-10

0.013

1000

1.2

1.E+02

1.00E+07

2.00E+04

3

Rh-106m

131 min

β / ph

1.90E-10

1.60E-10

0.436

1000

1.7

1.E+01

[1]

3.00E+07

4.00E+04

3

Rh-107

21.7 min

β / ph

2.80E-11

2.40E-11

0.051

1000

1.6

1.E+02

[1]

2.00E+08

3.00E+05

3

→ Pd-107

Pd-100

3.63 d

ec / ph

9.70E-10

9.40E-10

0.050

20

0.1

1.E+00

[2]

5.00E+06

9.00E+03

100

→ Rh-100 [6]

Pd-101

8.47 h

ec, β+ / ph

1.00E-10

9.40E-11

0.081

100

0.2

1.E+02

5.00E+07

8.00E+04

30

→ Rh-101m

Pd-103

16.991 d

ec / ph

3.00E-10

1.90E-10

0.019

3

<0.1

1.E+03

[1]

2.00E+07

3.00E+04

1000

→ Rh-103m

Pd-107

6.5 E6 a

β

2.90E-10

3.70E-11

<0.001

<1

<0.1

1.E+03

2.00E+07

3.00E+04

1000

Pd-109

13.7012 h

β / ph

5.00E-10

5.50E-10

0.010

1000

2

1.E+02

[2]

1.00E+07

2.00E+04

3

Ag-102

12.9 min

ec, β+ / ph

3.20E-11

4.00E-11

0.546

800

1.4

1.E+01

[1]

2.00E+08

3.00E+05

3

Ag-103

65.7 min

ec, β+ / ph

4.50E-11

4.30E-11

0.125

500

0.8

1.E+01

[1]

1.00E+08

2.00E+05

10

→ Pd-103

Ag-104

69.2 min

ec, β+ / ph

7.10E-11

6.00E-11

0.410

300

0.5

1.E+01

[1]

7.00E+07

1.00E+05

10

Ag-104m

33.5 min

ec, β+, it / ph

4.50E-11

5.40E-11

0.188

400

0.8

1.E+01

[1]

1.00E+08

2.00E+05

10

→ Ag-104 [6]

Ag-105

41.29 d

ec / ph

8.00E-10

4.70E-10

0.102

50

0.1

1.E+00

6.00E+06

1.00E+04

100

Ag-106

23.96 min

ec, β+, b- / ph

2.70E-11

3.20E-11

0.117

700

1

1.E+01

[1]

2.00E+08

3.00E+05

10

Ag-106m

8.28 d

ec / ph

1.60E-09

1.50E-09

0.435

60

0.2

1.E+00

3.00E+06

5.00E+03

30

Ag-108m / Ag-108

418 a

ec, it / ph

1.90E-08

2.30E-09

0.263

100

0.3

1.E-01

[2]

3.00E+05

4.00E+02

30

Ag-110m / Ag-110

249.76 d

β, it / ph

7.30E-09

2.80E-09

0.409

500

0.6

1.E-01

[2]

7.00E+05

1.00E+03

10

Ag-111

7.45 d

β / ph

1.60E-09

1.30E-09

0.004

1000

1.6

1.E+02

3.00E+06

5.00E+03

3

Ag-112

3.130 h

β / ph

2.60E-10

4.30E-10

0.640

1000

1.7

1.E+01

[1]

2.00E+07

3.00E+04

3

Ag-115

20.0 min

β / ph

4.40E-11

6.00E-11

0.181

1000

1.7

1.E+01

[1]

1.00E+08

2.00E+05

3

→ Cd-115, Cd-115m

Cd-104

57.7 min

ec / ph

6.30E-11

5.80E-11

0.062

20

0.1

1.E+02

[1]

8.00E+07

1.00E+05

100

→ Ag-104 [6]

Cd-107

6.50 h

ec, β+ / ph

1.10E-10

6.20E-11

0.030

20

0.6

1.E+03

[1]

5.00E+07

8.00E+04

10

Cd-109

461.4 d

ec / ph

9.60E-09

2.00E-09

0.027

5

0.4

1.E+00

[2]

5.00E+05

9.00E+02

10

Cd-113

7.7 E15 a

β

1.40E-07

2.50E-08

<0.001

1000

0.9

1.E-01

4.00E+04

6.00E+01

10

Cd-113m

14.1 a

β, it

1.30E-07

2.30E-08

<0.001

1000

1.4

1.E-01

[2]

4.00E+04

6.00E+01

3

Cd-115

53.46 h

β / ph

1.30E-09

1.40E-09

0.037

1000

1.5

1.E+01

[2]

4.00E+06

6.00E+03

3

→ In-115

Cd-115m

44.6 d

β / ph

6.40E-09

3.30E-09

0.003

1000

1.6

1.E+02

[2]

8.00E+05

1.00E+03

3

→ In-115

Cd-117

2.49 h

β / ph

2.50E-10

2.80E-10

0.158

1000

1.5

1.E+01

[1]

2.00E+07

3.00E+04

3

→ In-117m, In-117

Cd-117m

3.36 h

β / ph

3.20E-10

2.80E-10

0.282

1000

1.5

1.E+01

[1]

2.00E+07

3.00E+04

3

→ In-117, In-117m

In-109

4.2 h

ec, β+ / ph

7.30E-11

6.60E-11

0.117

300

0.3

1.E+01

[1]

7.00E+07

1.00E+05

30

→ Cd-109

In-110

4.9 h

ec, β+ / ph

2.50E-10

2.40E-10

0.468

60

0.2

1.E+01

[1]

2.00E+07

3.00E+04

30

In-110m

69.1 min

ec, β+ / ph

8.10E-11

1.00E-10

0.238

700

1.1

1.E+01

[1]

6.00E+07

1.00E+05

3

In-111

2.8047 d

ec / ph

3.10E-10

2.90E-10

0.082

400

0.3

1.E+01

[2]

2.00E+07

3.00E+04

30

In-112

14.97 min

ec, β+, β / ph

1.30E-11

1.00E-11

0.047

900

1

1.E+02

[1]

4.00E+08

6.00E+05

10

In-113m

1.6579 h

it / ph

3.20E-11

2.80E-11

0.047

500

0.6

1.E+02

[1]

2.00E+08

3.00E+05

10

In-114m / In-114

49.51 d

it, ec / ph

1.10E-08

4.10E-09

0.023

3000

3.2

1.E+01

[2]

5.00E+05

8.00E+02

3

In-115

4.41 E14 a

β

4.50E-07

3.20E-08

<0.001

1000

1.3

1.E+02

1.00E+04

2.00E+01

3

In-115m

4.486 h

it, β / ph

8.70E-11

8.60E-11

0.033

900

1

1.E+02

6.00E+07

1.00E+05

10

→ In-115

In-116m

54.41 min

β / ph

8.00E-11

6.40E-11

0.356

1000

1.7

1.E+01

[1]

6.00E+07

1.00E+05

3

In-117

43.2 min

β / ph

4.80E-11

3.10E-11

0.109

2000

1.8

1.E+01

[1]

1.00E+08

2.00E+05

3

In-117m

116.2 min

β, it / ph

1.10E-10

1.20E-10

0.019

1000

1.4

1.E+02

[1]

5.00E+07

8.00E+04

3

→ In-117 [6]

In-119m / In-119

18.0 min

β, it / ph

2.90E-11

4.70E-11

0.033

1000

1.7

1.E+02

[1]

2.00E+08

3.00E+05

3

Sn-110

4.11 h

ec / ph

2.60E-10

3.50E-10

0.064

70

0.1

1.E+02

[2]

2.00E+07

3.00E+04

100

→ In-110S [6]

Sn-111

35.3 min

ec, β+ / ph

2.20E-11

2.30E-11

0.087

400

0.6

1.E+02

[1]

2.00E+08

4.00E+05

10

→ In-111

Sn-113

115.09 d

ec / ph

1.90E-09

7.30E-10

0.019

4

<0.1

1.E+00

[2]

3.00E+06

4.00E+03

300

→ In-113m

Sn-117m

13.76 d

it / ph

2.20E-09

7.10E-10

0.038

3000

2.4

1.E+02

2.00E+06

4.00E+03

3

Sn-119m

293.1 d

it / ph

1.50E-09

3.40E-10

0.011

1

<0.1

1.E+01

3.00E+06

6.00E+03

1000

Sn-121

27.03 h

β

2.80E-10

2.30E-10

<0.001

1000

1.1

1.E+03

2.00E+07

3.00E+04

3

Sn-121m

43.9 a

it, β / ph

3.30E-09

3.80E-10

0.004

300

0.3

1.E+00

[2]

2.00E+06

3.00E+03

30

→ Sn-121

Sn-123

129.2 d

β / ph

5.60E-09

2.10E-09

0.001

1000

1.6

1.E+02

9.00E+05

1.00E+03

3

Sn-123m

40.06 min

β / ph

4.40E-11

3.80E-11

0.024

2000

1.9

1.E+02

[1]

1.00E+08

2.00E+05

3

Sn-125

9.64 d

β / ph

2.80E-09

3.10E-09

0.053

1000

1.5

1.E+01

2.00E+06

3.00E+03

3

→ Sb-125

Sn-126

2.30 E5 a

β / ph

1.80E-08

4.70E-09

0.017

1000

1.2

1.E-01

[2]

3.00E+05

5.00E+02

3

→ Sb-126 [6]

Sn-127

2.10 h

β / ph

2.00E-10

2.00E-10

0.313

1000

1.6

1.E+01

[1]

3.00E+07

4.00E+04

3

→ Sb-127 [6]

Sn-128

59.07 min

β / ph

1.50E-10

1.50E-10

0.138

1000

1.5

1.E+01

[1]

3.00E+07

6.00E+04

3

→ Sb-128S [6]

Sb-115

32.1 min

ec, β+ / ph

2.30E-11

2.40E-11

0.151

400

0.6

1.E+01

[1]

2.00E+08

4.00E+05

10

Sb-116

15.8 min

ec, β+ / ph

2.30E-11

2.60E-11

0.321

500

0.9

1.E+01

[1]

2.00E+08

4.00E+05

10

Sb-116m

60.3 min

ec, β+ / ph

8.50E-11

6.70E-11

0.487

400

0.9

1.E+01

[1]

6.00E+07

1.00E+05

10

Sb-117

2.80 h

ec, β+ / ph

2.70E-11

1.80E-11

0.045

400

0.3

1.E+02

[1]

2.00E+08

3.00E+05

30

Sb-118m

5.00 h

ec, β+ / ph

2.30E-10

2.10E-10

0.411

200

0.3

1.E+01

[1]

2.00E+07

4.00E+04

30

Sb-119

38.19 h

ec / ph

5.90E-11

8.10E-11

0.022

3

<0.1

1.E+03

[1]

8.00E+07

1.00E+05

1000

Sb-120

15.89 min

ec, β+ / ph

1.20E-11

1.40E-11

0.079

500

0.7

1.E+02

[1]

4.00E+08

7.00E+05

10

Sb-120m

5.76 d

ec / ph

1.30E-09

1.20E-09

0.386

400

0.4

1.E+00

4.00E+06

6.00E+03

10

Sb-122

2.7238 d

β, ec, β+ / ph

1.20E-09

1.70E-09

0.068

1000

1.6

1.E+01

4.00E+06

7.00E+03

3

Sb-124

60.20 d

β / ph

4.70E-09

2.50E-09

0.261

1000

1.5

1.E+00

1.00E+06

2.00E+03

3

Sb-124n

20.2 min

it / ph

8.30E-12

8.00E-12

<0.001

<1

<0.1

1.E+02

[1]

6.00E+08

1.00E+06

1000

→ Sb-124 [6]

Sb-125

2.75856 a

β / ph

3.30E-09

1.10E-09

0.076

700

0.7

1.E-01

[2]

2.00E+06

3.00E+03

10

→ Te-125m

Sb-126

12.35 d

β / ph

3.20E-09

2.40E-09

0.434

1000

1.5

1.E+00

2.00E+06

3.00E+03

3

Sb-126m

19.15 min

β, it / ph

3.30E-11

3.60E-11

0.239

1000

1.5

1.E+01

[1]

2.00E+08

3.00E+05

3

→ Sb-126 [6]

Sb-127

3.85 d

β / ph

1.70E-09

1.70E-09

0.106

1000

1.6

1.E+01

[2]

3.00E+06

5.00E+03

3

→ Te-127, Te-127m

Sb-128

9.01 h

β / ph

6.70E-10

7.60E-10

0.472

1000

1.8

1.E+01

7.00E+06

1.00E+04

3

Sb-128m

10.4 min

β, it / ph

2.60E-11

3.30E-11

0.313

1000

1.8

1.E+01

[1]

2.00E+08

3.00E+05

3

Sb-129

4.40 h

β / ph

3.50E-10

4.20E-10

0.212

1000

1.6

1.E+01

[1]

1.00E+07

2.00E+04

3

→ Te-129, Te-129m

Sb-130

39.5 min

β / ph

9.10E-11

9.10E-11

0.505

2000

2.1

1.E+01

[1]

5.00E+07

9.00E+04

3

Sb-131

23.03 min

β / ph

8.30E-11

1.00E-10

0.278

1000

1.7

1.E+01

[1]

6.00E+07

1.00E+05

3

→ Te-131, Te-131m

Te-116

2.49 h

ec, β+ / ph

1.70E-10

1.70E-10

0.033

8

0.2

1.E+02

[1]

3.00E+07

5.00E+04

30

→ Sb-116 [6]

Te-119m

4.70 d

ec, β+ / ph

1.E+00

8.00E+06

1.00E+04

300

Te-121

19.16 d

ec / ph

4.40E-10

4.30E-10

0.104

20

0.1

1.E+01

1.00E+07

2.00E+04

100

Te-121m

154 d

it, ec / ph

3.60E-09

2.30E-09

0.043

200

0.4

1.E+00

1.00E+06

2.00E+03

10

→ Te-121 [6]

Te-123

6.00 E14 a

ec / ph

5.00E-09

4.40E-09

0.017

2

<0.1

1.E-01

1.00E+06

2.00E+03

100

Te-123m

119.25 d

it / ph

3.40E-09

1.40E-09

0.032

400

0.8

1.E+00

1.00E+06

2.00E+03

10

→ Te-123

Te-125m

57.40 d

it / ph

2.90E-09

8.70E-10

0.027

500

1.1

1.E+03

2.00E+06

3.00E+03

3

Te-127

9.35 h

β / ph

1.80E-10

1.70E-10

0.001

1000

1.4

1.E+03

3.00E+07

5.00E+04

3

Te-127m

109 d

it, β / ph

6.20E-09

2.30E-09

0.009

40

0.5

1.E+01

[2]

8.00E+05

1.00E+03

10

→ Te-127

Te-129

69.6 min

β / ph

5.70E-11

6.30E-11

0.012

1000

1.6

1.E+02

[1]

9.00E+07

1.00E+05

3

→ I-129

Te-129m

33.6 d

it, β / ph

5.40E-09

3.00E-09

0.011

600

1.2

1.E+01

[2]

9.00E+05

2.00E+03

3

→ Te-129

Te-131

25.0 min

β / ph

6.10E-11

8.70E-11

0.067

2000

2

1.E+02

8.00E+07

1.00E+05

3

→ I-131

Te-131m

30 h

β, it / ph

1.60E-09

1.90E-09

0.208

2000

1.5

1.E+01

[2]

3.00E+06

5.00E+03

3

→ I-131, Te-131

Te-132

3.204 d

β / ph

3.00E-09

3.70E-09

0.050

700

0.7

1.E+00

[2]

2.00E+06

3.00E+03

10

→ I-132 [6]

Te-133

12.5 min

β / ph

4.40E-11

7.20E-11

0.151

1000

1.7

1.E+01

[1]

1.00E+08

2.00E+05

3

→ I-133

Te-133m

55.4 min

β, it / ph

1.90E-10

2.80E-10

0.344

1000

1.8

1.E+01

[1]

3.00E+07

4.00E+04

3

→ I-133, Te-133

Te-134

41.8 min

β / ph

1.10E-10

1.10E-10

0.142

2000

1.7

1.E+01

[1]

5.00E+07

8.00E+04

3

→ I-134 [6]

I-120

81.6 min

ec, β+ / ph

1.90E-10

3.40E-10

1.155

800

1.5

1.E+01

[1]

3.00E+07

4.00E+04

3

I-120m

53 min

ec, β+ / ph

1.40E-10

2.10E-10

1.108

800

1.7

1.E+01

[1]

4.00E+07

6.00E+04

3

I-121

2.12 h

ec, β+ / ph

3.90E-11

8.20E-11

0.077

400

0.4

1.E+02

[1]

1.00E+08

2.00E+05

10

→ Te-121

I-123

13.27 h

ec / ph

1.10E-10

2.10E-10

0.043

400

0.3

1.E+02

5.00E+07

8.00E+04

30

→ Te-123

I-124

4.1760 d

ec, β+ / ph

6.30E-09

1.30E-08

0.170

300

0.5

1.E+01

8.00E+05

1.00E+03

10

I-125

59.400 d

ec / ph

7.30E-09

1.50E-08

0.033

4

<0.1

1.E+02

7.00E+05

1.00E+03

10

I-126

12.93 d

ec, β+, β / ph

1.40E-08

2.90E-08

0.078

700

0.7

1.E+01

4.00E+05

6.00E+02

10

I-128

24.99 min

β, ec, β+ / ph

2.20E-11

4.60E-11

0.016

1000

1.5

1.E+02

[1]

2.00E+08

4.00E+05

3

I-129

1.57 E7 a

β / ph

5.10E-08

1.10E-07

0.016

100

0.3

1.E-02

1.00E+05

2.00E+02

3

→ Xe-129

I-130

12.36 h

β / ph

9.60E-10

2.00E-09

0.325

1000

1.6

1.E+01

5.00E+06

9.00E+03

3

I-131

8.02070 d

β / ph

1.10E-08

2.20E-08

0.062

1000

1.4

1.E+01

5.00E+05

8.00E+02

3

→ Xe-131m

I-132

2.295 h

β / ph

2.00E-10

2.90E-10

0.338

1000

1.7

1.E+01

[1]

3.00E+07

4.00E+04

3

I-132m

1.387 h

it, β / ph

1.10E-10

2.20E-10

0.055

300

1

1.E+02

5.00E+07

8.00E+04

10

→ I-132 [6]

I-133

20.8 h

β / ph

2.10E-09

4.30E-09

0.093

1000

1.6

1.E+01

2.00E+06

4.00E+03

3

→ Xe-133, Xe-133m

I-134

52.5 min

β / ph

7.90E-11

1.10E-10

0.385

1000

1.8

1.E+01

[1]

6.00E+07

1.00E+05

3

I-135

6.57 h

β / ph

4.60E-10

9.30E-10

0.223

1000

1.6

1.E+01

[2]

1.00E+07

2.00E+04

3

→ Xe-135, Xe-135m

Xe-122 / I-122

20.1 h

ec, β+ / ph

0.284

800

1.3

7.00E+07

7.00E+04

Xe-123

2.08 h

ec, β+ / ph

0.107

800

0.9

1.00E+08

1.00E+05

→ I-123

Xe-125

16.9 h

ec, β+ / ph

0.060

300

0.2

3.00E+08

3.00E+05

→ I-125

Xe-127

36.4 d

ec / ph

0.059

400

0.3

2.00E+08

2.00E+05

Xe-129m

8.88 d

it / ph

0.030

3000

1.9

3.00E+09

3.00E+06

Xe-131m

11.84 d

it / ph

0.012

3000

2.1

8.00E+09

8.00E+06

Xe-133

5.243 d

β / ph

0.016

1000

1

2.00E+09

2.00E+06

Xe-133m

2.19 d

it / ph

0.016

2000

1.7

2.00E+09

2.00E+06

→ Xe-133

Xe-135

9.14 h

β / ph

0.040

2000

1.6

3.00E+08

3.00E+05

→ Cs-135

Xe-135m

15.29 min

it, β / ph

0.069

200

0.4

2.00E+08

2.00E+05

→ Cs-135

Xe-137

3.818 min

β / ph

1.167

2

1.7

3.00E+08

3.00E+05

Xe-138

14.08 min

β / ph

0.166

1000

1.7

5.00E+07

5.00E+04

→ Cs-138 [6]

Cs-125

45 min

ec, β+ / ph

2.30E-11

3.50E-11

0.114

500

0.7

1.E+01

[1]

2.00E+08

4.00E+05

10

→ Xe-125

Cs-127

6.25 h

ec, β+ / ph

4.00E-11

2.40E-11

0.079

100

0.2

1.E+02

1.00E+08

2.00E+05

30

→ Xe-127

Cs-129

32.06 h

ec, β+ / ph

8.10E-11

6.00E-11

0.063

30

<0.1

1.E+01

6.00E+07

1.00E+05

1000

Cs-130

29.21 min

ec, β+, β / ph

1.50E-11

2.80E-11

0.087

500

0.8

1.E+02

[1]

3.00E+08

6.00E+05

10

Cs-131

9.689 d

ec / ph

4.50E-11

5.80E-11

0.016

2

<0.1

1.E+03

[1]

1.00E+08

2.00E+05

1000

Cs-132

6.479 d

ec, β+, β / ph

3.80E-10

5.00E-10

0.119

50

0.1

1.E+01

1.00E+07

2.00E+04

100

Cs-134

2.0648 a

β, ec / ph

9.60E-09

1.90E-08

0.236

1000

1.1

1.E-01

5.00E+05

9.00E+02

3

Cs-134m

2.903 h

it / ph

2.60E-11

2.00E-11

0.009

1000

1.5

1.E+03

2.00E+08

3.00E+05

3

→ Cs-134 [6]

Cs-135

2.3 E6 a

β

9.90E-10

2.00E-09

0.000

600

0.7

1.E+02

5.00E+06

8.00E+03

10

Cs-135m

53 min

it / ph

2.40E-11

1.90E-11

0.239

70

0.2

1.E+01

[1]

2.00E+08

3.00E+05

30

→ Cs-135

Cs-136

13.16 d

β / ph

1.90E-09

3.00E-09

0.327

1000

1.5

1.E+00

3.00E+06

4.00E+03

3

Cs-137 / Ba-137m

30.1671 a

β, it / ph

6.70E-09

1.30E-08

0.092

2000

1.5

1.E-01

[2]

7.00E+05

1.00E+03

3

Cs-138

33.41 min

β / ph

4.60E-11

9.20E-11

0.445

1000

1.8

1.E+01

[1]

1.00E+08

2.00E+05

3

Ba-126 / Cs-126

100 min

ec, β+ / ph

1.20E-10

2.60E-10

0.805

900

1.6

1.E+02

[1]

4.00E+07

7.00E+04

3

Ba-128 / Cs-128

2.43 d

ec, β+ / ph

1.30E-09

2.70E-09

0.209

700

1.2

1.E+02

[2]

4.00E+06

6.00E+03

3

Ba-131

11.50 d

ec / ph

3.50E-10

4.50E-10

0.087

300

0.4

1.E+01

1.00E+07

2.00E+04

10

→ Cs-131

Ba-131m

14.6 min

it / ph

6.40E-12

4.90E-12

0.019

50

0.4

1.E+02

[1]

8.00E+08

1.00E+06

10

→ Ba-131

Ba-133

10.52 a

ec / ph

1.80E-09

1.00E-09

0.085

70

0.1

1.E-01

3.00E+06

5.00E+03

100

Ba-133m

38.9 h

it, ec / ph

2.80E-10

5.50E-10

0.019

2000

1.5

1.E+02

2.00E+07

3.00E+04

3

→ Ba-133

Ba-135m

28.7 h

it / ph

2.30E-10

4.50E-10

0.018

2000

1.5

1.E+02

2.00E+07

4.00E+04

3

Ba-139

83.06 min

β / ph

5.50E-11

1.20E-10

0.012

1000

1.7

1.E+02

[1]

9.00E+07

2.00E+05

3

Ba-140

12.752 d

β / ph

1.60E-09

2.50E-09

0.031

1000

1.5

1.E+00

3.00E+06

5.00E+03

3

→ La-140 [6]

Ba-141

18.27 min

β / ph

3.50E-11

7.00E-11

0.152

1000

1.9

1.E+02

[1]

1.00E+08

2.00E+05

3

→ La-141

Ba-142

10.6 min

β / ph

2.70E-11

3.50E-11

0.160

1000

1.7

1.E+02

[1]

2.00E+08

3.00E+05

3

→ La-142 [6]

La-131

59 min

ec, β+ / ph

3.60E-11

3.50E-11

0.116

400

0.6

1.E+01

[1]

1.00E+08

2.00E+05

10

→ Ba-131

La-132

4.8 h

ec, β+ / ph

2.80E-10

3.90E-10

0.379

400

0.8

1.E+01

[1]

2.00E+07

3.00E+04

10

La-135

19.5 h

ec, β+ / ph

2.50E-11

3.00E-11

0.017

2

<0.1

1.E+03

2.00E+08

3.00E+05

1000

La-137

6.0 E4 a

ec / ph

1.00E-08

8.10E-11

0.014

2

<0.1

1.E+02

5.00E+05

8.00E+02

1000

La-138

1.02 E11 a

ec, β / ph

1.80E-07

1.10E-09

0.185

400

0.4

1.E-01

3.00E+04

5.00E+01

10

La-140

1.6781 d

β / ph

1.50E-09

2.00E-09

0.332

1000

1.8

1.E+00

3.00E+06

6.00E+03

3

La-141

3.92 h

β / ph

2.20E-10

3.60E-10

0.016

1000

1.6

1.E+02

[1]

2.00E+07

4.00E+04

3

→ Ce-141

La-142

91.1 min

β / ph

1.50E-10

1.80E-10

0.490

1000

1.8

1.E+01

[1]

3.00E+07

6.00E+04

3

La-143

14.2 min

β / ph

3.30E-11

5.60E-11

0.219

1000

1.6

1.E+02

[1]

2.00E+08

3.00E+05

3

→ Ce-143

Ce-134 / La -134

3.16 d

ec, β+ / ph

1.60E-09

2.50E-09

0.149

600

1

1.E+03

[2]

3.00E+06

5.00E+03

10

Ce-135

17.7 h

ec, β+ / ph

7.60E-10

7.90E-10

0.271

2000

1.8

1.E+01

7.00E+06

1.00E+04

3

→ La-135

Ce-137

9.0 h

ec, β+ / ph

1.90E-11

2.50E-11

0.016

10

<0.1

1.E+03

3.00E+08

4.00E+05

1000

→ La-137

Ce-137m

34.4 h

it, ec / ph

5.90E-10

5.40E-10

0.016

2000

1.6

1.E+02

[2]

8.00E+06

1.00E+04

3

→ Ce-137, La-137

Ce-139

137.641 d

ec / ph

1.40E-09

2.60E-10

0.036

500

0.5

1.E+00

4.00E+06

6.00E+03

10

Ce-141

32.508 d

β / ph

3.10E-09

7.10E-10

0.014

2000

1.6

1.E+02

2.00E+06

3.00E+03

3

Ce-143

33.039 h

β / ph

1.00E-09

1.10E-09

0.053

1000

1.6

1.E+01

5.00E+06

8.00E+03

3

→ Pr-143

Ce-144 / Pr-144m

284.91 d

β / ph

2.90E-08

5.20E-09

0.005

800

0.9

1.E+01

[2]

2.00E+05

3.00E+02

10

→ Pr-144

Pr-136

13.1 min

ec, β+ / ph

2.50E-11

3.30E-11

0.375

600

1.1

1.E+01

[1]

2.00E+08

3.00E+05

3

Pr-137

1.28 h

ec, β+ / ph

3.50E-11

4.00E-11

0.083

300

0.5

1.E+02

[1]

1.00E+08

2.00E+05

10

→ Ce-137

Pr-138m

2.12 h

ec, β+ / ph

1.30E-10

1.30E-10

0.379

600

0.8

1.E+01

[1]

4.00E+07

6.00E+04

10

Pr-139

4.41 h

ec, β+ / ph

3.00E-11

3.10E-11

0.028

100

0.1

1.E+02

[1]

2.00E+08

3.00E+05

100

→ Ce-139

Pr-142

19.12 h

β, ec / ph

7.40E-10

1.30E-09

0.011

1000

1.6

1.E+02

7.00E+06

1.00E+04

3

Pr-142m

14.6 min

it / ph

9.40E-12

1.70E-11

<0.001

<1

<0.1

1.E+07

[1]

5.00E+08

9.00E+05

1000

→ Pr-142

Pr-143

13.57 d

β

2.20E-09

1.20E-09

0.000

1000

1.5

1.E+03

2.00E+06

4.00E+03

3

Pr-144

17.28 min

β / ph

3.00E-11

5.00E-11

0.099

1000

1.6

1.E+02

[1]

2.00E+08

3.00E+05

3

Pr-145

5.984 h

β / ph

2.60E-10

3.90E-10

0.002

1000

1.6

1.E+03

2.00E+07

3.00E+04

3

Pr-147

13.4 min

β / ph

3.00E-11

3.30E-11

0.144

1000

1.8

1.E+01

[1]

2.00E+08

3.00E+05

3

→ Nd-147

Nd-136

50.65 min

ec, β+ / ph

8.90E-11

9.90E-11

0.061

200

0.3

1.E+02

[1]

6.00E+07

9.00E+04

30

→ Pr-136 [6]

Nd-138 / Pr-138

5.04 h

ec / ph

3.80E-10

6.40E-10

0.398

700

1.3

1.E+03

[2]

1.00E+07

2.00E+04

3

Nd-139

29.7 min

ec, β+ / ph

1.70E-11

2.00E-11

0.070

300

0.4

1.E+02

[1]

3.00E+08

5.00E+05

10

→ Pr-139

Nd-139m

5.50 h

ec, β+, it / ph

2.50E-10

2.50E-10

0.246

500

0.6

1.E+01

[1]

2.00E+07

3.00E+04

10

→ Pr-139, Nd-139

Nd-140

3.37 d

ec / ph

1.E+04

[2]

3.00E+06

4.00E+03

100

Nd-141

2.49 h

ec, β+ / ph

8.80E-12

8.30E-12

0.021

50

0.1

1.E+02

[1]

6.00E+08

9.00E+05

100

Nd-147

10.98 d

β / ph

2.10E-09

1.10E-09

0.027

1000

1.5

1.E+02

2.00E+06

4.00E+03

3

→ Pm-147

Nd-149

1.728 h

β / ph

1.30E-10

1.20E-10

0.063

2000

1.8

1.E+02

[1]

4.00E+07

6.00E+04

3

→ Pm-149

Nd-151

12.44 min

β / ph

2.90E-11

3.00E-11

0.137

1000

1.7

1.E+01

[1]

2.00E+08

3.00E+05

3

→ Pm-151

Pm-141

20.90 min

ec, β+ / ph

2.50E-11

3.60E-11

0.137

500

0.9

1.E+01

[1]

2.00E+08

3.00E+05

10

→ Nd-141, Nd-141m

Pm-143

265 d

ec / ph

9.60E-10

2.30E-10

0.057

7

<0.1

1.E+00

5.00E+06

9.00E+03

1000

Pm-144

363 d

ec / ph

5.40E-09

9.70E-10

0.248

40

0.1

1.E-01

9.00E+05

2.00E+03

100

Pm-145

17.7 a

ec, α / ph

2.40E-09

1.10E-10

0.013

10

<0.1

1.E+01

2.00E+06

3.00E+03

1000

Pm-146

5.53 a

ec, β / ph

1.30E-08

9.00E-10

0.122

500

0.6

1.E-01

4.00E+05

6.00E+02

10

→ Sm-146

Pm-147

2.6234 a

β

3.50E-09

2.60E-10

<0.001

500

0.6

1.E+03

1.00E+06

2.00E+03

10

→ Sm-147

Pm-148

5.368 d

β / ph

2.20E-09

2.70E-09

0.091

1000

1.6

1.E+01

2.00E+06

4.00E+03

3

Pm-148m

41.29 d

β, it / ph

4.30E-09

1.80E-09

0.306

1000

1.4

1.E+00

1.00E+06

2.00E+03

3

→ Sm-148

Pm-149

53.08 h

β / ph

8.20E-10

9.90E-10

0.002

1000

1.6

1.E+03

6.00E+06

1.00E+04

3

Pm-150

2.68 h

β / ph

2.10E-10

2.60E-10

0.226

1000

1.8

1.E+01

[1]

2.00E+07

4.00E+04

3

Pm-151

28.40 h

β / ph

6.40E-10

7.30E-10

0.052

1000

1.5

1.E+01

8.00E+06

1.00E+04

3

→ Sm-151

Sm-141

10.2 min

ec, β+ / ph

2.70E-11

3.90E-11

0.287

500

1

1.E+01

[1]

2.00E+08

3.00E+05

10

→ Pm-141 [6]

Sm-141m

22.6 min

ec, β+, it / ph

5.60E-11

6.50E-11

0.338

900

1.1

1.E+01

[1]

9.00E+07

1.00E+05

3

→ Pm-141, Sm-141

Sm-142 / Pm-142

72.49 min

ec, β+ / ph

1.10E-10

1.90E-10

0.752

800

1.5

1.E+02

[1]

5.00E+07

8.00E+04

3

Sm-145

340 d

ec / ph

1.10E-09

2.10E-10

0.026

20

<0.1

1.E+02

5.00E+06

8.00E+03

1000

→ Pm-145

Sm-146

1.03 E8 a

α

6.70E-06

5.40E-08

<0.001

<1

<0.1

1.E+00

7.00E+02

1.00E+00

3

Sm-147

1.060 E11 a

α

6.10E-06

4.90E-08

<0.001

<1

<0.1

1.E+00

8.00E+02

1.00E+00

3

Sm-151

90 a

β

2.60E-09

9.80E-11

<0.001

<1

<0.1

1.E+03

2.00E+06

3.00E+03

1000

Sm-153

46.50 h

β / ph

6.80E-10

7.40E-10

0.016

1000

1.6

1.E+02

7.00E+06

1.00E+04

3

Sm-155

22.3 min

β / ph

2.80E-11

2.90E-11

0.019

1000

1.6

1.E+02

[1]

2.00E+08

3.00E+05

3

→ Eu-155

Sm-156

9.4 h

β / ph

2.80E-10

2.50E-10

0.022

1000

1.4

1.E+02

2.00E+07

3.00E+04

3

→ Eu-156 [6]

Eu-145

5.93 d

ec, β+ / ph

7.30E-10

7.50E-10

0.217

60

0.2

1.E+00

7.00E+06

1.00E+04

30

→ Sm-145

Eu-146

4.61 d

ec, β+ / ph

1.20E-09

1.30E-09

0.375

100

0.3

1.E+00

4.00E+06

7.00E+03

30

→ Sm-146

Eu-147

24.1 d

ec, β+, α / ph

1.00E-09

4.40E-10

0.085

300

0.3

1.E+01

5.00E+06

8.00E+03

30

→ Sm-147, Pm-143

Eu-148

54.5 d

ec, β+, α / ph

2.30E-09

1.30E-09

0.327

70

0.2

1.E+00

2.00E+06

4.00E+03

30

→ Pm-144

Eu-149

93.1 d

ec / ph

2.30E-10

1.00E-10

0.018

20

<0.1

1.E+01

2.00E+07

4.00E+04

1000

Eu-150

36.9 a

ec, β+ / ph

3.40E-08

1.30E-09

0.238

100

0.2

1.E-01

1.00E+05

2.00E+02

30

Eu-150m

12.8 h

β, ec, β+ / ph

2.80E-10

3.80E-10

0.008

1000

1.4

1.E+03

[1]

2.00E+07

3.00E+04

3

Eu-152

13.537 a

ec, β+, β / ph

2.70E-08

1.40E-09

0.179

700

0.8

1.E-01

2.00E+05

3.00E+02

10

→ Gd-152

Eu-152m

9.3116 h

β, ec, β+ / ph

3.20E-10

5.00E-10

0.047

900

1.3

1.E+02

2.00E+07

3.00E+04

3

→ Gd-152

Eu-154

8.593 a

β, ec / ph

3.50E-08

2.00E-09

0.185

2000

1.8

1.E-01

1.00E+05

2.00E+02

3

Eu-155

4.7611 a

β / ph

4.70E-09

3.20E-10

0.012

200

0.3

1.E+00

1.00E+06

2.00E+03

30

Eu-156

15.19 d

β / ph

3.00E-09

2.20E-09

0.188

1000

1.5

1.E+00

2.00E+06

3.00E+03

3

Eu-157

15.18 h

β / ph

4.40E-10

6.00E-10

0.049

1000

1.6

1.E+02

1.00E+07

2.00E+04

3

Eu-158

45.9 min

β / ph

7.50E-11

9.40E-11

0.220

1000

1.8

1.E+01

[1]

7.00E+07

1.00E+05

3

Gd-145

23.0 min

ec, β+ / ph

3.50E-11

4.40E-11

0.360

500

0.9

1.E+01

[1]

1.00E+08

2.00E+05

10

→ Eu-145 [6]

Gd-146

48.27 d

ec / ph

5.20E-09

9.60E-10

0.057

600

0.9

1.E+00

[2]

1.00E+06

2.00E+03

10

→ Eu-146 [6]

Gd-147

38.1 h

ec, β+ / ph

5.90E-10

6.10E-10

0.206

400

0.4

1.E+01

[1]

8.00E+06

1.00E+04

10

→ Eu-147

Gd-148

74.6 a

α

3.00E-05

5.50E-08

<0.001

<1

<0.1

1.E+00

2.00E+02

3.00E-01

3

Gd-149

9.28 d

ec, β+ / ph

7.90E-10

4.50E-10

0.076

400

0.6

1.E+01

6.00E+06

1.00E+04

10

→ Eu-149

Gd-151

124 d

ec, αα / ph

9.30E-10

2.00E-10

0.018

200

0.2

1.E+01

5.00E+06

9.00E+03

30

→ Sm-147

Gd-152

1.08 E14 a

α

2.20E-05

4.10E-08

<0.001

<1

<0.1

1.E+01

[1]

2.00E+02

4.00E-01

3

Gd-153

240.4 d

ec / ph

2.50E-09

2.70E-10

0.029

30

0.1

1.E+01

2.00E+06

3.00E+03

100

Gd-159

18.479 h

β / ph

3.90E-10

4.90E-10

0.010

1000

1.5

1.E+02

1.00E+07

2.00E+04

3

Tb-147

1.64 h

ec, β+ / ph

1.20E-10

1.60E-10

0.356

400

0.8

1.E+01

[1]

4.00E+07

7.00E+04

10

→ Gd-147 [6]

Tb-149

4.118 h

ec, β+, α / ph

3.10E-09

2.50E-10

0.241

400

0.6

1.E-01

2.00E+06

3.00E+03

10

→ Gd-149, Eu-145

Tb-150

3.48 h

ec, β+, α / ph

1.80E-10

2.50E-10

0.346

400

0.8

1.E+01

[1]

3.00E+07

5.00E+04

10

Tb-151

17.609 h

ec, β+, α / ph

3.30E-10

3.40E-10

0.147

400

0.6

1.E+01

2.00E+07

3.00E+04

10

→ Gd-151, Eu-147

Tb-153

2.34 d

ec, β+ / ph

2.40E-10

2.50E-10

0.045

100

0.1

1.E+01

2.00E+07

3.00E+04

100

→ Gd-153

Tb-154

21.5 h

ec, β+ / ph

6.00E-10

6.50E-10

0.313

400

0.6

1.E+01

[1]

8.00E+06

1.00E+04

10

Tb-155

5.32 d

ec / ph

2.50E-10

2.10E-10

0.031

200

0.2

1.E+02

2.00E+07

3.00E+04

30

Tb-156

5.35 d

ec / ph

1.40E-09

1.20E-09

0.277

500

0.8

1.E+00

4.00E+06

6.00E+03

10

Tb-156m

24.4 h

it / ph

2.30E-10

1.70E-10

0.007

4

<0.1

1.E+01

2.00E+07

4.00E+04

1000

Tb-156n

5.3 h

it / ph

1.30E-10

8.10E-11

0.001

8

0.6

1.E+04

[1]

4.00E+07

6.00E+04

10

→ Tb-156 [6]

Tb-157

71 a

ec / ph

7.90E-10

3.40E-11

0.001

6

<0.1

1.E+02

6.00E+06

1.00E+04

1000

Tb-158

180 a

ec, β / ph

3.00E-08

1.10E-09

0.127

400

0.6

1.E-01

2.00E+05

3.00E+02

10

Tb-160

72.3 d

β / ph

5.40E-09

1.60E-09

0.169

1000

1.7

1.E+00

9.00E+05

2.00E+03

3

Tb-161

6.906 d

β / ph

1.20E-09

7.20E-10

0.013

1000

1.3

1.E+03

4.00E+06

7.00E+03

3

Dy-155

9.9 h

ec, β+ / ph

1.20E-10

1.30E-10

0.094

100

0.1

1.E+01

[1]

4.00E+07

7.00E+04

100

→ Tb-155

Dy-157

8.14 h

ec / ph

5.50E-11

6.10E-11

0.065

40

0.1

1.E+02

9.00E+07

2.00E+05

100

→ Tb-157

Dy-159

144.4 d

ec / ph

2.50E-10

1.00E-10

0.015

10

<0.1

1.E+03

2.00E+07

3.00E+04

1000

Dy-165

2.334 h

β / ph

8.70E-11

1.10E-10

0.005

1000

1.6

1.E+03

6.00E+07

1.00E+05

3

Dy-166

81.6 h

β / ph

1.80E-09

1.60E-09

0.010

1000

1.1

1.E+02

3.00E+06

5.00E+03

3

→ Ho-166

Ho-155

48 min

ec, β+ / ph

3.20E-11

3.70E-11

0.066

300

0.5

1.E+02

[1]

2.00E+08

3.00E+05

10

→ Dy-155

Ho-157

12.6 min

ec, β+ / ph

7.60E-12

6.50E-12

0.088

300

0.3

1.E+02

[1]

7.00E+08

1.00E+06

30

→ Dy-157

Ho-159

33.05 min

ec, β+ / ph

1.00E-11

7.90E-12

0.069

200

0.2

1.E+02

[1]

5.00E+08

8.00E+05

30

→ Dy-159

Ho-161

2.48 h

ec / ph

1.00E-11

1.30E-11

0.022

20

<0.1

1.E+02

[1]

5.00E+08

8.00E+05

1000

Ho-162

15.0 min

ec, β+ / ph

4.50E-12

3.30E-12

0.032

70

0.2

1.E+02

[1]

1.00E+09

2.00E+06

30

Ho-162m

67.0 min

it, ec, β+ / ph

3.30E-11

2.60E-11

0.094

300

0.3

1.E+01

[1]

2.00E+08

3.00E+05

30

→ Ho-162

Ho-164

29 min

ec, β / ph

1.30E-11

9.50E-12

0.009

600

0.7

1.E+03

[1]

4.00E+08

6.00E+05

10

Ho-164m

38.0 min

it / ph

1.60E-11

1.60E-11

0.014

20

<0.1

1.E+03

[1]

3.00E+08

5.00E+05

1000

→ Ho-164

Ho-166

26.80 h

β / ph

8.30E-10

1.40E-09

0.005

1000

1.7

1.E+02

6.00E+06

1.00E+04

3

Ho-166m

1.20 E3 a

β / ph

7.80E-08

2.00E-09

0.268

800

0.9

1.E-01

6.00E+04

1.00E+02

10

Ho-167

3.1 h

β / ph

1.00E-10

8.30E-11

0.061

1000

1.4

1.E+02

[1]

5.00E+07

8.00E+04

3

Er-161

3.21 h

ec, β+

8.50E-11

8.00E-11

0.139

400

0.4

1.E+01

[1]

6.00E+07

1.00E+05

10

→ Ho-161

Er-165

10.36 h

ec

1.40E-11

1.90E-11

0.011

7

<0.1

1.E+03

[1]

4.00E+08

6.00E+05

1000

Er-169

9.40 d

β

9.20E-10

3.70E-10

<0.001

1000

1

1.E+03

5.00E+06

9.00E+03

10

Er-171

7.516 h

β

3.00E-10

3.60E-10

0.064

2000

1.9

1.E+02

2.00E+07

3.00E+04

3

→ Tm-171

Er-172

49.3 h

β

1.20E-09

1.00E-09

0.084

1000

1

1.E+01

4.00E+06

7.00E+03

10

→ Tm-172

Tm-162

21.70 min

ec, β+ / ph

2.70E-11

2.90E-11

0.261

300

0.9

1.E+01

[1]

2.00E+08

3.00E+05

10

Tm-166

7.70 h

ec, β+ / ph

2.80E-10

2.80E-10

0.270

200

0.4

1.E+01

2.00E+07

3.00E+04

10

Tm-167

9.25 d

ec / ph

1.00E-09

5.60E-10

0.029

2000

1.1

1.E+02

[1]

5.00E+06

8.00E+03

3

Tm-170

128.6 d

β, ec / ph

5.20E-09

1.30E-09

0.001

1000

1.6

1.E+02

1.00E+06

2.00E+03

3

Tm-171

1.92 a

β / ph

9.10E-10

1.10E-10

<0.001

<1

<0.1

1.E+03

5.00E+06

9.00E+03

1000

Tm-172

63.6 h

β / ph

1.40E-09

1.70E-09

0.069

1000

1.5

1.E+01

4.00E+06

6.00E+03

3

Tm-173

8.24 h

β / ph

2.60E-10

3.10E-10

0.063

1000

1.6

1.E+02

2.00E+07

3.00E+04

3

Tm-175

15.2 min

β / ph

3.10E-11

2.70E-11

0.160

2000

2

1.E+01

[1]

2.00E+08

3.00E+05

3

→ Yb-175

Yb-162

18.87 min

ec, β+ / ph

2.30E-11

2.30E-11

0.027

60

0.1

1.E+02

[1]

2.00E+08

4.00E+05

100

→ Tm-162 [6]

Yb-166

56.7 h

ec / ph

9.50E-10

9.50E-10

0.022

10

0.1

1.E+02

[1]

5.00E+06

9.00E+03

100

→ Tm-166 [6]

Yb-167

17.5 min

ec, β+ / ph

9.50E-12

6.70E-12

0.053

200

0.4

1.E+02

[1]

5.00E+08

9.00E+05

10

→ Tm-167

Yb-169

32.026 d

ec / ph

2.40E-09

7.10E-10

0.061

1000

1

1.E+01

2.00E+06

3.00E+03

10

Yb-175

4.185 d

β / ph

7.00E-10

4.40E-10

0.007

1000

1.1

1.E+02

7.00E+06

1.00E+04

3

Yb-177

1.911 h

β / ph

9.40E-11

9.70E-11

0.028

1000

1.5

1.E+02

[1]

5.00E+07

9.00E+04

3

→ Lu-177

Yb-178

74 min

β / ph

1.10E-10

1.20E-10

0.006

1000

1.3

1.E+03

[2]

5.00E+07

8.00E+04

3

→ Lu-178

Lu-169

34.06 h

ec, β+ / ph

4.90E-10

4.60E-10

0.154

100

0.2

1.E+01

[1]

1.00E+07

2.00E+04

30

→ Yb-169

Lu-170

2.012 d

ec, β+ / ph

9.50E-10

9.90E-10

0.281

60

0.3

1.E+01

[1]

5.00E+06

9.00E+03

30

Lu-171

8.24 d

ec, β+ / ph

9.30E-10

6.70E-10

0.115

30

0.1

1.E+01

5.00E+06

9.00E+03

100

Lu-172

6.70 d

ec, β+ / ph

1.80E-09

1.30E-09

0.283

300

0.5

1.E+00

3.00E+06

5.00E+03

10

Lu-173

1.37 a

ec / ph

1.50E-09

2.60E-10

0.028

30

0.1

1.E+00

3.00E+06

6.00E+03

100

Lu-174

3.31 a

ec, β+ / ph

2.90E-09

2.70E-10

0.024

10

<0.1

1.E+00

2.00E+06

3.00E+03

1000

Lu-174m

142 d

it, ec / ph

2.60E-09

5.30E-10

0.015

30

<0.1

1.E+01

2.00E+06

3.00E+03

300

→ Lu-174

Lu-176

3.85 E10 a

β / ph

4.60E-08

1.80E-09

0.081

2000

2.3

1.E-01

1.00E+05

2.00E+02

3

Lu-176m

3.635 h

β, ec / ph

1.60E-10

1.70E-10

0.003

1000

1.8

1.E+03

3.00E+07

5.00E+04

3

Lu-177

6.647 d

β / ph

1.10E-09

5.30E-10

0.006

1000

1.3

1.E+02

5.00E+06

8.00E+03

3

Lu-177m

160.4 d

β, it / ph

1.20E-08

1.70E-09

0.166

2000

2.6

1.E-01

[2]

4.00E+05

7.00E+02

3

→ Lu-177

Lu-178

28.4 min

β / ph

4.10E-11

4.70E-11

0.022

1000

1.8

1.E+02

[1]

1.00E+08

2.00E+05

3

Lu-178m

23.1 min

β / ph

5.60E-11

3.80E-11

0.182

2000

2.8

1.E+01

[1]

9.00E+07

1.00E+05

3

Lu-179

4.59 h

β / ph

1.60E-10

2.10E-10

0.005

1000

1.6

1.E+03

3.00E+07

5.00E+04

3

Hf-170

16.01 h

ec / ph

4.30E-10

4.80E-10

0.091

200

0.3

1.E+02

[1]

1.00E+07

2.00E+04

30

→ Lu-170 [6]

Hf-172

1.87 a

ec / ph

3.70E-08

1.00E-09

0.030

100

0.1

1.E+01

[2]

1.00E+05

2.00E+02

100

→ Lu-172 [6]

Hf-173

23.6 h

ec, β+ / ph

2.20E-10

2.30E-10

0.071

300

0.3

1.E+01

2.00E+07

4.00E+04

30

→ Lu-173

Hf-175

70 d

ec / ph

8.80E-10

4.10E-10

0.065

200

0.2

1.E+00

6.00E+06

9.00E+03

30

Hf-177m

51.4 min

it / ph

1.50E-10

8.10E-11

0.370

4000

4.5

1.E+01

[1]

3.00E+07

6.00E+04

1

Hf-178m

31 a

it / ph

3.10E-07

4.70E-09

0.378

2000

2.1

1.E+01

[1]

2.00E+04

3.00E+01

3

Hf-179m

25.05 d

it / ph

3.20E-09

1.20E-09

0.149

1000

1.6

1.E+01

[1]

2.00E+06

3.00E+03

3

Hf-180m

5.5 h

it, β / ph

2.00E-10

1.70E-10

0.166

700

1.1

1.E+01

[1]

3.00E+07

4.00E+04

3

Hf-181

42.39 d

β / ph

4.10E-09

1.10E-09

0.089

2000

1.9

1.E+00

1.00E+06

2.00E+03

3

Hf-182

9E6 a

β / ph

3.60E-07

3.00E-09

0.039

500

0.6

1.E-01

[2]

1.00E+04

2.00E+01

10

→ Ta-182 [6]

Hf-182m

61.5 min

β, it / ph

7.10E-11

4.20E-11

0.150

1000

1.8

1.E+01

[1]

7.00E+07

1.00E+05

3

→ Ta-182 [6], Hf-182

Hf-183

1.067 h

β / ph

8.30E-11

7.30E-11

0.116

1000

1.6

1.E+01

[1]

6.00E+07

1.00E+05

3

→ Ta-183

Hf-184

4.12 h

β / ph

4.50E-10

5.20E-10

0.043

2000

2.2

1.E+02

[1]

1.00E+07

2.00E+04

3

→ Ta-184

Ta-172

36.8 min

ec, β+ / ph

5.70E-11

5.30E-11

0.244

700

1.5

1.E+01

[1]

9.00E+07

1.00E+05

3

→ Hf-172 [6]

Ta-173

3.14 h

ec, β+ / ph

1.60E-10

1.90E-10

0.098

500

0.7

1.E+01

[1]

3.00E+07

5.00E+04

10

→ Hf-173

Ta-174

1.14 h

ec, β+ / ph

6.60E-11

5.70E-11

0.106

700

1.2

1.E+01

[1]

8.00E+07

1.00E+05

3

→ Hf-174

Ta-175

10.5 h

ec, β+ / ph

2.00E-10

2.10E-10

0.137

200

0.3

1.E+01

[1]

3.00E+07

4.00E+04

30

→ Hf-175

Ta-176

8.09 h

ec, β+ / ph

3.30E-10

3.10E-10

0.280

100

0.5

1.E+01

2.00E+07

3.00E+04

10

Ta-177

56.56 h

ec / ph

1.30E-10

1.10E-10

0.015

100

0.2

1.E+02

[1]

4.00E+07

6.00E+04

30

Ta-178

9.31 min

ec, β+ / ph

0.021

10

0.2

1.E+01

[1]

30

Ta-178m

2.36 h

ec / ph

1.10E-10

7.80E-11

0.172

700

1.2

5.00E+07

8.00E+04

3

Ta-179

1.82 a

ec / ph

2.90E-10

6.50E-11

0.008

6

<0.1

1.E+01

2.00E+07

3.00E+04

1000

Ta-180

8.152 h

ec, β / ph

6.20E-11

5.40E-11

0.011

200

0.4

1.E+01

[1]

8.00E+07

1.00E+05

10

Ta-180m

1E13 a

1.40E-08

8.40E-10

0.094

600

1

1.E+03

4.00E+05

6.00E+02

10

Ta-182

114.43 d

β / ph

7.40E-09

1.50E-09

0.194

1000

1.8

1.E-01

7.00E+05

1.00E+03

3

Ta-182m

15.84 min

it / ph

3.60E-11

1.20E-11

0.044

3000

2.7

1.E+02

[1]

1.00E+08

2.00E+05

3

→ Ta-182 [6]

Ta-183

5.1 d

β / ph

2.00E-09

1.30E-09

0.051

2000

2.3

1.E+01

3.00E+06

4.00E+03

3

Ta-184

8.7 h

β / ph

6.30E-10

6.80E-10

0.247

2000

2.8

1.E+01

[1]

8.00E+06

1.00E+04

3

Ta-185

49.4 min

β / ph

7.20E-11

6.80E-11

0.033

2000

2.3

1.E+02

[1]

7.00E+07

1.00E+05

3

→ W-185

Ta-186

10.5 min

β / ph

3.10E-11

3.30E-11

0.252

2000

2.5

1.E+01

[1]

2.00E+08

3.00E+05

3

W-176

2.3 h

7.60E-11

1.10E-10

0.036

20

0.1

1.E+02

[1]

7.00E+07

1.00E+05

100

→ Ta-176 [6]

W-177

132 min

ec, β+ / ph

4.60E-11

6.10E-11

0.140

300

0.4

1.E+01

[1]

1.00E+08

2.00E+05

10

→ Ta-177

W-178 / Ta-178-1

21.6 d

ec / ph

1.20E-10

2.50E-10

0.024

20

0.2

1.E+01

[1]

4.00E+07

7.00E+04

30

W-179

37.05 min

ec / ph

1.80E-12

3.30E-12

0.019

10

<0.1

1.E+02

[1]

3.00E+09

5.00E+06

1000

→ Ta-179

W-181

121.2 d

ec / ph

4.30E-11

8.20E-11

0.009

7

<0.1

1.E+01

1.00E+08

2.00E+05

1000

W-185

75.1 d

β

2.20E-10

5.00E-10

<0.001

1000

1.1

1.E+03

2.00E+07

4.00E+04

3

W-187

23.72 h

β / ph

3.30E-10

7.10E-10

0.075

2000

1.6

1.E+01

2.00E+07

3.00E+04

3

→ Re-187

W-188

69.78 d

β / ph

8.40E-10

2.30E-09

<0.001

1000

1

1.E+01

[2]

6.00E+06

1.00E+04

10

→ Re-188

Re-177

0.233 h

2.20E-11

2.20E-11

0.100

300

0.8

1.E+01

[1]

2.00E+08

4.00E+05

10

→ W-177 [6]

Re-178

13.2 min

ec, β+ / ph

2.40E-11

2.50E-11

0.256

700

1.6

1.E+01

[1]

2.00E+08

3.00E+05

3

→ W-178

Re-181

19.9 h

ec, β+ / ph

3.70E-10

4.20E-10

0.124

500

0.6

1.E+01

1.00E+07

2.00E+04

10

→ W-181

Re-182

64.0 h

ec / ph

1.70E-09

1.40E-09

0.177

80

0.6

1.E+00

3.00E+06

5.00E+03

10

Re-182m

12.7 h

ec, β+ / ph

3.00E-10

2.70E-10

0.282

900

1.7

1.E+01

2.00E+07

3.00E+04

3

Re-183

70.0 d

ec / ph

1.E+01

3.00E+06

5.00E+03

300

Re-184

38.0 d

ec, β+ / ph

1.80E-09

1.00E-09

0.138

300

0.6

1.E+00

3.00E+06

5.00E+03

10

Re-184m

169 d

it, ec / ph

4.80E-09

1.50E-09

0.063

300

0.8

1.E-01

1.00E+06

2.00E+03

10

→ Re-184 [6]

Re-186

3.7183 d

β, ec / ph

1.20E-09

1.50E-09

0.004

2000

1.6

1.E+03

4.00E+06

7.00E+03

3

Re-186m

2.00 E5 a

it / ph

7.90E-09

2.20E-09

0.004

10

0.1

1.E+00

[2]

6.00E+05

1.00E+03

100

→ Re-186

Re-187

4.12 E10 a

β

4.60E-12

5.10E-12

<0.001

<1

<0.1

1.E+03

1.00E+09

2.00E+06

1000

Re-188

17.0040 h

β / ph

7.40E-10

1.40E-09

0.010

1000

1.8

1.E+02

7.00E+06

1.00E+04

3

Re-188m

18.59 min

it / ph

2.00E-11

3.00E-11

0.016

40

0.2

1.E+02

[1]

3.00E+08

4.00E+05

30

→ Re-188

Re-189

24.3 h

β / ph

6.00E-10

7.80E-10

0.011

2000

1.6

1.E+02

[2]

8.00E+06

1.00E+04

3

→ Os-189m

Os-180 / Re-180

21.5 min

ec, β+ / ph

2.50E-11

1.70E-11

0.199

300

1

1.E+02

[1]

2.00E+08

3.00E+05

10

Os-181

105 min

ec, β+ / ph

1.00E-10

8.90E-11

0.186

400

0.6

1.E+01

[1]

5.00E+07

8.00E+04

10

→ Re-181 [6]

Os-182

22.10 h

ec / ph

5.20E-10

5.60E-10

0.071

100

0.2

1.E+01

1.00E+07

2.00E+04

30

→ Re-182-1 [6]

Os-185

93.6 d

ec / ph

1.40E-09

5.10E-10

0.112

40

0.1

1.E+00

4.00E+06

6.00E+03

100

Os-189m

5.8 h

it / ph

7.90E-12

1.80E-11

<0.001

5

<0.1

1.E+04

[1]

6.00E+08

1.00E+06

1000

Os-191

15.4 d

β / ph

1.50E-09

5.70E-10

0.015

400

0.4

1.E+02

[2]

3.00E+06

6.00E+03

10

Os-191m

13.10 h

it / ph

1.40E-10

9.60E-11

0.002

5

0.1

1.E+03

4.00E+07

6.00E+04

100

→ Os-191

Os-193

30.11 h

β / ph

6.80E-10

8.10E-10

0.012

1000

1.6

1.E+02

7.00E+06

1.00E+04

3

Os-194

6.0 a

β / ph

4.20E-08

2.40E-09

0.001

2

<0.1

1.E+00

[2]

1.00E+05

2.00E+02

100

→ Ir-194

Ir-182

15 min

ec, β+ / ph

4.00E-11

4.80E-11

0.584

1000

1.9

1.E+01

[1]

1.00E+08

2.00E+05

3

→ Os-182

Ir-184

3.09 h

ec, β+ / ph

1.90E-10

1.70E-10

0.296

1000

1.5

1.E+01

[1]

3.00E+07

4.00E+04

3

Ir-185

14.4 h

ec, β+ / ph

2.60E-10

2.60E-10

0.091

300

0.5

1.E+01

[1]

2.00E+07

3.00E+04

10

→ Os-185 [6]

Ir-186

16.64 h

ec, β+ / ph

5.00E-10

4.90E-10

0.243

1000

1

1.E+01

[1]

1.00E+07

2.00E+04

10

Ir-186m

1.92 h

ec, β+, it / ph

7.10E-11

6.10E-11

0.152

900

0.9

1.E+01

[1]

7.00E+07

1.00E+05

10

Ir-187

10.5 h

ec, β+ / ph

1.20E-10

1.20E-10

0.059

100

0.1

1.E+02

4.00E+07

7.00E+04

100

Ir-188

41.5 h

ec, β+ / ph

6.20E-10

6.30E-10

0.223

500

0.5

1.E+01

[1]

8.00E+06

1.00E+04

10

Ir-189

13.2 d

ec / ph

4.60E-10

2.40E-10

0.016

50

0.1

1.E+02

[2]

1.00E+07

2.00E+04

100

Ir-190

11.78 d

ec / ph

2.50E-09

1.20E-09

0.228

800

1.3

1.E+00

[2]

2.00E+06

3.00E+03

3

Ir-190m

1.120 h

it / ph

1.10E-11

8.00E-12

<0.001

5

<0.1

1.E+04

[1]

5.00E+08

8.00E+05

1000

→ Ir-190 [6]

Ir-190n

3.087 h

ec, it / ph

1.40E-10

1.20E-10

0.247

900

0.9

1.E+01

[1]

4.00E+07

6.00E+04

10

→ Ir-190

Ir-192

73.827 d

β, ec / ph

4.90E-09

1.40E-09

0.131

2000

1.6

1.E+00

1.00E+06

2.00E+03

3

Ir-192n

241 a

it / ph

1.90E-08

3.10E-10

0.025

2

<0.1

1.E+02

[1]

3.00E+05

4.00E+02

1000

→ Ir-192 [6]

Ir-193m

10.53 d

it / ph

1.00E-09

2.70E-10

1.E+04

5.00E+06

8.00E+03

1000

Ir-194

19.28 h

β / ph

7.50E-10

1.30E-09

0.017

1000

1.6

1.E+02

7.00E+06

1.00E+04

3

Ir-194m

171 d

β / ph

8.20E-09

2.10E-09

0.367

1000

1.5

1.E+01

[2]

6.00E+05

1.00E+03

3

Ir-195

2.5 h

β / ph

1.00E-10

1.00E-10

0.012

1000

1.7

1.E+02

[1]

5.00E+07

8.00E+04

3

Ir-195m

3.8 h

β, it / ph

2.40E-10

2.10E-10

0.073

2000

2.6

1.E+02

[1]

2.00E+07

3.00E+04

3

→ Ir-195

Pt-186

2.08 h

ec, α / ph

6.60E-11

9.30E-11

0.115

20

0.1

1.E+01

[1]

8.00E+07

1.00E+05

100

→ Ir-186-1 [6], Os-182

Pt-188

10.2 d

ec, α / ph

6.30E-10

7.60E-10

0.035

800

0.8

1.E+01

[1]

8.00E+06

1.00E+04

10

→ Ir-188 [6]

Pt-189

10.87 h

ec, β+ / ph

7.30E-11

1.20E-10

0.054

200

0.2

1.E+02

7.00E+07

1.00E+05

30

→ Ir-189

Pt-190

6.50 E11 a

α

1.E+00

2.00E+04

4.00E+01

30

Pt-191

2.802 d

ec / ph

1.90E-10

3.40E-10

0.053

200

0.3

1.E+01

[2]

3.00E+07

4.00E+04

30

Pt-193

50 a

ec / ph

2.70E-11

3.10E-11

0.001

4

<0.1

1.E+01

2.00E+08

3.00E+05

1000

Pt-193m

4.33 d

it / ph

2.10E-10

4.50E-10

0.003

2000

1.8

1.E+03

[1]

2.00E+07

4.00E+04

3

→ Pt-193

Pt-195m

4.02 d

it / ph

3.10E-10

6.30E-10

0.016

2000

2.1

1.E+02

[1]

2.00E+07

3.00E+04

3

Pt-197

19.8915 h

β / ph

1.60E-10

4.00E-10

0.005

1000

1.5

1.E+03

3.00E+07

5.00E+04

3

Pt-197m

95.41 min

it, β / ph

4.30E-11

8.40E-11

0.015

2000

1.6

1.E+02

[1]

1.00E+08

2.00E+05

3

→ Pt-197

Pt-199

30.80 min

β / ph

2.20E-11

3.90E-11

0.031

1000

1.7

1.E+02

[1]

2.00E+08

4.00E+05

3

→ Au-199

Pt-200

12.5 h

β / ph

4.00E-10

1.20E-09

0.011

1000

1.5

1.E+02

[2]

1.00E+07

2.00E+04

3

→ Au-200

Au-193

17.65 h

ec / ph

1.60E-10

1.30E-10

0.029

400

0.5

1.E+02

3.00E+07

5.00E+04

10

→ Pt-193

Au-194

38.02 h

ec, β+ / ph

3.80E-10

4.20E-10

0.157

200

0.2

1.E+01

1.00E+07

2.00E+04

30

Au-195

186.098 d

ec / ph

1.20E-09

2.50E-10

0.017

40

0.2

1.E+01

4.00E+06

7.00E+03

30

Au-196

6.183 d

ec, β / ph

1.E+01

1.00E+07

2.00E+04

1000

Au-198

2.69517 d

β / ph

1.10E-09

1.00E-09

0.065

1000

1.6

1.E+01

5.00E+06

8.00E+03

3

Au-198m

2.27 d

it / ph

2.00E-09

1.30E-09

0.094

3000

3.9

1.E+01

3.00E+06

4.00E+03

1

→ Au-198

Au-199

3.139 d

β / ph

7.60E-10

4.40E-10

0.015

2000

1.5

1.E+02

7.00E+06

1.00E+04

3

Au-200

48.4 min

β / ph

5.60E-11

6.80E-11

0.044

1000

1.6

1.E+02

[1]

9.00E+07

1.00E+05

3

Au-200m

18.7 h

β, it / ph

1.00E-09

1.10E-09

0.323

2000

2.1

1.E+01

[1]

5.00E+06

8.00E+03

3

→ Au-200

Au-201

26 min

β / ph

2.90E-11

2.40E-11

0.008

1000

1.6

1.E+02

[1]

2.00E+08

3.00E+05

3

Hg-193

3.80 h

ec, β+ / ph

1.00E-10

8.20E-11

0.037

800

1.1

1.E+02

[1]

5.00E+07

8.00E+04

3

→ Au-193

Hg-193m

11.8 h

ec, β+, it / ph

3.80E-10

4.00E-10

0.162

1000

0.9

1.E+01

[1]

1.00E+07

2.00E+04

10

→ Hg-193

Hg-194

440 a

ec / ph

1.90E-08

5.10E-08

0.001

4

<0.1

1.E-01

[2]

3.00E+05

4.00E+02

3

→ Au-194 [6]

Hg-195

10.53 h

ec, β+ / ph

9.20E-11

9.70E-11

0.034

60

0.1

1.E+02

5.00E+07

9.00E+04

100

→ Au-195

Hg-195m

41.6 h

it, ec, β+ / ph

6.50E-10

5.60E-10

0.037

1000

1.3

1.E+02

[2]

8.00E+06

1.00E+04

3

→ Hg-195, Au-195

Hg-197

64.94 h

ec / ph

2.80E-10

2.30E-10

0.014

20

0.1

1.E+02

2.00E+07

3.00E+04

100

Hg-197m

23.8 h

it, ec / ph

6.60E-10

4.70E-10

0.017

3000

2.7

1.E+02

8.00E+06

1.00E+04

3

→ Hg-197

Hg-199m

42.66 min

it / ph

5.20E-11

3.10E-11

0.032

2000

2.3

1.E+02

[1]

1.00E+08

2.00E+05

3

Hg-203

46.612 d

β / ph

1.90E-09

1.90E-09

0.039

800

0.9

1.E+01

3.00E+06

4.00E+03

10

Tl-194

33.0 min

ec, β+ / ph

8.90E-12

8.10E-12

0.125

90

0.1

1.E+01

[1]

6.00E+08

9.00E+05

100

→ Hg-194

Tl-194m

32.8 min

ec, β+ / ph

3.60E-11

4.00E-11

0.368

700

1.3

1.E+01

[1]

1.00E+08

2.00E+05

3

→ Hg-194

Tl-195

1.16 h

ec, β+ / ph

3.00E-11

2.70E-11

0.159

200

0.3

1.E+01

[1]

2.00E+08

3.00E+05

30

→ Hg-195

Tl-197

2.84 h

ec, β+ / ph

2.70E-11

2.30E-11

0.065

300

0.3

1.E+02

[1]

2.00E+08

3.00E+05

30

→ Hg-197

Tl-198

5.3 h

ec, β+ / ph

1.20E-10

7.30E-11

0.280

100

0.2

1.E+01

[1]

4.00E+07

7.00E+04

30

Tl-198m

1.87 h

ec, β+, it / ph

7.30E-11

5.40E-11

0.188

2000

1.5

1.E+01

[1]

7.00E+07

1.00E+05

3

→ Tl-198 [6]

Tl-199

7.42 h

ec, β+ / ph

3.70E-11

2.60E-11

0.042

600

0.5

1.E+02

1.00E+08

2.00E+05

10

Tl-200

26.1 h

ec, β+ / ph

2.50E-10

2.00E-10

0.198

100

0.2

1.E+01

2.00E+07

3.00E+04

30

Tl-201

72.912 h

ec / ph

7.60E-11

9.50E-11

0.018

100

0.2

1.E+02

7.00E+07

1.00E+05

30

Tl-202

12.23 d

ec / ph

3.10E-10

4.50E-10

0.077

60

0.1

1.E+01

2.00E+07

3.00E+04

100

Tl-204

3.78 a

β, ec / ph

6.20E-10

1.30E-09

<0.001

1000

1.4

1.E+00

8.00E+06

1.00E+04

3

→ Pb-204

Tl-209

2.161 min

β / ph

0.296

1000

1.9

3

→ Pb-209

Pb-195m

15 min

ec, β+ / ph

3.00E-11

2.90E-11

0.254

600

1.9

1.E+01

[1]

2.00E+08

3.00E+05

3

→ Tl-195 [6]

Pb-198

2.4 h

ec / ph

8.70E-11

1.00E-10

0.073

600

0.6

1.E+02

[1]

6.00E+07

1.00E+05

10

→ Tl-198 [6]

Pb-199

90 min

ec, β+ / ph

4.80E-11

5.40E-11

0.218

200

0.3

1.E+01

[1]

1.00E+08

2.00E+05

30

→ Tl-199

Pb-200

21.5 h

ec / ph

2.60E-10

4.00E-10

0.037

1000

1

1.E+01

2.00E+07

3.00E+04

10

→ Tl-200 [6]

Pb-201

9.33 h

ec, β+ / ph

1.20E-10

1.60E-10

0.120

300

0.3

1.E+01

4.00E+07

7.00E+04

30

→ Tl-201

Pb-202

5.25 E4 a

ec, α / ph

1.40E-08

8.70E-09

0.001

4

<0.1

1.E-01

[2]

4.00E+05

6.00E+02

30

→ Tl-202

Pb-202m

3.53 h

it, ec / ph

1.20E-10

1.30E-10

0.310

900

1

1.E+01

[1]

4.00E+07

7.00E+04

10

→ Pb-202, Tl-202

Pb-203

51.873 h

ec / ph

1.60E-10

2.40E-10

0.054

500

0.4

1.E+01

3.00E+07

5.00E+04

10

Pb-205

1.53 E7 a

ec / ph

4.10E-10

2.80E-10

0.001

4

<0.1

1.E+01

1.00E+07

2.00E+04

1000

Pb-209

3.253 h

β

3.20E-11

5.70E-11

<0.001

1000

1.4

1.E+03

2.00E+08

3.00E+05

3

Pb-210

22.20 a

β, α / ph

1.10E-06

6.80E-07

0.003

3

<0.1

1.E-01

[2]

5.00E+03

8.00E+00

0.3

→ Bi-210

Pb-211 / Bi-211

36.1 min

β, α / ph

5.60E-09

1.80E-10

0.016

1000

1.7

1.E+02

[1]

9.00E+05

1.00E+03

3

Pb-212

10.64 h

β / ph

3.30E-08

5.90E-09

0.025

2000

1.8

1.E+01

[2]

2.00E+05

3.00E+02

3

→ Bi-212 [6]

Pb-214

26.8 min

β / ph

4.80E-09

1.40E-10

0.041

2000

1.9

1.E+02

[1]

1.00E+06

2.00E+03

3

→ Bi-214 [6]

Bi-200

36.4 min

ec, β+ / ph

5.60E-11

5.10E-11

0.371

600

0.7

1.E+01

[1]

9.00E+07

1.00E+05

10

→ Pb-200

Bi-201

108 min

ec, β+ / ph

1.10E-10

1.20E-10

0.205

500

0.8

1.E+01

[1]

5.00E+07

8.00E+04

10

→ Pb-201 [6]

Bi-202

1.72 h

ec, β+ / ph

1.00E-10

8.90E-11

0.367

500

0.6

1.E+01

[1]

5.00E+07

8.00E+04

10

→ Pb-202

Bi-203

11.76 h

ec, β+ / ph

4.50E-10

4.80E-10

0.310

200

0.4

1.E+01

[1]

1.00E+07

2.00E+04

10

→ Pb-203

Bi-205

15.31 d

ec, β+ / ph

1.00E-09

9.00E-10

0.239

100

0.2

1.E+01

[1]

5.00E+06

8.00E+03

30

→ Pb-205

Bi-206

6.243 d

ec, β+ / ph

2.10E-09

1.90E-09

0.487

600

1

1.E+00

2.00E+06

4.00E+03

10

Bi-207

32.9 a

ec, β+ / ph

3.20E-09

1.30E-09

0.233

100

0.3

1.E-01

2.00E+06

3.00E+03

30

Bi-208

3.68 E5 a

ec / ph

1.E-02

1.00E+06

2.00E+03

300

Bi-210

5.013 d

β, α

6.00E-08

1.30E-09

<0.001

1000

1.6

1.E+03

8.00E+04

1.00E+02

3

→ Po-210

Bi-210m

3.04 E6 a

α / ph

2.10E-06

1.50E-08

0.042

500

0.4

1.E-01

[2]

2.00E+03

4.00E+00

10

→ Tl-206

Bi-212 / Po-212, Tl-208

60.55 min

β, α / ph

3.90E-08

2.60E-10

0.180

1000

1.7

1.E+01

[1]

1.00E+05

2.00E+02

3

Bi-213 / Po-213, Tl-209

45.59 min

β, α / ph

4.10E-08

2.00E-10

0.027

1000

1.6

1.E+02

[1]

1.00E+05

2.00E+02

3

Bi-214

19.9 min

β, α / ph

2.10E-08

1.10E-10

0.239

1000

1.7

1.E+01

[1]

2.00E+05

4.00E+02

3

→ Po-214→ Pb-210

Po-203

36.7 min

ec, β+, α / ph

6.10E-11

5.20E-11

0.245

1000

1

1.E+01

[1]

8.00E+07

1.00E+05

10

→ Bi-203 [6]

Po-205

1.66 h

ec, β+, α / ph

8.90E-11

5.90E-11

0.233

200

0.3

1.E+01

[1]

6.00E+07

9.00E+04

30

→ Bi-205 [6], Pb-201

Po-206

8.8 d

ec, α / ph

1.E+00

1.00E+04

2.00E+01

3

→ Bi-206 [6]

Po-207

5.80 h

ec, β+, α / ph

1.50E-10

1.40E-10

0.201

200

0.3

1.E+01

[1]

3.00E+07

6.00E+04

30

→ Bi-207 [6]

Po-208

2.898 a

α, ec

1.E+00

2.00E+03

3.00E+00

0.3

→ Bi-208

Po-209

102 a

α, ec / ph

1.E+00

2.00E+03

3.00E+00

0.3

→ Pb-205

Po-210

138.376 d

α

2.20E-06

2.40E-07

<0.001

<1

<0.1

1.E+00

2.00E+03

4.00E+00

1

At-207

1.80 h

ec, β+, α / ph

1.90E-09

2.30E-10

0.198

500

0.5

1.E+01

[1]

3.00E+06

4.00E+03

10

→ Po-207 [6], Bi-203

At-211

7.214 h

ec, α / ph

1.10E-07

1.10E-08

0.008

3

<0.1

1.E+03

[2]

5.00E+04

8.00E+01

30

→ Po-211, Bi-207 [6]

Rn-220

55.6 s

α / ph

<0.001

<1

<0.1

→ Po-216→ Pb-212

Rn-222

3.8235 d

α / ph

<0.001

<1

<0.1

→ Po-218→ Pb-214

Fr-222

14.2 min

β / ph

2.10E-08

7.10E-10

0.001

1000

1.6

1.E+03

[2]

2.00E+05

4.00E+02

3

→ Ra-222 etc.

Fr-223

22.00 min

β, α / ph

1.30E-09

2.30E-09

0.017

2000

1.8

1.E+02

[1]

4.00E+06

6.00E+03

3

→ Ra-223

Ra-223

11.43 d

α / ph

5.70E-06

1.00E-07

0.024

600

0.5

1.E+01

[2]

9.00E+02

1.00E+00

3

→ Rn-219→ Po-215→ Pb-211

Ra-224

3.66 d

α / ph

2.40E-06

6.50E-08

0.002

30

<0.1

1.E+00

[2]

2.00E+03

3.00E+00

3

→ Rn-220 etc.

Ra-225

14.9 d

β / ph

4.80E-06

9.50E-08

0.007

1000

0.9

1.E+01

1.00E+03

2.00E+00

3

→ Ac-225

Ra-226

1600 a

α / ph

2.20E-06

2.80E-07

0.001

50

<0.1

1.E-02

[2]

2.00E+03

4.00E+00

1

→ Rn-222

Ra-226 (+ Töchter)

0.283

5000

5.2

1.E-02

2.00E+03

4.00E+00

1

Ra-227

42.2 min

β / ph

2.10E-10

8.40E-11

0.038

2000

1.8

1.E+02

[1]

2.00E+07

4.00E+04

3

→ Ac-227

Ra-228

5.75 a

β / ph

1.70E-06

6.70E-07

<0.001

<1

<0.1

1.E-01

[2]

3.00E+03

5.00E+00

0.3

→ Ac-228

Ac-224

2.78 h

ec, α / ph

9.90E-08

7.00E-10

0.038

100

0.2

1.E+02

[1]

5.00E+04

8.00E+01

30

→ Ra-224, Fr-220 etc.

Ac-225

10.0 d

α / ph

6.50E-06

2.40E-08

0.005

20

0.1

1.E+01

[2]

8.00E+02

1.00E+00

10

→ Fr-221 etc.

Ac-226

29.37 h

β, ec, α / ph

1.00E-06

1.00E-08

0.024

1000

1.3

1.E+02

[2]

5.00E+03

8.00E+00

3

→ Th-226, Ra-226, Fr-222

Ac-227

21.772 a

β, α / ph

6.30E-04

1.10E-06

<0.001

<1

<0.1

1.E-02

[2]

8.00E+00

1.00E-02

0.1

→ Th-227, Fr-223

Ac-228

6.15 h

β / ph

2.90E-08

4.30E-10

0.145

2000

1.8

1.E+01

[1]

2.00E+05

3.00E+02

3

→ Th-228

Th-226

30.57 min

α / ph

7.80E-08

3.60E-10

0.002

100

0.3

1.E+03

[1]

6.00E+04

1.00E+02

30

→ Ra-222 etc.

Th-227

18.68 d

α / ph

7.60E-06

8.90E-09

0.023

200

0.2

1.E+01

7.00E+02

1.00E+00

10

→ Ra-223

Th-228

1.9116 a

α / ph

3.20E-05

7.00E-08

0.002

3

<0.1

1.E-01

[2]

2.00E+02

3.00E-01

3

→ Ra-224

Th-229

7.34 E3 a

α / ph

6.90E-05

4.80E-07

0.027

300

0.5

1.E-01

[2]

7.00E+01

1.00E-01

0.3

→ Ra-225

Th-230

7.538 E4 a

α / ph

2.80E-05

2.10E-07

0.001

3

<0.1

1.E-01

2.00E+02

3.00E-01

1

→ Ra-226

Th-231

25.52 h

β / ph

4.00E-10

3.40E-10

0.019

700

0.8

1.E+03

1.00E+07

2.00E+04

10

→ Pa-231

Th-232

1.405 E10 a

α / ph

2.90E-05

2.20E-07

0.001

3

<0.1

1.E-01

[2]

2.00E+02

3.00E-01

1

→ Ra-228

Th-234 / Pa-234m

24.10 d

β / ph

5.80E-09

3.40E-09

0.008

1000

1.9

1.E+02

[2]

9.00E+05

1.00E+03

3

→ Pa-234

Th (+ Töchter)

0.355

6000

5.4

2.00E+02 [11]

Pa-227

38.3 min

α, ec / ph

9.70E-08

4.50E-10

0.007

5

<0.1

1.E+01

[1]

5.00E+04

9.00E+01

300

→ Ac-223

Pa-228

22 h

ec, β+, α / ph

5.10E-08

7.80E-10

0.168

400

0.9

1.E+01

1.00E+05

2.00E+02

10

→ Th-228, Ac-224

Pa-230

17.4 d

ec, β, α / ph

5.70E-07

9.20E-10

0.108

200

0.3

1.E+01

9.00E+03

1.00E+01

30

→ Th-230, U-230, Ac-226

Pa-231

3.276 E4 a

α / ph

8.90E-05

7.10E-07

0.020

40

0.1

1.E-02

6.00E+01

9.00E-02

0.3

→ Ac-227

Pa-232

1.31 d

β, ec / ph

6.80E-09

7.20E-10

0.151

1000

1.3

1.E+01

7.00E+05

1.00E+03

3

→ U-232

Pa-233

26.967 d

β / ph

3.20E-09

8.70E-10

0.041

2000

1.4

1.E+01

2.00E+06

3.00E+03

3

→ U-233

Pa-234

6.70 h

β / ph

5.80E-10

5.10E-10

0.281

2000

2.9

1.E+01

9.00E+06

1.00E+04

3

→ U-234

U-230

20.8 d

α / ph

1.20E-05

5.50E-08

0.003

6

<0.1

1.E+01

[2]

4.00E+02

7.00E-01

3

→ Th-226

U-231

4.2 d

ec, α / ph

4.00E-10

2.80E-10

0.032

10

0.1

1.E+02

1.00E+07

2.00E+04

100

→ Pa-231, Th-227

U-232

68.9 a

α / ph

2.60E-05

3.30E-07

0.002

6

<0.1

1.E-01

[2]

2.00E+02

3.00E-01

1

→ Th-228

U-233

1.592 E5 a

α / ph

6.90E-06

5.00E-08

0.001

2

<0.1

1.E+00

7.00E+02

1.00E+00

3

→ Th-229

U-234

2.455 E5 a

α / ph

6.80E-06

4.90E-08

0.002

3

<0.1

1.E+00

7.00E+02

1.00E+00

3

→ Th-230

U-235

7.04 E8 a

α / ph

6.10E-06

4.60E-08

0.028

100

0.2

1.E+00

[2]

8.00E+02

1.00E+00

3

→ Th-231

U-236

2.342E7 a

α / ph

6.30E-06

4.60E-08

0.002

1

<0.1

1.E+01

[1]

8.00E+02

1.00E+00

3

→ Th-232

U-237

6.75 d

β / ph

1.70E-09

7.70E-10

0.037

1000

1.6

1.E+02

3.00E+06

5.00E+03

3

→ Np-237

U-238

4.468 E9 a

α, fs / ph

5.70E-06

4.40E-08

0.002

1

<0.1

1.E+00

[2]

9.00E+02

1.00E+00

10

→ Th-234

U-239

23.45 min

β / ph

3.50E-11

2.80E-11

0.012

1000

1.6

1.E+02

[1]

1.00E+08

2.00E+05

3

→ Np-239

U-240

14.1 h

β / ph

8.40E-10

1.10E-09

0.009

1000

1

1.E+02

[2]

6.00E+06

1.00E+04

10

→ Np-240

U (+ Töchter)

0.296

6000

7.1

9.00E+02 [11]

Np-232

14.7 min

ec, β+ / ph

3.50E-11

9.70E-12

0.199

400

0.6

1.E+01

[1]

1.00E+08

2.00E+05

10

→ U-232

Np-233

36.2 min

ec, α / ph

3.00E-12

2.20E-12

0.022

40

<0.1

1.E+02

[1]

2.00E+09

3.00E+06

1000

→ U-233

Np-234

4.4 d

ec, β+ / ph

7.30E-10

8.10E-10

0.219

80

0.2

1.E+01

7.00E+06

1.00E+04

30

→ U-234

Np-235

396.1 d

ec, α / ph

2.70E-10

5.30E-11

0.008

3

<0.1

1.E+03

2.00E+07

3.00E+04

1000

→ U-235, Pa-231

Np-236

1.54 E5 a

ec, β, α / ph

2.00E-06

1.70E-08

0.046

1000

1.8

1.E+00

3.00E+03

4.00E+00

3

→ U-236, Pu-236

Np-236m

22.5 h

ec, β / ph

3.60E-09

1.90E-10

0.013

600

0.6

1.E+02

1.00E+06

2.00E+03

10

→ U-236, Pu-236

Np-237

2.144 E6 a

α / ph

1.50E-05

1.10E-07

0.018

30

0.1

1.E+00

[2]

3.00E+02

6.00E-01

3

→ Pa-233

Np-238

2.117 d

β / ph

1.70E-09

9.10E-10

0.089

1000

1.1

1.E+01

3.00E+06

5.00E+03

3

→ Pu-238

Np-239

2.3565 d

β / ph

1.10E-09

8.00E-10

0.039

2000

2.3

1.E+02

5.00E+06

8.00E+03

3

→ Pu-239

Np-240

61.9 min

β / ph

1.30E-10

8.20E-11

0.225

3000

3.4

1.E+01

[1]

4.00E+07

6.00E+04

1

→ Pu-240

Np-240m

7.22 min

β, it / ph

0.060

1000

1.6

1.E+03

3

→ Pu-240

Pu-234

8.8 h

ec, α / ph

1.80E-08

1.60E-10

0.018

6

<0.1

1.E+02

[1]

3.00E+05

5.00E+02

1000

→ Np-234, U-230

Pu-235

25.3 min

ec, α / ph

2.60E-12

2.10E-12

0.026

8

<0.1

1.E+02

[1]

2.00E+09

3.00E+06

1000

→ Np-235, U-231

Pu-236

2.858 a

α, fs / ph

1.30E-05

8.60E-08

0.003

1

<0.1

1.E+00

4.00E+02

6.00E-01

3

→ U-232

Pu-237

45.2 d

ec, α / ph

3.00E-10

1.00E-10

0.018

6

<0.1

1.E+02

2.00E+07

3.00E+04

1000

→ Np-237, U-233

Pu-238

87.7 a

α, fs / ph

3.00E-05

2.30E-07

0.002

<1

<0.1

1.E-01

2.00E+02

3.00E-01

1

→ U-234

Pu-239

2.411 E4 a

α / ph

3.20E-05

2.50E-07

0.001

<1

<0.1

1.E-01

[2]

2.00E+02

3.00E-01

1

→ U-235

Pu-240

6564 a

α, fs / ph

3.20E-05

2.50E-07

0.002

<1

<0.1

1.E-01

2.00E+02

3.00E-01

1

→ U-236

Pu-241

14.35 a

β, a

5.80E-07

4.70E-09

<0.001

<1

<0.1

1.E+01

9.00E+03

1.00E+01

30

→ Am-241, U-237

Pu-242

3.75 E5 a

α, fs / ph

3.10E-05

2.40E-07

0.002

<1

<0.1

1.E-01

2.00E+02

3.00E-01

1

→ U-238

Pu-243

4.956 h

β / ph

1.10E-10

8.50E-11

0.007

1000

1.3

1.E+03

5.00E+07

8.00E+04

3

→ Am-243

Pu-244 [9]

8.00 E7 a

α, fs / ph

3.00E-05

2.40E-07

0.053

1

0.1

1.E-01

[2]

2.00E+02

3.00E-01

1

→ U-240

Pu-245

10.5 h

β / ph

6.50E-10

7.20E-10

0.070

2000

2

1.E+02

[2]

8.00E+06

1.00E+04

3

→ Am-245

Pu-246

10.84 d

β / ph

7.00E-09

3.30E-09

0.034

700

0.7

1.E+01

[2]

7.00E+05

1.00E+03

10

→ Am-246

Am-237

73.0 min

ec, α / ph

3.60E-11

1.80E-11

0.073

800

0.7

1.E+02

[1]

1.00E+08

2.00E+05

10

→ Pu-237, Np-233

Am-238

98 min

ec, β+, α / ph

6.60E-11

3.20E-11

0.145

60

0.1

1.E+01

[1]

8.00E+07

1.00E+05

100

→ Pu-238, Np-234

Am-239

11.9 h

ec, α / ph

2.90E-10

2.40E-10

0.059

1000

1.4

1.E+02

[1]

2.00E+07

3.00E+04

3

→ Pu-239, Np-235

Am-240

50.8 h

ec, α / ph

5.90E-10

5.80E-10

0.171

50

0.3

1.E+01

8.00E+06

1.00E+04

30

→ Pu-240, Np-236

Am-241

432.2 a

α / ph

2.70E-05

2.00E-07

0.019

6

<0.1

1.E-01

2.00E+02

3.00E-01

1

→ Np-237

Am-242

16.02 h

β, ec / ph

1.20E-08

3.00E-10

0.009

1000

1.1

1.E+03

4.00E+05

7.00E+02

3

→ Cm-242, Pu-242

Am-242m

141 a

it, α / ph

2.40E-05

1.90E-07

0.006

2

<0.1

1.E-01

[2]

2.00E+02

3.00E-01

1

→ Am-242, Np-238

Am-243

7.37 E3 a

α / ph

2.70E-05

2.00E-07

0.014

2

<0.1

1.E-01

[2]

2.00E+02

3.00E-01

1

→ Np-239

Am-244

10.1 h

β / ph

1.50E-09

4.60E-10

0.145

3000

2.9

1.E+01

3.00E+06

6.00E+03

3

→ Cm-244

Am-244m

26 min

β / ph

6.20E-11

2.90E-11

0.002

1000

1.6

1.E+04

[1]

8.00E+07

1.00E+05

3

→ Cm-244

Am-245

2.05 h

β / ph

7.60E-11

6.20E-11

0.007

2000

1.8

1.E+03

7.00E+07

1.00E+05

3

→ Cm-245

Am-246

39 min

β / ph

1.10E-10

5.80E-11

0.135

4000

4.5

1.E+01

[1]

5.00E+07

8.00E+04

1

→ Cm-246

Am-246m

25.0 min

β / ph

3.80E-11

3.40E-11

0.154

1000

1.7

1.E+01

[1]

1.00E+08

2.00E+05

3

→ Cm-246

Cm-238

2.4 h

ec, α / ph

4.80E-09

8.00E-11

0.021

7

<0.1

1.E+02

[1]

1.00E+06

2.00E+03

1000

→ Am-238, Pu-234

Cm-240

27 d

α, fs / ph

2.30E-06

7.60E-09

0.003

<1

<0.1

1.E+02

2.00E+03

4.00E+00

30

→ Pu-236

Cm-241

32.8 d

ec, α / ph

2.60E-08

9.10E-10

0.100

600

0.7

1.E+01

2.00E+05

3.00E+02

10

→ Am-241, Pu-237

Cm-242

162.8 d

α, fs / ph

3.70E-06

1.20E-08

0.002

<1

<0.1

1.E+01

1.00E+03

2.00E+00

10

→ Pu-238

Cm-243

29.1 a

ec / ph

2.00E-05

1.50E-07

0.033

1000

1.1

1.E+00

3.00E+02

4.00E-01

1

→ Pu-239, Am-243

Cm-244

18.10 a

α, fs / ph

1.70E-05

1.20E-07

0.002

<1

<0.1

1.E+00

3.00E+02

5.00E-01

3

→ Pu-240

Cm-245

8.5 E3 a

α, fs / ph

2.70E-05

2.10E-07

0.028

400

0.4

1.E-01

2.00E+02

3.00E-01

1

→ Pu-241

Cm-246 [9]

4.76 E3 a

α, fs / ph

2.70E-05

2.10E-07

0.013

<1

<0.1

1.E-01

2.00E+02

3.00E-01

1

→ Pu-242

Cm-247

1.56 E7 a

α / ph

2.50E-05

1.90E-07

0.053

100

0.1

1.E-01

[2]

2.00E+02

3.00E-01

1

→ Pu-243

Cm-248 [9]

3.48 E5 a

α, fs / ph

9.50E-05

7.70E-07

3.8

<1

<0.1

1.E-01

5.00E+01

9.00E-02

0.3

→ Pu-244

Cm-249

64.15 min

β / ph

5.10E-11

3.10E-11

0.003

1000

1.5

1.E+03

1.00E+08

2.00E+05

3

→ Bk-249

Cm-250 [9]

8300 a

α, β, fs / ph

5.40E-04

4.40E-06

36

<1

<0.1

1.E-02

[2]

9.00E+00

2.00E-02

0.1

→ Pu-246, Bk-250

Bk-245

4.94 d

ec, α / ph

1.80E-09

5.70E-10

0.054

2000

1.6

1.E+02

3.00E+06

5.00E+03

3

→ Cm-245, Am-241

Bk-246

1.80 d

ec / ph

4.60E-10

4.80E-10

0.161

30

0.1

1.E+01

[1]

1.00E+07

2.00E+04

100

→ Cm-246

Bk-247

1.38 E3 a

α / ph

4.50E-05

3.50E-07

0.021

800

0.7

1.E-01

1.00E+02

2.00E-01

1

→ Am-243

Bk-249

330 d

β, α

1.00E-07

9.70E-10

<0.001

20

<0.1

1.E+02

5.00E+04

8.00E+01

300

→ Cf-249, Am-245

Bk-250

3.212 h

β / ph

7.10E-10

1.40E-10

0.137

1000

1.5

1.E+01

[1]

7.00E+06

1.00E+04

3

→ Cf-250

Cf-244

19.4 min

α / ph

1.80E-08

7.00E-11

0.003

<1

<0.1

1.E+04

[1]

3.00E+05

5.00E+02

1000

→ Cm-240

Cf-246

35.7 h

α, fs / ph

3.50E-07

3.30E-09

0.002

<1

<0.1

1.E+03

1.00E+04

2.00E+01

100

→ Cm-242

Cf-248 [9]

334 d

α, fs / ph

6.10E-06

2.80E-08

0.003

<1

<0.1

1.E+00

8.00E+02

1.00E+00

10

→ Cm-244

Cf-249

351 a

α, fs / ph

4.50E-05

3.50E-07

0.060

200

0.2

1.E-01

1.00E+02

2.00E-01

1

→ Cm-245

Cf-250 [9]

13.08 a

α, fs / ph

2.20E-05

1.60E-07

0.035

<1

<0.1

1.E+00

2.00E+02

4.00E-01

1

→ Cm-246

Cf-251

900 a

α / ph

4.60E-05

3.60E-07

0.037

1000

1.8

1.E-01

1.00E+02

2.00E-01

1

→ Cm-247

Cf-252 [9]

2.645 a

α, fs / ph

1.30E-05

9.00E-08

1.3

<1

<0.1

1.E+00

4.00E+02

6.00E-01

3

→ Cm-248

Cf-253

17.81 d

β, α / ph

1.00E-06

1.40E-09

<0.001

800

0.8

1.E+02

[2]

5.00E+03

8.00E+00

10

→ Es-253, Cm-249

Cf-254 [9]

60.5 d

α, fs / ph

2.20E-05

4.00E-07

42

<1

<0.1

1.E+00

2.00E+02

4.00E-01

1

→ Cm-250

Es-250

8.6 h

ec / ph

4.20E-10

2.10E-11

0.071

20

0.1

1.E+02

[1]

1.00E+07

2.00E+04

100

→ Cf-250

Es-251

33 h

ec, α / ph

1.70E-09

1.70E-10

0.028

200

0.2

1.E+02

[1]

3.00E+06

5.00E+03

30

→ Cf-251, Bk-247

Es-253

20.47 d

α, fs / ph

2.10E-06

6.10E-09

0.001

1

<0.1

1.E+02

2.00E+03

4.00E+00

30

→ Bk-249

Es-254

275.7 d

α, β, fs / ph

6.00E-06

2.80E-08

0.021

6

<0.1

1.E-01

[2]

8.00E+02

1.00E+00

10

→ Bk-250

Es-254m

39.3 h

β, α, ec, fs / ph

3.70E-07

4.20E-09

0.077

1000

1.4

1.E+01

[2]

1.00E+04

2.00E+01

3

→ Fm-254, Bk-250

Fm-252

25.39 h

α, fs / ph

2.60E-07

2.70E-09

0.002

<1

<0.1

1.E+03

2.00E+04

3.00E+01

100

→ Cf-248

Fm-253

3.00 d

ec, α / ph

3.00E-07

9.10E-10

0.023

200

0.2

1.E+02

2.00E+04

3.00E+01

30

→ Es-253, Cf-249

Fm-254

3.240 h

α, fs / ph

7.70E-08

4.40E-10

0.002

<1

<0.1

1.E+04

[1]

6.00E+04

1.00E+02

1000

→ Cf-250

Fm-255

20.07 h

α, fs / ph

2.60E-07

2.50E-09

0.016

5

0.1

1.E+02

2.00E+04

3.00E+01

100

→ Cf-251

Fm-257

100.5 d

α, fs / ph

5.20E-06

1.50E-08

0.032

600

0.8

1.E+01

1.00E+03

2.00E+00

10

→ Cf-253

Md-257

5.2 h

2.00E-08

1.20E-10

0.027

30

<0.1

1.E+02

[1]

3.00E+05

4.00E+02

1000

→ Fm-257, Es-253

Md-258

55 d

4.40E-06

1.30E-08

0.007

2

<0.1

1.E+01

1.00E+03

2.00E+00

10

→ Es-254

Explanatory notes on the individual columns

1–3 General data on the radionuclide [source: International Commission on Radiological Protection, ICRP Publication 107]. Daughter nuclides with a half-life of less than ten minutes are not listed separately. Their properties are included in the row for the parent nuclide.

1 Radionuclide; m: metastable. A daughter nuclide with a half-life of less than ten minutes is given after a slash.

2 Half-life: s, second(s); min, minute(s); h, hour(s); d, day(s); a, year(s); E, exponential notation. Source: International Commission on Radiological Protection, ICRP Publication 107. For individual nuclides not listed therein: IAEA Safety Standards: Radiation Protection and Safety of Radiation Sources: International Basic Safety Standards (BSS), Revision of IAEA Safety Series No. 115, GOV/2011/42, 15 August 2011; Table III.2A.

3 Type of decay/radiation: α, alpha radiation; β+, β-, beta radiation; ec, electron capture; it, isomeric transition; sf, spontaneous fission. For «/radiation», «/ph» is given for each radionuclide where decay involves emission of photon radiation (γ or X-rays) with an energy of more than 10-4 MeV per decay.

4, 5 Dose coefficient for the committed effective dose resulting from inhalation or ingestion of a radionuclide in adults [source: IAEA Safety Standards: Radiation Protection and Safety of Radiation Sources: International Basic Safety Standards, Revision of IAEA Safety Series No. 115, GOV/2011/42, 15 August 2011;Table III.2A, Columne(g)5µmfor inhalation and Columne(g) for ingestion.For individual nuclides not listed therein: ICRP Database of Dose Coefficients: Workers and Members of the Public, available on the ICRP website under «Free Educational CD Downloads».

4 Dose coefficient for the committed effective dose resulting from inhalation of a radionuclide. The inhalation of 1 Bq yields, at most, the committed effective dose (in Sv) indicated. The value given is the maximum for the various types (or rates) of absorption from the lung into the blood (fast, moderate or slow), with an activity median aerodynamic diameter (AMAD) of 5 µm

Note: For twelve radionuclides [Nb-91, Nb-91m, Nb-92m, Te-119m,
Nd-140, Re‑183, Pt-190, Au-196, Bi-208, Po-206, Po-208, Po-209] the einh values are not included either in the IAEA BSS or on the ICRP CD. For the RPO of 22 June 199466, the values for these radionuclides were taken from the National Radiological Protection Board report NRPB-R245 (1991). As this source is no longer up to date and these radionuclides are of only minor importance, dose coefficients are not given for these twelve radionuclides in this Ordinance.

5 Dose coefficient for the committed effective dose resulting from ingestion of a radionuclide. The ingestion of 1 Bq yields, at most, the committed effective dose (in Sv) indicated.

Note: For twelve radionuclides (as for einh) the eing values are not included either in the IAEA BSS or on the ICRP CD. For the RPO of 22 June 1994, the values for these radionuclides were taken from the National Radiological Protection Board report NRPB-R245 (1991). As this source is no longer up to date and these radionuclides are of only minor importance, dose coefficients are not given for these twelve radionuclides in this Ordinance.

6–8 Dose coefficient for external radiation [source: Petoussi et al., GSF Report 7/93, National Research Center for Environment and Health, Neuherberg]. If the daughter nuclide has a half-life of less than 10 minutes, the sum of the values for parent and daughter is given.

6 Dose rate at a depth of 10 mm in tissue (ambient dose equivalent rate) at a distance of 1 m from a radioactive source with an activity of 1 GBq (109 Bq).

7 Dose rate at a depth of 0.07 mm in tissue (directional dose equivalent rate) at a distance of 10 cm from a radioactive source with an activity of 1 GBq.

8 Dose coefficient for skin contamination. Skin contamination of 1 kBq/cm2 (averaged over 100 cm2) yields the dose rate (directional dose equivalent rate) indicated.

9–12 Clearance limit,licensing limitandguidance values

9 Clearance limit for specific activity in Bq/g (LL). [Sources: IAEA, Safety Standards: Radiation Protection and Safety of Radiation Sources: International Basic Safety Standards, Revision of IAEA Safety Series No. 115, GOV/2011/42, 15 August 2011; Table I.2; Brenk Systemplanung, Berechnung von Freigrenzen and Freigabewerten für Nuklide, für die keine Werte in den IAEA-BSS vorliegen, Endbericht, Aachen, 2012.] For radionuclides with a short half-life, the exemption levels calculated in the report by Brenk Systemplanung are often higher than the exemption levels for specific activity which are specified for moderate amounts of material in the IAEA BSS. In such cases, and for the small number of radionuclides for which no value was calculated by Brenk Systemplanung, the values specified for moderate amounts of material in the IAEA BSS are used in this Ordinance [source: IAEA, Safety Standards: Radiation Protection and Safety of Radiation Sources: International Basic Safety Standards, Revision of IAEA Safety Series No. 115, GOV/2011/42, 15 August 2011; Table I.1, Column «Activity concentration»]. Radionuclides for which the exemption levels given for moderate amounts of material in the IAEA BSS are used are marked [1] in Column 9 of the Table.

Radionuclides for which the contribution of daughter nuclides was taken into account in determining the LL value are marked [2] in Column 9 of the Table. The Table below indicates, for each radionuclide for which a daughter nuclide was taken into account, the last radionuclide in the decay chain which was used together with the parent to calculate the LL value.

Example: Ra-226 -> Po-214 means that the daughter nuclides of Ra-226 up to Po-214 (i.e. Rn-222, Po-218, Pb-214, Bi-214 and Po-214) were taken into account, together with the parent, in calculating the clearance level.

For H-3 and S-35, which can occur in various chemical forms, the LL was calculated in the Brenk Systemplanung report using the more pessimistic dose coefficient for each exposure pathway (e.g. in the case of S-35, with eing for S‑35 org. and einh for S-35 inorg.). The LL values thus determined were applied to all chemical forms of the radionuclide.

10 Licensing limit (LA). The licensing limit values are derived from Column 4 since inhalation is the main risk when radionuclides are handled in the laboratory. The inhalation of activity at the licensing limit on a single occasion yields a committed effective dose of 5 mSv.

For inert gases, C-11, N-13, O-15, F-18 and Cl-38, the licensing limit corresponds to the activity in an enclosed space of 1000 m3 and a CA concentration as specified in Column 11.

11 Guidance value for chronic airborne activity for occupationally exposed persons (CA). Exposure to an airborne activity concentration CA for 40 hours per week and 50 weeks per year yields a committed effective dose of 20 mSv.

For inhalation: CA [Bq/m3] = 0.02 Sv / (einh . 2400 m3/a).

For inert gases, immersion in a semi-infinite hemispherical cloud for 40 hours per week and 50 weeks per year yields an effective dose of 20 mSv. (The dose coefficients for immersion eimm are taken from ICRP Publication 119 if they are not covered by Guideline ENSI-G14.) In most cases, the CA value relates to the parent nuclide. The exceptional cases where the CA value is given for the daughter nuclide are indicated as such. Also indicated by a footnote are those cases where immersion leads to irradiation of the skin or all organs and where the dose resulting from immersion is greater than that from inhalation. [5]: In the case of Kr-88, values are given for the daughter nuclide for immersion. [3]: Derived from the effective dose for immersion. [4]: Derived from the skin dose for immersion. In this case, the dose coefficients eimm for the skin are taken from the publication: Federal Guidance Report No. 12, External exposure to radionuclides in air, water and soil, Keith F. Eckerman and Jeffrey C. Ryman, Sept. 1993.

12 Guidance value for surface contamination outside of controlled areas, averaged over 100 cm2 (CS).

The CS value is calculated on the basis of the following scenarios, with the most unfavourable being chosen:

chronic exposure throughout the year (8760 hours) resulting from skin contamination yields an equivalent dose of 50 mSv per year (1/10 of the dose limit for the skin);
daily ingestion of contamination on an area of 10 cm2 yields an effective dose of 0.5 mSv per year;
a single inhalation of 10% of the activity of contamination on an area of 100 cm2 yields a dose of 0.5 mSv (1/10 of the licensing limit);
a maximum value of 1000 Bq/cm2.

13 Unstable daughter nuclide

13 Unstable daughter nuclide; → means: decays into …; in the case of branching, the different nuclides formed are separated by commas; a second arrow indicates a decay series. [6]: The h10 value of the daughter nuclide exceeds 0.1 (mSv/h)/GBq at a distance of 1 m (attention may need to be paid to the daughter nuclide!).

List of footnotes:

[1] Radionuclides for which the values given for moderate amounts of material in the IAEA BSS are used as the clearance limit.

[2] Radionuclides for which the contribution of daughter nuclides was taken into account in determining the LL value (Column 9). The Table below indicates, for each of these radionuclides, the last radionuclide in the decay chain which was used together with the parent to calculate the LL value.

[3] Derived from the effective dose for immersion (Column 11).

[4] Derived from the skin dose for immersion (Column 11).

[5] In the case of Kr-88, values are given for the daughter nuclide for immersion (Column 11).

[6] The h10 value of the daughter nuclide exceeds 0.1 (mSv/h)/GBq at a distance of 1 m (attention may need to be paid to the daughter nuclide! Column 13).

[7] The H-3, HTO fraction must also be taken into account.

[8] For Kr-85, LA was chosen so that the dose rate at a distance of 10 cm
is 5 µSv/h.

[9 ] Spontaneous fission is included in h10. The spontaneous fission rate is taken from Table of Isotopes (8th edition, 1996, John Wiley & Sons) and from the ENDF database, Brookhaven National Laboratory. For the average number of neutrons per fission and the dose coefficient, the values for Cf-252 were used. Photons produced during nuclear fission and photons emitted by the resultant fission products are not considered.

[10] Potassium salts in quantities less than 1000 kg are exempted.

[11] For nuclide mixtures of uranium (U-238/U-235/U-234 + daughters) and of thorium (Th-232/Th-230/Th-228 + daughters), the licensing limit of the dominant nuclide applies.

Nuclide mixtures

In the case of nuclide mixtures, the summation rule applies for Columns 9, 11 and 12:

Rule used to assess compliance with activity limits for mixtures of nuclides. Here, the various nuclides are weighted according to the hazard they pose. If the following inequalities are satisfied, then the mixtures are below the clearance limit or below the guidance value for surface contamination.

a1, a2, ... an: specific activities of nuclides 1, 2, ..., n in Bq/g.

LL1, LL2, ... LLn : clearance limits for nuclides 1, 2, ..., n in Bq/g as specified in Annex 3 Column 9.

c1, c2, ... cn : contamination values for nuclides 1, 2, ..., n in Bq/cm2.

CS1, CS2, ... CSn: Guidance values for surface contamination for nuclides 1, 2, ..., n in Bq/cm2 as specified in Annex 3 Column 12.

For Footnote [2]: Daughter nuclides taken into account in calculating the clearance limit

Nuclide

Daughter nuclides

Nuclide

Daughter nuclides

Nuclide

Daughter nuclides

Nuclide

Daughter nuclides

Nuclide

Daughter nuclides

Mg-28

-> Al-28

Mo-99

-> Tc-99m

I-135

-> Xe-135m

Hg-195m

-> Hg-195

Np-237

-> Pa-233

Si-32

-> P-32

Tc-95m

-> Tc-95

Cs-137

-> Ba-137m

Pb-202

-> Tl-202

Pu-239

-> U-235m

Ca-45

-> Sc-45m

Ru-103

-> Rh-103m

Ba-128

-> Cs-128

Pb-210

-> Bi-210

Pu-244

-> Np-240

Sc-44m

-> Sc-44

Ru-106

-> Rh-106

Ce-134

-> La-134

Pb-212

-> Tl-208

Pu-245

-> Am-245

Ti-44

-> Sc-44

Pd-100

-> Rh-100

Ce-137m

-> Ce-137

Bi-210m

-> Tl-206

Pu-246

-> Am-246m

Fe-52

-> Mn-52m

Pd-109

-> Ag-109m

Ce-144

-> Pr-144

At-211

-> Po-211

Am-242m

-> Np-238

Fe-60

-> Co-60

Ag-108m

-> Ag-108

Nd-138

-> Pr-138

Rn-222

-> Tl-210

Am-243

-> Np-239

Ni-66

-> Cu-66

Ag-110m

-> Ag-110

Nd-140

-> Pr-140

Fr-222

-> Po-214

Cm-247

-> Pu-243

Zn-62

-> Cu-62

Cd-109

-> Ag-109m

Gd-146

-> Eu-146

Ra-223

-> Tl-207

Cm-250

-> Am-246m

Zn-69m

-> Zn-69

Cd-113m

-> In-113m

Yb-178

-> Lu-178

Ra-224

-> Tl-208

Cf-253

-> Cm-249

Zn-72

-> Ga-72m

Cd-115

-> In-115m

Lu-177m

-> Lu-177

Ra-226

-> Po-214

Ge-68

-> Ga-68

Cd-115m

-> In-115m

Hf-172

-> Sn-121m

Ra-228

-> Ac-228

As-73

-> Ge-73m

In-111

-> Cd-111m

Hf-182

-> Ta-182

Ac-225

-> Pb-209

Br-80m

-> Br-80

In-114m

-> In-114

W-188

-> Re-188

Ac-226

-> Th-226

Br-83

-> Kr-83m

Sn-110

-> In-110m

Re-186m

-> Re-186

Ac-227

-> Bi-211

Rb-83

-> Kr-83m

Sn-113

-> In-113m

Re-189

-> Os-189m

Th-228

-> Tl-208

Sr-80

-> Rb-80

Sn-121m

-> Sn-121

Os-191

-> Ir-191m

Th-229

-> Pb-209

Sr-89

-> Y-89m

Sn-126

-> Sb-126

Os-194

-> Ir-194

Th-232

-> Tl-208

Sr-90

-> Y-90

Sb-125

-> Te-125m

Ir-189

-> Os-189m

Th-234

-> Pa-234

Sr-91

-> Y-91m

Sb-127

-> Te-127

Ir-190

-> Os-190m

U-230

-> Po-214

Y-87

-> Sr-87m

Te-127m

-> Te-127

Ir-194m

-> Ir-194

U-232

-> Tl-208

Zr-86

-> Y-86m

Te-129m

-> Te-129

Pt-191

-> Ir-191m

U-235

-> Th-231

Zr-95

-> Nb-95m

Te-131m

-> Te-131

Pt-200

-> Au-200

U-238

-> Pa-234

Zr-97

-> Nb-97

Te-132

-> I-132

Hg-194

-> Au-194

U-240

-> Np-240

66 [AS 1994 1947, 1995 4959No II 2, 1996 2129, 2000 1079342894, 2001 3294No II 7, 2005 601Annex 7 No 3 2885 Annex No 7, 2007 1469Annex 4 No 44 5651, 2008 3153Art. 10 No 2 5747 Annex No 22, 2010 5191Art. 20 No 4 5395 Annex 2 No II 3, 2011 5227No I 2.7, 2012 7065No I 5 7157, 2013 3041No I 5 3407 Annex 6 No 3]

Annex 4

(Art. 2 para. 2 let. b, Art. 22, Art. 61 para. 1 and Art. 194 para. 3)

Dose quantities and method for determination of the radiation dose

1 Dose quantities

1.1 Absorbed dose, D

The fundamental dose quantity given by:

whereis the mean energy imparted to matter of mass dm by ionising radiation. The SI unit for absorbed dose is joule per kilogram (J/kg), and its special name is gray (Gy).

1.2 Mean absorbed dose in a tissue or organ, DT

The absorbed dose DT, averaged over the tissue or organ T, which is given by:

whereis the mean total energy imparted in a tissue or organ T, andis the mass of that tissue or organ.

1.3 Equivalent dose, HT

The dose in a tissue or organ T given by:

where DT.R is the mean absorbed dose from radiation R in a tissue or organ T, and wR is the radiation weighting factor. Since wR is dimensionless, the unit for the equivalent dose is the same as for absorbed dose, J/kg. Its special name is sievert (Sv).

1.4 Radiation weighting factors

Radiation type and energy range

Radiation weighting factor,wR

Photons, all energies

1

Electrons and muons, all energies

1

Neutrons, energy

– under 1 MeV
– 1 MeV–50 MeV
– over 50 MeV
2,5+18,2·e-[ln(E)]²/6
5,0+17,0·e-[ln(2·E)]²/6
2,5+3,25·e-[ln(0,04·E)]²/6

Protons and charged pions

2

Alpha particles, fission fragments, heavy nuclei

20

1.5 Committed equivalent dose, HT()

The time integral of the equivalent dose rate in a particular tissue or organ that will be received following intake of radioactive material into the body by a Reference Person, where is the integration time in years.

1.6 Effective dose, E

The tissue-weighted sum of the equivalent doses in all specified tissues and organs of the body, given by the expression:

where HT or wRDT.R is the equivalent dose in a tissue or organ T and wT is the tissue weighting factor. The unit for the effective dose is the same as for absorbed dose, J/kg, and its special name is sievert (Sv).

1.7 Tissue weighting factors

Tissue or organ

Tissue weighting factor,wT

Bone-marrow (red)

0.12

Colon

0.12

Lung

0.12

Stomach

0.12

Breast

0.12

Gonads

0.08

Bladder

0.04

Liver

0.04

Oesophagus

0.04

Thyroid

0.04

Brain

0.01

Skin

0.01

Bone surface

0.01

Salivary glands

0.01

Remainder tissues

0.12

1.8 Committed effective dose, E()

The sum of the products of the committed organ or tissue equivalent doses and the appropriate tissue weighting factors (wT), where is the integration time in years following the intake. The commitment period is taken to be 50 years for adults, and up to age 70 years for children.

1.9 Dose equivalent, H

1.9.1 The product of D and Q at a point in tissue, where D is the absorbed dose and Q is the quality factor for the specific radiation at this point, thus:

1.9.2 The unit of dose equivalent is joule per kilogram (J/kg), and its special name is sievert (Sv). For the relevant operational quantities, see personal dose equivalent and ambient dose equivalent.

1.10 Ambient dose

The dose equivalent measured at a specific location. The quantities ambient dose equivalent H*(10) and directional dose equivalent H'(d,Ω) are taken to be the ambient dose.

1.11 Personal dose equivalent, Hp(d)

1.11.1 One dose equivalent: the dose equivalent in soft tissue (commonly interpreted as the «ICRU sphere») at an appropriate depth, d [mm], below a specified point on the human body, usually given by the position where the individual’s dosimeter is worn. The unit of personal dose equivalent is joule per kilogram (J/kg), and its special name is sievert (Sv).

1.11.2 The personal dose equivalent Hp(10) is used as an estimate of the effective dose. The personal dose equivalent Hp(0.07) is used as an estimate of the dose to the skin and to the lens of the eye. Alternatively, the personal dose equivalent Hp(3) may be used as an estimate of the dose to the lens of the eye.

1.12 Directional dose equivalent, H'(d,Ω)

1.12.1 The dose equivalent at a point in a radiation field that would be produced by the corresponding expanded field in the ICRU sphere at a depth,d, on a radius in a specified direction, Ω. The unit of directional dose equivalent is joule per kilogram (J/kg), and its special name is sievert (Sv).

1.12.2 In the particular case of a unidirectional field, the direction can be specified in terms of the angle α between the radius opposing the incident field and the specified radius Ω. If α= 0°, the quantity H'(d, 0°) may be written as H'(d) and is equal to H*(d).

1.12.3 The recommended values for d are 10 mm for penetrating radiation, 0.07 mm for low-penetrating radiation and 3 mm for the lens of the eye (see operational quantities for area monitoring).

1.13 Ambient dose equivalent, H*(10)

The dose equivalent at a point in a radiation field that would be produced by the corresponding expanded and aligned field in the ICRU sphere at a depth of 10 mm on the radius vector opposing the direction of the aligned field. The unit of ambient dose equivalent is joule per kilogram (J/kg), and its special name is sievert (Sv).

1.14 ICRU sphere

A sphere of tissue-equivalent material, 30 cm in diameter, with a density of 1 g/cm3 and a mass composition of 76.2% oxygen, 11.1% carbon, 10.1% hydrogen and 2.6% nitrogen.

1.15 Quality factor, Q(L)

1.15.1 The factor characterising the biological effectiveness of a radiation, based on the ionisation density along the tracks of charged particles in tissue. Q is defined as a function of the unrestricted linear energy transfer, LET (L in keV/μm), of charged particles in water:

1.15.2 Q has been superseded by the radiation weighting factor, wR, in the definition of equivalent dose, but it is still used in calculating the operational dose equivalent quantities used in monitoring.

2 Method for determination of the radiation dose

2.1 Principle

The effective dose and equivalent doses are generally determined using operational quantities.

2.2 Operational quantities

2.2.1 The operational quantities for individual monitoring of external exposure are:

a.
the personal dose equivalent Hp(10), with the short form Hp;
b.
the personal dose equivalent Hp(0.07), with the short form Hs;
c.
the personal dose equivalent Hp(3).

2.2.2 The operational quantities for area monitoring are:

a.
the ambient dose equivalent H*(10);
b.
the directional dose equivalent H'(0.07);
c.
the directional dose equivalent H'(3).

2.2.3 The operational quantity for internal exposure is the committed effective dose E50, calculated using standard models and the dose coefficients specified in Annexes 3 and 6.

2.3 Personal doses and ambient doses below the relevant dose limits

2.3.1 In situations of external exposure, the equivalent dose for organs is taken to be equal to the personal dose equivalent Hp(10), or to the ambient dose equivalent H*(10), for all tissues and organs apart from the skin and the lens of the eye.

2.3.2 In situations of external exposure, the equivalent dose for the skin, hands and feet is taken to be equal to the personal dose equivalent Hp(0.07), or to the directional dose equivalent H'(0.07).

2.3.3 In situations of external exposure, the equivalent dose for the lens of the eye is taken to be equal to the personal dose equivalent Hp(0.07), or to the directional dose equivalent H'(0.07). Alternatively, it may also be taken to be equal to the personal dose equivalent Hp(3), or to the directional dose equivalent H'(3).

2.3.4 The effective dose is taken to be equal to the sum of:

a.
the personal dose equivalent Hp(10), or the ambient dose equivalent H*(10); and
b.
the committed effective dose E50.

2.4 Personal doses above the relevant dose limits

If the dose values determined in accordance with point 2.3 are above the relevant limits, then the effective dose or equivalent doses for the person concerned must be individually determined by a radiological protection expert, in cooperation with the supervisory authority, using calculation methods and dose coefficients in accordance with the current state of science and technology. The value thus determined is decisive in establishing whether or not a dose limit has been exceeded.

2.5 Area monitoring

Where ambient dose limits are specified by this Ordinance, the ambient dose is taken to be:

a.
the quantity H*(10) (ambient dose equivalent) for penetrating radiation;
b.
the quantity H'(0.07) (directional dose equivalent) for low-penetrating radiation.

Annex 5

(Art. 139 para. 2 and 194 para. 3)

Dose coefficients for members of the public

1. Inhalation

Nuclide

Absorption class

Infant (1 year)

Child (10 years)

Adult

Type

einh
Sv/Bq

hinh, Organ
Sv/Bq

Organ

einh
Sv/Bq

hinh, Organ
Sv/Bq

Organ

einh
Sv/Bq

hinh, Organ
Sv/Bq

Organ

H-3, HTO [1]

V

4.8 E-11

4.8 E-11

GK

2.3 E-11

2.3 E-11

GK

1.8 E-11

1.8 E-11

GK

H-3, OBT [2]

V

1.1 E-10

1.1 E-10

GK

5.5 E-11

5.5 E-11

GK

4.1 E-11

4.1 E-11

GK

C-14 organisch

V

1.6 E-09

1.6 E-09

GK

7.9 E-10

7.9 E-10

GK

5.8 E-10

5.8 E-10

GK

Na-22

F

7.3 E-09

6.4 E-08

ET

2.4 E-09

2.0 E-08

ET

1.3 E-09

9.2 E-09

ET

Na-24

F

1.8 E-09

4.3 E-08

ET

5.7 E-10

1.3 E-08

ET

2.7 E-10

6.0 E-09

ET

Sc-47

F

2.8 E-09

1.4 E-08

Lu

1.1 E-09

6.7 E-09

Lu

7.3 E-10

5.1 E-09

Lu

Cr-51

M

1.9 E-10

8.2 E-10

ET

6.4 E-11

2.6 E-10

ET

3.2 E-11

1.4 E-10

Lu

Mn-54

M

6.2 E-09

2.5 E-08

ET

2.4 E-09

9.1 E-09

Lu

1.5 E-09

6.3 E-09

Lu

Fe-59

M

1.3 E-08

6.7 E-08

Lu

5.5 E-09

3.1 E-08

Lu

3.7 E-09

2.3 E-08

Lu

Co-57

M

2.2 E-09

1.2 E-08

Lu

8.5 E-10

4.8 E-09

Lu

5.5 E-10

3.3 E-09

Lu

Co-58

M

6.5 E-09

3.0 E-08

ET

2.4 E-09

1.2 E-08

Lu

1.6 E-09

8.9 E-09

Lu

Co-60

M

3.4 E-08

1.6 E-07

Lu

1.5 E-08

7.3 E-08

Lu

1.0 E-08

5.2 E-08

Lu

Zn-65

M

6.5 E-09

1.9 E-08

ET

2.4 E-09

7.5 E-09

Lu

1.6 E-09

5.1 E-09

Lu

Se-75

F

6.0 E-09

2.4 E-08

Ni

2.5 E-09

9.2 E-09

Ni

1.0 E-09

5.4 E-09

Ni

Br-82

M

3.0 E-09

5.0 E-08

ET

1.1 E-09

1.5 E-08

ET

6.3 E-10

7.0 E-09

ET

Sr-89

M

2.4 E-08

1.5 E-07

Lu

9.1 E-09

6.3 E-08

Lu

6.1 E-09

4.5 E-08

Lu

Sr-90

M

1.1 E-07

7.0 E-07

Lu

5.1 E-08

2.9 E-07

Lu

3.6 E-08

2.1 E-07

Lu

Y-91

M

3.0 E-08

1.7 E-07

Lu

1.1 E-08

6.9 E-08

Lu

7.1 E-09

5.0 E-08

Lu

Zr-95

M

1.6 E-08

9.1 E-08

Lu

6.8 E-09

4.2 E-08

Lu

4.8 E-09

3.1 E-08

Lu

Nb-95

M

5.2 E-09

2.8 E-08

Lu

2.2 E-09

1.3 E-08

Lu

1.5 E-09

9.5 E-09

Lu

Mo-99

M

4.4 E-09

1.8 E-08

DD

1.5 E-09

7.2 E-09

Lu

8.9 E-10

5.3 E-09

Lu

Tc-99m

M

9.9 E-11

1.4 E-09

ET

3.4 E-11

4.3 E-10

ET

1.9 E-11

2.1 E-10

ET

Ru-103

M

8.4 E-09

5.3 E-08

Lu

3.5 E-09

2.4 E-08

Lu

2.4 E-09

1.8 E-08

Lu

Ru-106

M

1.1 E-07

7.1 E-07

Lu

4.1 E-08

2.8 E-07

Lu

2.8 E-08

2.0 E-07

Lu

Ag-110m

M

2.8 E-08

1.1 E-07

Lu

1.2 E-08

5.1 E-08

Lu

7.6 E-09

3.6 E-08

Lu

Sn-125

M

1.5 E-08

6.5 E-08

Lu

5.0 E-09

2.7 E-08

Lu

3.1 E-09

2.0 E-08

Lu

Sb-122

M

5.7 E-09

2.7 E-08

DD

1.8 E-09

7.5 E-09

Lu

1.0 E-09

5.5 E-09

Lu

Sb-124

M

2.4 E-08

1.4 E-07

Lu

9.6 E-09

6.1 E-08

Lu

6.4 E-09

4.4 E-08

Lu

Sb-125

M

1.6 E-08

1.0 E-07

Lu

6.8 E-09

4.5 E-08

Lu

4.8 E-09

3.2 E-08

Lu

Sb-127

M

7.3 E-09

3.1 E-08

Lu

2.7 E-09

1.4 E-08

Lu

1.7 E-09

1.1 E-08

Lu

Te-125m

M

1.1 E-08

7.4 E-08

Lu

4.8 E-09

3.5 E-08

Lu

3.4 E-09

2.6 E-08

Lu

Te-127m

M

2.6 E-08

1.7 E-07

Lu

1.1 E-08

7.7 E-08

Lu

7.4 E-09

5.6 E-08

Lu

Te-129m

M

2.6 E-08

1.5 E-07

Lu

9.8 E-09

6.6 E-08

Lu

6.6 E-09

4.8 E-08

Lu

Te-131m

M

5.8 E-09

3.2 E-08

ET

1.9 E-09

9.8 E-09

ET

9.4 E-10

4.6 E-09

Lu

Te-132

M

1.3 E-08

5.6 E-08

ET

4.0 E-09

1.7 E-08

ET

2.0 E-09

1.0 E-08

Lu

I-125

F

2.3 E-08

4.5 E-07

SD

1.1 E-08

2.2 E-07

SD

5.1 E-09

1.0 E-07

SD

I-125 organisch

V

4.0 E-08

8.1 E-07

SD

2.2 E-08

4.4 E-07

SD

1.1 E-08

2.1 E-07

SD

I-125 elementar

V

5.2 E-08

1.0 E-06

SD

2.8 E-08

5.6 E-07

SD

1.4 E-08

2.7 E-07

SD

I-129

F

8.6 E-08

1.7 E-06

SD

6.7 E-08

1.3 E-06

SD

3.6 E-08

7.1 E-07

SD

I-129 organisch

V

1.5 E-07

3.0 E-06

SD

1.3 E-07

2.7 E-06

SD

7.4 E-08

1.5 E-06

SD

I-129 elementar

V

2.0 E-07

3.9 E-06

SD

1.7 E-07

3.4 E-06

SD

9.6 E-08

1.9 E-06

SD

I-131

F

7.2 E-08

1.4 E-06

SD

1.9 E-08

3.7 E-07

SD

7.4 E-09

1.5 E-07

SD

I-131 organisch

V

1.3 E-07

2.5 E-06

SD

3.7 E-08

7.4 E-07

SD

1.5 E-08

3.1 E-07

SD

I-131 elementar

V

1.6 E-07

3.2 E-06

SD

4.8 E-08

9.5 E-07

SD

2.0 E-08

3.9 E-07

SD

I-133

F

1.8 E-08

3.5 E-07

SD

3.8 E-09

7.4 E-08

SD

1.5 E-09

2.8 E-08

SD

I-133 organisch

V

3.2 E-08

6.3 E-07

SD

7.6 E-09

1.5 E-07

SD

3.1 E-09

6.0 E-08

SD

I-133 elementar

V

4.1 E-08

8.0 E-07

SD

9.7 E-09

1.9 E-07

SD

4.0 E-09

7.6 E-08

SD

I-135

F

3.7 E-09

7.0 E-08

SD

7.9 E-10

1.5 E-08

SD

3.2 E-10

5.7 E-09

SD

I-135 organisch

V

6.7 E-09

1.3 E-07

SD

1.6 E-09

3.1 E-08

SD

6.8 E-10

1.3 E-08

SD

I-135 elementar

V

8.5 E-09

1.6 E-07

SD

2.1 E-09

3.8 E-08

SD

9.2 E-10

1.5 E-08

SD

Cs-134

F

7.3 E-09

4.9 E-08

ET

5.3 E-09

1.8 E-08

ET

6.6 E-09

1.2 E-08

ET

Cs-136

F

5.2 E-09

5.9 E-08

ET

2.0 E-09

1.9 E-08

ET

1.2 E-09

8.8 E-09

ET

Cs-137 / Ba-137m

F

5.4 E-09

2.5 E-08

ET

3.7 E-09

9.7 E-09

ET

4.6 E-09

7.4 E-09

ET

Ba-140

M

2.0 E-08

1.1 E-07

Lu

7.6 E-09

4.8 E-08

Lu

5.1 E-09

3.5 E-08

Lu

La-140

M

6.3 E-09

4.4 E-08

ET

2.0 E-09

1.3 E-08

ET

1.1 E-09

6.2 E-09

ET

Ce-141

M

1.1 E-08

6.9 E-08

Lu

4.6 E-09

3.2 E-08

Lu

3.2 E-09

2.4 E-08

Lu

Ce-144

M

1.6 E-07

6.5 E-07

Lu

5.5 E-08

2.6 E-07

Lu

3.6 E-08

1.9 E-07

Lu

Pr-143

M

8.4 E-09

4.6 E-08

Lu

3.2 E-09

2.1 E-08

Lu

2.2 E-09

1.5 E-08

Lu

Pb-210

M

3.7 E-06

2.2 E-05

Lu

1.5 E-06

1.1 E-05

KH

1.1 E-06

1.3 E-05

KH

Bi-210

M

3.0 E-07

2.4 E-06

Lu

1.3 E-07

1.1 E-06

Lu

9.3 E-08

7.7 E-07

Lu

Po-210

M

1.1 E-05

8.1 E-05

Lu

4.6 E-06

3.5 E-05

Lu

3.3 E-06

2.6 E-05

Lu

Ra-224

M

8.2 E-06

6.7 E-05

Lu

3.9 E-06

3.2 E-05

Lu

3.0 E-06

2.5 E-05

Lu

Ra-226

M

1.1 E-05

9.1 E-05

Lu

4.9 E-06

3.8 E-05

Lu

3.5 E-06

2.8 E-05

Lu

Th-227

S

3.0 E-05

2.5 E-04

Lu

1.4 E-05

1.2 E-04

Lu

1.0 E-05

8.7 E-05

Lu

Th-228

S

1.3 E-04

1.1 E-03

Lu

5.5 E-05

4.5 E-04

Lu

4.0 E-05

3.3 E-04

Lu

Th-230

S

3.5 E-05

2.6 E-04

KH

1.6 E-05

2.4 E-04

KH

1.4 E-05

2.8 E-04

KH

Th-232

S

5.0 E-05

3.5 E-04

Lu

2.6 E-05

2.6 E-04

KH

2.5 E-05

2.9 E-04

KH

Pa-231

M

2.3 E-04

1.0 E-02

KH

1.5 E-04

7.5 E-03

KH

1.4 E-04

6.8 E-03

KH

U-234

M

1.1 E-05

9.0 E-05

Lu

4.8 E-06

3.8 E-05

Lu

3.5 E-06

2.7 E-05

Lu

U-235

M

1.0 E-05

8.1 E-05

Lu

4.3 E-06

3.4 E-05

Lu

3.1 E-06

2.4 E-05

Lu

U-238

M

9.4 E-06

7.5 E-05

Lu

4.0 E-06

3.1 E-05

Lu

2.9 E-06

2.2 E-05

Lu

Np-237

M

4.0 E-05

8.3 E-04

KH

2.2 E-05

6.7 E-04

KH

2.3 E-05

1.0 E-03

KH

Np-239

M

4.2 E-09

1.8 E-08

ET

1.4 E-09

8.4 E-09

Lu

9.3 E-10

6.3 E-09

Lu

Pu-238

M

7.4 E-05

1.2 E-03

KH

4.4 E-05

9.8 E-04

KH

4.6 E-05

1.4 E-03

KH

Pu-239

M

7.7 E-05

1.3 E-03

KH

4.8 E-05

1.1 E-03

KH

5.0 E-05

1.5 E-03

KH

Pu-240

M

7.7 E-05

1.3 E-03

KH

4.8 E-05

1.1 E-03

KH

5.0 E-05

1.5 E-03

KH

Pu-241

M

9.7 E-07

2.2 E-05

KH

8.3 E-07

2.4 E-05

KH

9.0 E-07

3.1 E-05

KH

Am-241

M

6.9 E-05

1.4 E-03

KH

4.0 E-05

1.2 E-03

KH

4.2 E-05

1.7 E-03

KH

Cm-242

M

1.8 E-05

1.2 E-04

KH

7.3 E-06

4.8 E-05

Lu

5.2 E-06

3.5 E-05

Lu

Cm-244

M

5.7 E-05

9.6 E-04

KH

2.7 E-05

6.4 E-04

KH

2.7 E-05

9.2 E-04

KH

Absorption class

The absorption class indicates the rate at which an inhaled substance is absorbed from the lung into the blood. Type F: fast, Type M: moderate, Type S: slow, Type V: very rapid/instantaneous (only applies to certain gases and vapours)

einh:

Committed effective dose; integration period: 50 years for adults, 70 years for children
Dose coefficients taken from: ICRP, 2012. Compendium of Dose Coefficients based on ICRP Publication 60. ICRP Publication 119. Ann. ICRP 41(Suppl.). Tables G.1 and H.1 (AMAD = 1µm)

Dose coefficients for other nuclides and for other age categories can be found in ICRP Publication 119.

hinh, Organ:

Committed dose in the most affected organ [WB: whole body, Go: gonads, BM: bone marrow (red), Co: colon, Lu: lung, St: stomach, Bl: bladder, Br: breast, Li: liver, Oe: oesophagus, Th: thyroid, Sk: skin, BS: bone surface, remainder (ET: extrathoracic airways,
Ut: uterus, Ki: kidney, Sp: spleen)]

Dose coefficients taken from: ICRP Database of Dose Coefficients: Workers and Members of the Public; Ver. 3.0 – Free Educational CD Downloads (AMAD = 1µm)

[1]

Tritiated water vapour

[2]

Organically bound tritium

2. Ingestion

Nuclide

Infant (1a)

Child (10a)

Adult

eing
Sv/Bq

hing, Organ
Sv/Bq

Organ

eing
Sv/Bq

hing, Organ
Sv/Bq

Organ

eing
Sv/Bq

hing,Organ
Sv/Bq

Organ

H-3, HTO

4.8E-11

4.8E-11

GK

2.3E-11

2.3E-11

GK

1.8E-11

1.8E-11

GK

H-3, OBT [2]

1.2E-10

1.6E-10

Ma

5.7E-11

6.7E-11

Ma

4.2E-11

4.7E-11

Ma

C-14

1.6E-09

1.9E-09

Ma

8.0E-10

8.9E-10

Ma

5.8E-10

6.3E-10

Ma

Na-22

1.5E-08

2.8E-08

KH

5.5E-09

1.1E-08

KH

3.2E-09

6.3E-09

KH

Na-24

2.3E-09

6.7E-09

Ma

7.7E-10

2.1E-09

Ma

4.3E-10

1.2E-09

Ma

Sc-47

3.9E-09

3.0E-08

DD

1.2E-09

9.0E-09

DD

5.4E-10

4.1E-09

DD

Cr-51

2.3E-10

1.4E-09

DD

7.8E-11

4.5E-10

DD

3.8E-11

2.1E-10

DD

Mn-54

3.1E-09

8.3E-09

DD

1.3E-09

3.3E-09

DD

7.1E-10

1.8E-09

DD

Fe-59

1.3E-08

3.5E-08

DD

4.7E-09

1.2E-08

DD

1.8E-09

5.8E-09

DD

Co-57

1.6E-09

5.6E-09

DD

5.8E-10

1.8E-09

DD

2.1E-10

9.4E-10

DD

Co-58

4.4E-09

1.4E-08

DD

1.7E-09

4.9E-09

DD

7.4E-10

2.8E-09

DD

Co-60

2.7E-08

5.1E-08

DD

1.1E-08

2.0E-08

Le

3.4E-09

8.7E-09

DD

Zn-65

1.6E-08

2.2E-08

KH

6.4E-09

8.9E-09

KH

3.9E-09

5.4E-09

KH

Se-75

1.3E-08

5.1E-08

Ni

6.0E-09

2.2E-08

Ni

2.6E-09

1.4E-08

Ni

Br-82

2.6E-09

4.0E-09

DD

9.5E-10

1.5E-09

DD

5.4E-10

8.3E-10

Ma

Sr-89

1.8E-08

9.2E-08

DD

5.8E-09

2.7E-08

DD

2.6E-09

1.4E-08

DD

Sr-90

7.3E-08

7.3E-07

KH

6.0E-08

1.0E-06

KH

2.8E-08

4.1E-07

KH

Y-91

1.8E-08

1.4E-07

DD

5.2E-09

4.2E-08

DD

2.4E-09

1.9E-08

DD

Zr-95

5.6E-09

3.4E-08

DD

1.9E-09

1.1E-08

DD

9.5E-10

5.1E-09

DD

Nb-95

3.2E-09

1.6E-08

DD

1.1E-09

5.6E-09

DD

5.8E-10

2.8E-09

DD

Mo-99

3.5E-09

1.6E-08

Le

1.1E-09

5.5E-09

Le/Ni

6.0E-10

3.1E-09

Ni

Tc-99m

1.3E-10

4.7E-10

SD

4.3E-11

1.4E-10

DD

2.2E-11

6.7E-11

DD

Ru-103

4.6E-09

2.9E-08

DD

1.5E-09

9.2E-09

DD

7.3E-10

4.3E-09

DD

Ru-106

4.9E-08

3.3E-07

DD

1.5E-08

1.0E-07

DD

7.0E-09

4.5E-08

DD

Ag-110m

1.4E-08

4.6E-08

DD

5.2E-09

1.7E-08

DD

2.8E-09

8.5E-09

DD

Sn-125

2.2E-08

1.8E-07

DD

6.7E-09

5.2E-08

DD

3.1E-09

2.4E-08

DD

Sb-122

1.2E-08

9.1E-08

DD

3.7E-09

2.7E-08

DD

1.7E-09

1.2E-08

DD

Sb-124

1.6E-08

9.6E-08

DD

5.2E-09

3.0E-08

DD

2.5E-09

1.4E-08

DD

Sb-125

6.1E-09

3.3E-08

KH

2.1E-09

1.3E-08

KH

1.1E-09

9.0E-09

KH

Sb-127

1.2E-08

8.4E-08

DD

3.6E-09

2.5E-08

DD

1.7E-09

1.2E-08

DD

Te-125m

6.3E-09

9.0E-08

KH

1.9E-09

3.4E-08

KH

8.7E-10

2.0E-08

KH

Te-127m

1.8E-08

1.4E-07

KH

5.2E-09

5.5E-08

KH

2.3E-09

3.2E-08

KH

Te-129m

2.4E-08

1.1E-07

DD

6.6E-09

3.2E-08

DD

3.0E-09

1.4E-08

DD

Te-131m

1.4E-08

1.5E-07

SD

4.3E-09

4.5E-08

SD

1.9E-09

1.8E-08

SD

Te-132

3.0E-08

3.2E-07

SD

8.3E-09

7.5E-08

SD

3.8E-09

3.1E-08

SD

I-125

5.7E-08

1.1E-06

SD

3.1E-08

6.2E-07

SD

1.5E-08

3.0E-07

SD

I-129

2.2E-07

4.3E-06

SD

1.9E-07

3.8E-06

SD

1.1E-07

2.1E-06

SD

I-131

1.8E-07

3.6E-06

SD

5.2E-08

1.0E-06

SD

2.2E-08

4.3E-07

SD

I-133

4.4E-08

8.6E-07

SD

1.0E-08

2.0E-07

SD

4.3E-09

8.2E-08

SD

I-135

8.9E-09

1.7E-07

SD

2.2E-09

3.9E-08

SD

9.3E-10

1.6E-08

SD

Cs-134

1.6E-08

2.4E-08

DD

1.4E-08

1.7E-08

DD

1.9E-08

2.1E-08

DD

Cs-136

9.5E-09

1.3E-08

DD

4.4E-09

5.3E-09

DD

3.0E-09

3.4E-09

DD

Cs-137 / Ba-137m

1.2E-08

2.3E-08

DD

1.0E-08

1.3E-08

DD

1.3E-08

1.5E-08

DD

Ba-140

1.8E-08

1.2E-07

DD

5.8E-09

3.5E-08

DD

2.6E-09

1.7E-08

DD

La-140

1.3E-08

8.7E-08

DD

4.2E-09

2.7E-08

DD

2.0E-09

1.3E-08

DD

Ce-141

5.1E-09

4.0E-08

DD

1.5E-09

1.2E-08

DD

7.1E-10

5.5E-09

DD

Ce-144

3.9E-08

3.1E-07

DD

1.1E-08

9.2E-08

DD

5.2E-09

4.2E-08

DD

Pr-143

8.7E-09

7.0E-08

DD

2.6E-09

2.1E-08

DD

1.2E-09

9.3E-09

DD

Pb-210

3.6E-06

3.8E-05

KH

1.9E-06

4.4E-05

KH

6.9E-07

2.3E-05

KH

Bi-210

9.7E-09

7.6E-08

DD

2.9E-09

2.3E-08

DD

1.3E-09

1.0E-08

DD

Po-210

8.8E-06

7.6E-05

Mi

2.6E-06

2.5E-05

Mi

1.2E-06

1.3E-05

Ni

Ra-224

6.6E-07

2.3E-05

KH

2.6E-07

1.1E-05

KH

6.5E-08

1.7E-06

KH

Ra-226

9.6E-07

2.9E-05

KH

8.0E-07

3.9E-05

KH

2.8E-07

1.2E-05

KH

Th-227

7.0E-08

8.0E-07

KH

2.3E-08

3.9E-07

KH

8.8E-09

8.8E-08

KH

Th-228

3.7E-07

8.4E-06

KH

1.4E-07

4.3E-06

KH

7.2E-08

2.5E-06

KH

Th-230

4.1E-07

1.3E-05

KH

2.4E-07

1.1E-05

KH

2.1E-07

1.2E-05

KH

Th-232

4.5E-07

1.3E-05

KH

2.9E-07

1.2E-05

KH

2.3E-07

1.2E-05

KH

Pa-231

1.3E-06

6.0E-05

KH

9.2E-07

4.6E-05

KH

7.1E-07

3.6E-05

KH

U-234

1.3E-07

1.8E-06

KH

7.4E-08

1.5E-06

KH

4.9E-08

7.8E-07

KH

U-235

1.3E-07

1.7E-06

KH

7.1E-08

1.4E-06

KH

4.7E-08

7.4E-07

KH

U-238

1.2E-07

1.6E-06

KH

6.8E-08

1.4E-06

KH

4.5E-08

7.1E-07

KH

Np-237

2.1E-07

5.0E-06

KH

1.1E-07

4.1E-06

KH

1.1E-07

5.4E-06

KH

Np-239

5.7E-09

4.4E-08

DD

1.7E-09

1.3E-08

DD

8.0E-10

6.0E-09

DD

Pu-238

4.0E-07

6.9E-06

KH

2.4E-07

5.9E-06

KH

2.3E-07

7.4E-06

KH

Pu-239

4.2E-07

7.6E-06

KH

2.7E-07

6.8E-06

KH

2.5E-07

8.2E-06

KH

Pu-240

4.2E-07

7.6E-06

KH

2.7E-07

6.8E-06

KH

2.5E-07

8.2E-06

KH

Pu-241

5.7E-09

1.2E-07

KH

5.1E-09

1.4E-07

KH

4.8E-09

1.6E-07

KH

Am-241

3.7E-07

8.3E-06

KH

2.2E-07

7.3E-06

KH

2.0E-07

9.0E-06

KH

Cm-242

7.6E-08

9.7E-07

KH

2.4E-08

3.5E-07

KH

1.2E-08

1.9E-07

KH

Cm-244

2.9E-07

5.8E-06

KH

1.4E-07

3.9E-06

KH

1.2E-07

4.9E-06

KH

eing:

Committed effective dose; integration period: 50 years for adults, 70 years for children

Dose coefficients taken from: ICRP, 2012. Compendium of Dose Coefficients based on ICRP Publication 60. ICRP Publication 119. Ann. ICRP 41(Suppl.). Table F.1 (AMAD = 1µm)

Dose coefficients for other nuclides and for other age categories can be found in ICRP Publication 119.

hing, Organ:

Committed dose in the most affected organ [WB: whole body, Go: gonads, BM: bone marrow (red), Co: colon, Lu: lung, St: stomach, Bl: bladder, Br: breast, Li: liver, Oe: oesophagus, Th: thyroid, Sk: skin, BS: bone surface, remainder (ET: extrathoracic airways,
Ut: uterus, Ki: kidney, Sp: spleen)]

Dose coefficients taken from: ICRP Database of Dose Coefficients: Workers and Members of the Public; Ver. 3.0 – Free Educational CD Downloads (AMAD = 1µm)

[2]

Organically bound tritium

Annex 6

(Art. 139 para. 2 and 194 para. 3)

Dose coefficients for cloudshine and groundshine

Nuclide

External exposure from cloudshine

External exposure from groundshine

eimm
(mSv/h)/(Bq/m3)

esol
(mSv/h)/(Bq/m2)

H-3

0.0E+00

0.0E+00

C-11

1.6E-07

3.6E-09

C-14

9.4E-12

4.6E-14

O-15

1.7E-07

3.9E-09

F-18

1.6E-07

3.4E-09

Na-22

3.7E-07

7.4E-09

Na-24

7.5E-07

1.3E-08

Sc-47

1.7E-08

3.6E-10

Cr-51

5.0E-09

1.1E-10

Mn-54

1.4E-07

2.8E-09

Fe-59

2.0E-07

4.0E-09

Co-57

1.8E-08

3.9E-10

Co-58

1.6E-07

3.3E-09

Co-60

4.3E-07

8.3E-09

Zn-65

9.8E-08

1.9E-09

Se-75

6.0E-08

1.3E-09

Br-82

4.4E-07

8.9E-09

Kr-79

4.0E-08

8.5E-10

Kr-81

8.8E-10

5.7E-12

Kr-83m

8.8E-12

1.2E-12

Kr-85

9.2E-10

3.8E-11

Kr-85m

2.5E-08

5.6E-10

Kr-87

1.4E-07

3.0E-09

Kr-88

3.5E-07

6.2E-09

Kr-88/Rb-88

4.7E-07

8.9E-09

Kr-89

3.4E-07

6.6E-09

Sr-89

1.6E-09

2.5E-10

Sr-90

3.5E-10

5.9E-12

Sr-90/Y-90

3.2E-09

4.0E-10

Y-91

2.2E-09

2.7E-10

Zr-95

1.2E-07

2.5E-09

Nb-95

1.3E-07

2.6E-09

Mo-99

2.5E-08

6.4E-10

Mo-99/Tc-99m

4.2E-08

1.0E-09

Tc-99m

1.9E-08

4.1E-10

Ru-103

8.0E-08

1.7E-09

Ru-106

0.0E+00

0.0E+00

Ru-106/Rh-106

3.9E-08

1.2E-09

Ag-110m

4.6E-07

9.3E-09

Sn-125

5.9E-08

1.4E-09

Sb-122

7.3E-08

1.8E-09

Sb-124

3.2E-07

6.2E-09

Sb-125

6.8E-08

1.5E-09

Sb-127

1.1E-07

2.4E-09

Te-125m

1.2E-09

9.6E-11

Te-127m

4.0E-10

3.1E-11

Te-129m

5.7E-09

2.1E-10

Te-131m

2.4E-07

4.9E-09

Te-132

3.4E-08

7.7E-10

Te-132/I-132

4.1E-07

8.6E-09

I-125

1.4E-09

1.1E-10

I-129

1.0E-09

7.2E-11

I-130

3.5E-07

7.4E-09

I-131

6.1E-08

1.3E-09

I-132

3.7E-07

7.8E-09

I-133

1.0E-07

2.2E-09

I-134

4.4E-07

9.0E-09

I-135

2.7E-07

5.3E-09

Xe-122

7.9E-09

2.2E-10

Xe-123

1.0E-07

2.2E-09

Xe-125

3.9E-08

8.9E-10

Xe-127

4.0E-08

9.2E-10

Xe-129m

3.4E-09

1.5E-10

Xe-131m

1.3E-09

5.9E-11

Xe-133

5.0E-09

1.5E-10

Xe-133m

4.6E-09

1.3E-10

Xe-135

4.0E-08

9.0E-10

Xe-135m

6.7E-08

1.5E-09

Xe-137

3.7E-08

1.3E-09

Xe-138

2.0E-07

3.9E-09

Cs-134

2.5E-07

5.3E-09

Cs-136

3.5E-07

7.2E-09

Cs-137

3.4E-10

1.1E-11

Cs-137/Ba-137m

9.2E-08

2.0E-09

Ba-140

2.9E-08

6.9E-10

Ba-140/La-140

4.3E-07

8.4E-09

La-140

4.0E-07

7.7E-09

Ce-141

1.1E-08

2.5E-10

Ce-144

2.6E-09

6.2E-11

Ce-144/Pr-144

1.2E-08

6.4E-10

Pr-143

7.0E-10

7.5E-11

Pb-210

1.7E-10

7.8E-12

Bi-210

9.3E-10

1.3E-10

Po-210

1.6E-12

3.3E-14

Ra-224

1.6E-09

3.5E-11

Ra-226

1.1E-09

2.4E-11

Th-227

1.9E-08

4.1E-10

Th-228

3.0E-10

7.8E-12

Th-230

5.5E-11

2.3E-12

Th-232

2.8E-11

1.6E-12

Pa-231

5.2E-09

1.2E-10

U-234

2.2E-11

2.1E-12

U-235

2.5E-08

5.4E-10

U-238

1.2E-11

1.4E-12

Np-237

3.1E-09

8.8E-11

Np-239

2.6E-08

5.8E-10

Pu-238

1.2E-11

2.2E-12

Pu-239

1.4E-11

1.1E-12

Pu-240

1.2E-11

2.0E-12

Pu-241

2.2E-13

5.1E-15

Am-241

2.4E-09

7.8E-11

Cm-242

1.4E-11

2.4E-12

Cm-244

1.4E-11

2.1E-12

eimm:

Dose coefficients for external exposure from immersion in a semi-infinite hemispherical cloud.

esol:

Dose coefficients for external exposure from ground deposition over a wide area.

Zero values:

Values less than 4.0E-19 are given as 0.0E+00.

Annex 7

(Art. 24 para. 1 and 2)

Immission limits

1 Immission limits for air (LIair):

1.1 The immission limits for air are defined in such a way that permanent residence (8766 hours per year = PR) at a location with an airborne activity concentration equal to the immission limit for a specific nuclide would lead, based on inhalation and immersion, to an annual dose of 0.3 mSv for the critical person: infant (eb), ten-year old child (e10) or adult (Ad).

1.2

Nuclide

Immission limit for air [Bq/m3]

Ad

e10

eb

Minimum

HTO

2.2E+03

2.3E+03

3.1E+03

2.2E+03

C-14 (org67)

6.8E+01

6.7E+01

9.3E+01

6.7E+01

Na-22

2.7E+01

2.0E+01

1.9E+01

1.9E+01

Na-24

6.4E+01

5.1E+01

4.8E+01

4.8E+01

Mn-54

2.5E+01

2.1E+01

2.3E+01

2.1E+01

Co-60

3.9E+00

3.5E+00

4.3E+00

3.5E+00

Zn-65

2.4E+01

2.1E+01

2.2E+01

2.1E+01

Br-82

4.7E+01

3.8E+01

3.9E+01

3.8E+01

Sr-90/Y-90

1.1E+00

1.0E+00

1.3E+00

1.0E+00

Tc-99m

1.4E+03

1.2E+03

1.1E+03

1.1E+03

I-131 (el68)

2.0E+00

1.1E+00

9.3E-01

9.3E-01

Cs-137/Ba-137m

8.5E+00

1.4E+01

2.7E+01

8.5E+00

Pu-239

7.9E-04

1.2E-03

1.9E-03

7.9E-04

1.3 The immission limits for air can be calculated for additional radionuclides using the following formula:

where einh,eb, einh,e10 and einh,ad [mSv/Bq] are the inhalation dose coefficients for infants, ten-year-old children and adults, and eimm [(mSv/h)/(Bq/m3)] is the immersion dose coefficient (non-age-dependent). The inhalation and immersion dose coefficients are taken from Annexes 5 and 6.

For immersion, a shielding factor (Fabs) of 0.4 is assumed for time spent indoors.

For breathing rates for infants, ten-year-old children and adults (DReb, DRe10 and DRad [m3/a]), the following values (ENSI-G14) were used:

a.
DReb = 2022 [m3/a]
b.
DRe10 = 5688 [m3/a]
c.
DRad= 7584[m3/a]

67 org = organic

68 el = elemental

2 Immission limits for waters (LIeaux):

2.1 The immission limits for publicly accessible waters are defined in such a way that the critical person entirely meeting their need for drinking water with water contaminated at a level corresponding to the immission limit would thus receive an annual ingestion dose of 0.3 mSv.

2.2

Nuclide

Immission limit for waters [Bq/l]

Ad

e10

eb

Minimum

HTO

2.6E+04

2.0E+04

2.5E+04

2.0E+04

C-14

8.0E+02

5.8E+02

7.5E+02

5.8E+02

Na-22

1.4E+02

8.4E+01

8.0E+01

8.0E+01

Na-24

1.1E+03

6.0E+02

5.2E+02

5.2E+02

Mn-54

6.5E+02

3.6E+02

3.9E+02

3.6E+02

Co-60

1.4E+02

4.2E+01

4.4E+01

4.2E+01

Zn-65

1.2E+02

7.2E+01

7.5E+01

7.2E+01

Sr-90/Y-90

1.6E+01

7.7E+00

1.6E+01

7.7E+00

Tc-99m

2.1E+04

1.1E+04

9.2E+03

9.2E+03

I-131 (el)

2.1E+01

8.9E+00

6.7E+00

6.7E+00

Cs-137/Ba-137m

3.6E+01

4.6E+01

1.0E+02

3.6E+01

Pu-239

1.8E+00

1.7E+00

2.9E+00

1.7E+00

Am-241

2.3E+00

2.1E+00

3.2E+00

2.1E+00

2.3 The immission limits for waters can be calculated for additional radionuclides using the following formula:

where eing,eb, eing,e10 and eing,ad [mSv/Bq] are the ingestion dose coefficients for infants, ten-year-old children and adults, and CoEeb, CoEe10,and CoEad are the drinking water consumption in litres per year [l/a] for infants, ten-year-old children and adults.

For drinking water consumption, 650 l/a was assumed for adults and ten-year-old children, and 250 l/a for infants. The ingestion dose coefficients are taken from Annex 5.

3 In the case of nuclide mixtures, the summation rule applies for the immission limits for air and for waters:

Rule used to assess compliance with immission limits for air and for waters in the case of nuclide mixtures. Here, the various nuclides are weighted according to the hazard they pose. If the following inequalities are satisfied, then the mixtures are below the immission limits.

a1, a2, … an: airborne activity concentrations of nuclides 1, 2, …, n in Bq/m3.

LIair1, LIair 2, … LIair n: immission limits for air for nuclides 1, 2, …, n in Bq/m3.

a1, a2, …an: airborne activity concentrations of nuclides 1, 2, ..., n in Bq/l.

LIeau1, LIeau2, … LIeau n: immission limits for air for nuclides 1, 2, ..., n in Bq/l.

Annex 8 69

69 Revised by the correction of 5 June 2018 (AS 2018 2273).

(Art. 46 para. 4 let. b, 80 para. 5 and 85 para. 5)

Marking of controlled and supervised areas

Controlled and supervised areas must be marked as follows, depending on the radiation sources used:

1 Sealed radioactive sources:

a.
the most radiotoxic nuclide or reference nuclide and its maximum activity, or the activity of and nuclide with the highest-energy gamma radiation;
b.
the ambient dose rate in mSv per hour in the accessible area, if appropriate;
c.
the hazard warning symbol.

2 Other radioactive material:

a.
the most radiotoxic nuclide or reference nuclide and its maximum activity;
b.
the classification of the working area (Type A, B or C) or the zone type;
c.
the maximum degree of contamination caused by loose contamination on surfaces, expressed in Bq/cm2 or as the number of guidance values for the nuclide concerned;
d.
the maximum degree of contamination of indoor air in Bq/m3;
e.
the ambient dose rate in mSv per hour in the accessible area, if appropriate;
f.
details of the protective clothing and protective measures required;
g.
the hazard warning symbol.

3 Installations (e.g. X-ray equipment, accelerators):

a.
the designation of the installation;
b.
the type of radiation (e.g. electrons, X-rays, neutrons, where not apparent from the designation);
c.
the ambient dose rate in mSv per hour in the accessible area, if appropriate;
d.
the hazard warning symbol.

4 Hazard warning symbol:

Ratio of radii: 1 : 1,5 : 5

Annex 9

(Art. 96)

Activity values for the definition of high-activity sealed sources

For radionuclides not listed in the Table below, the activity value is the D value given in the IAEA publication «Dangerous quantities of radioactive material (D values)» (EPR-D-VALUES 2006)70.

Radionuclide

Activity value (TBq)

Am-241

6×10-2

Am-241/Be

6×10-2

Cf-252

2×10-2

Cm-244

5×10-2

Co-60

3×10-2

Cs-137

1×10-1

Gd-153

1×100

Ir-192

8×10-2

Pm-147

4×101

Pu-238

6×10-2

Pu-239/Be71

6×10-2

Ra-226

4×10-2

Se-75

2×10-1

Sr-90 (Y-90)

1×100

Tm-170

2×101

Yb-169

3×10-1

70 The IAEA publications referred to in this O can be accessed free of charge on the IAEA website at www.iaea.org > Publications.

71 The activity of the alpha-emitting radionuclide is given.

Annex 10

(Art. 80 para. 2 let. b, 82 para. 1 and 2, 85 para. 2 let. b)

Zone types and area types

1. Depending on the degree of contamination which is present or to be expected, zones shall be classified into the following zone types:

Zone type

Surface contamination Cs

Airborne contamination CA

0

CS < 1.CS72

CA < 0.05.CA73

I

CC < 1.CS

0.05.CA ≤ CA < 0.1.CA

II

1.CS ≤ CS < 10.CS

0.05.CA ≤ CA < 0.1.CA

III

10.CS ≤ CS < 100.CS

0.1.CA ≤ CA < 10.CA

IV

CS ≥ 100.CS

CA ≥ 10.CA

If the degrees of airborne and surface contamination do not call for the same zone type, the more restrictive factor shall be decisive.

2. Within zones where ambient dose rates are elevated, for the planning and regulation of individual doses, the following areas must be designated with maximum permissible ambient dose rates:

Area type

Ambient dose rate D at accessible locations

V

D < 0.01 mSv/h

W

0.01 < D < 0.1 mSv/h

X

0.1 < D < 1 mSv/h

Y

1 < D < 10 mSv/h

Z

D > 10 mSv/h

72 Guidance value (Bq/cm2) for surface contamination as specified in Annex 3 Column 12; averaged over 100 cm2.

73 Guidance value (Bq/m3) for chronic airborne activity as specified in Annex 3 Column 11.

Annex 11

(Art. 201)

Amendments to other legislation

The ordinances below are amended as follows:

74

74 The amendments may be consulted under AS 2017 4261..

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden